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Left: HSI-RGB composites are shown with ROI of the tissue type 
outlined. Center: Respective histological gold standard with 
corresponding ROI outlined. Right: Artificially colored CNN 
classification results of the ROI only. True positive results 
representing correct tissue-subtype are visualized in blue, and false 
negatives are shown in red. Tissue within the ROI that is shown in 
grayscale represents tissue that is not classified due to glare pixels or 
insufficient area to produce the necessary patch-size. 
148 
Figure 6-6 HSI classification results ROC curves for HNSCC experiments 
generated using leave-one-out cross-validation. (c) binary 
classification of normal thyroid and thyroid carcinomas; (d) binary 
classification of MNG and MTC; (e) binary classification of MNG 
and classical PTC. 
149 
Figure 7-1 Histological images (101×101 pixel image-patches) showing 
anatomical diversity. Top: Patches of various normal structures, 
including chronic inflammation, stratified squamous epithelium, 
stroma, skeletal muscle, and salivary glands (from left to right). 
Bottom: Patches of SCC with varying histologic features: 
keratinizing SCC, keratinizing SCC with keratin pearls, basaloid 
SCC, SCC with chronic inflammation, SCC with hemorrhage (from 
left to right). 
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Figure 7-2 The ROC curves are shown for patch-level cancer detection (left) 
and slide-level cancer diagnosis (right) in the testing groups from all 
three datasets. The dotted gray line corresponds to random guess. 
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Figure 7-3 Representative whole-slide classification results. (a, b) Papillary 
thyroid carcinoma WSI from two patients. (c, d) SCC WSI from 
patients with tongue and retromolar trigone SCC. (e, f) Breast cancer 
metastasis to lymph node WSI from two patients. The cancer area is 
outlined in green on the H&E images, and the heat maps are shown 
of the cancer probability. 
170 
Figure 7-4 Heat maps representing cancer probability of several regions of 
interest. From left to right, the CNN correctly identifies salivary 
gland and muscular components as having a low probability of SCC; 
stratified squamous epithelium correctly shown as a true negative; a 
false positive area representing inflammatory infiltration near the 
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SCC border (not shown); correctly classified true positive SCC 
classified with a high probability of SCC. 
Figure 7-5 Representative, correctly-classified cancer image-patches from each 
dataset, visualized with cancer and normal components using the 
grad-CAM technique. The gradients were traced from the last 
convolutional layer before the inception modules to the cancer and 
normal logits separately to visualize contributions from cancer and 
normal features leading to a correct cancer prediction. (a) Breast 
cancer SLN metastasis image patch correctly classified as cancer 
with 58% probability. (b) Papillary thyroid carcinoma image patch 
correctly classified as cancer with 89% probability. (c) SCC image 
patch correctly classified as cancer with 99% probability. 
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Figure 7-6 Representative false negative resulting from slide scanning artifacts. 
This accounts for the misclassification result of the lowest 
performing WSI in the SCC test group. The left side of the WSI was 
a correct true positive classification (green box), but the out of focus 
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SUMMARY 
Surgeons performing routine cancer resections utilize palpation and visual 
inspection, along with time-consuming microscopic tissue analysis, to ensure removal of 
cancer. Despite this, inadequate surgical cancer margins are reported for up to 10-20% of 
head and neck squamous cell carcinoma (SCC) operations. There exists a need for surgical 
guidance with optical imaging to ensure complete cancer resection in the operating room. 
The objective of this dissertation is to evaluate hyperspectral imaging (HSI) as a non-
contact, label-free optical imaging modality to provide intraoperative diagnostic 
information. For comparison of different optical methods, autofluorescence, RGB 
composite images synthesized from HSI, and two fluorescent dyes are also acquired and 
investigated for head and neck cancer detection. A novel and comprehensive dataset was 
obtained of 585 excised tissue specimens from 204 patients undergoing routine head and 
neck cancer surgeries.  
The first specific aim of this thesis used SCC tissue specimens to determine if HSI 
has potential to perform surgical guidance in the challenging task of head and neck SCC 
detection. Currently, during SCC resections, several intraoperative pathology consultations 
are performed to investigate the excised tissues microscopically, which can take 20 to 45 
minutes each. Therefore, it is hypothesized that, if proven reliable, HSI could reduce time 
and provide quantitative cancer predictions. Deep learning algorithms have demonstrated 
success at image classification and segmentation tasks by extracting relevant features from 
extremely large training datasets to allow generalizable learning and classification ability. 
In the first specific aim of this thesis, state-of-the-art deep learning algorithms were 
developed for SCC detection at the registered cancer margin in excised tissue specimens. 
 xxiii 
The ground truth for the gross-level images was obtained from histology, which was 
demonstrated to be effective up to 2 mm, and a method to estimate cancer detection 
performance at several distances from the cancer margin was developed. Investigating all 
293 tissue specimens from 102 patients with SCC, HSI detected conventional type SCC 
with a median AUC score of 85% at 2 mm from the cancer margin. Evaluating performance 
of HSI by anatomical location demonstrated good SCC detection results in regions of the 
upper aerodigestive tract, such as the larynx (85% AUC score), oropharynx (95% AUC 
score), hypopharynx (78% AUC score), and nasal cavity (93% AUC score) at distances up 
to 2 mm from the cancer margin. To understand the ability of HSI for SCC detection, the 
most salient spectral features were calculated using gradients and correlated with known 
cancer physiology signals, notably oxygenated and deoxygenated hemoglobin. In 
conventional type SCC detection with HSI, the organ that produced the lowest results was 
the tongue, which may have been confounded by myoglobin signals. In HPV+ type SCC, 
autofluorescence imaging detected in tonsillar tissue with 91% AUC score, outperforming 
other modalities. The results of this aim indicate HSI may hold potential for guiding SCC 
resections. 
The second specific aim of this investigation was to evaluate HSI for tumor 
detection in thyroid and salivary glands. For comparing HSI to traditional RGB imagery, 
RGB images were synthesized from HSI using the spectral response curves of the human 
eye. Using deep learning and our dataset of 200 thyroid tissue specimens from 76 patients 
with thyroid cancer, HSI detected thyroid tumors with 86% average AUC score, which 
outperformed fluorescent dyes and autofluorescence. However, HSI-synthesized RGB 
imagery significantly outperformed HSI with 90% AUC score. To understand why this was 
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possible for thyroid tumors, the most salient spectral features were calculated using 
gradients and indicated that for thyroid tumors the visible spectrum is sufficient. The results 
overall showed that HSI along with other modalities can be used for developing thyroid 
tumor predictive algorithms successfully with deep learning. In salivary gland tumors, HSI 
demonstrated the best performance for tissue specimens from 3 patients with parotid gland 
tumors (92% AUC score), and autofluorescence performed best for tissue specimens from 
3 patients with tumors of other salivary glands (80% AUC score).  
In the process of surgical pathologist consultations, pathologists interpret many 
histological slides, and we hypothesize that a computer aided diagnostic tool can be created 
for assistance. The final aim of this investigation was to develop deep learning algorithms 
for head and neck cancer detection in hundreds of digitized histology slides made from the 
excised tissue specimens in this study. Slides containing any amount of SCC or thyroid 
carcinoma can be distinguished from entirely normal slides with 94% and 99% AUC 
scores, respectively. Additionally, the results demonstrated that SCC and thyroid 
carcinoma can be detected and localized within digital whole-slide histology images with 
92% and 95% AUC scores, respectively. The results of this aim indicate deep learning and 
digital histology could aid surgical pathologists. 
The outcomes of this thesis work demonstrate that HSI and deep learning methods 
could aid surgeons and pathologists in detecting head and neck cancers. Future steps 
necessary for streamlining deployment for potential clinical translation of HSI are outlined, 
including moving from ex-vivo to in-vivo acquisitions. Additionally, future steps needed 
for translation of deep learning for assisting surgical pathologists are outlined. In 
conclusion, the methods developed and presented for HSI and histological imaging are 
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valuable for the broader, medical optical imaging field and serve as an example for future 
studies and emerging modalities for optical surgical guidance. 
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CHAPTER 1. INTRODUCTION 
1.1 Background and Motivation 
Estimated cancer incidence world-wide in 2012 for cancers of the oral/nasal cavity, 
nasopharynx, oropharynx, hypopharynx, larynx, and thyroid combined was 1.4 million 
people newly diagnosed. This corresponds with an age-standardized incidence rate of about 
25 men out of 100,000 and 14 women out of 100,000 diagnosed in 2012 alone with these 
types of cancer [1]. Approximately 90% of cancer at sites including the lips, gums, mouth, 
palate, and anterior two-thirds of the tongue are squamous cell carcinoma (SCC) [2]. 
Significant risk factors for the development of these types of cancer are tobacco 
consumption, alcohol consumption, and infection with human papillomavirus (HPV) [3]. 
There were over 800,000 cancer deaths in 2012 from these types of cancer [1]. The 
diagnostic procedure of SCC typically involves physical examination and surgical 
evaluation by a physician, tissue biopsy, and diagnostic imaging, such as PET, MRI, or 
CT. The primary treatment for many cases of resectable SCC involves surgical cancer 
resection with potential adjuvant therapy, such as chemotherapy or radiation. For cases 
where routine surgery is the primary treatment modality, successful surgical cancer 
resection is required to prevent local disease recurrence and promote disease-free survival 
[4].  
The most common practice during surgery to identify cancer margins is frozen 
section analysis, which can take 20 to 45 minutes [5-7]. When determining negative and 
positive cancer margins, most studies on oral cavity and aerodigestive tract cancers 
typically use a threshold of normal tissue beyond the tumor site greater than 5 mm to define 
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margin adequacy [6]. Studies comparing disease recurrence using the 5 mm margin 
definition found that inadequate margins carry increased locoregional recurrence rates (30-
55%), compared to adequate, i.e. negative, margin recurrence rates (12-18%) [8-10]. 
Moreover, disease recurrence greatly affects likelihood for additional surgeries, reduced 
quality of life, and increased mortality rates [11]. Five recent studies, comprising 1,200 
patients, found that positive cancer margins significantly reduce disease-free patient 
survival rates, values reported from 7-52%, compared with disease-free survival rates of 
39-73% for cases where negative margins are achieved [8-10, 12, 13]. 
Hyperspectral imaging (HSI) is a non-contact and label-free optical imaging 
modality, which acquires a series of 2D images at hundreds of discrete wavelengths to 
capture both spatial information and a spectral signature of the target. Preliminary research 
demonstrates that HSI has potential for providing diagnostic information for a myriad of 
diseases, including anemia, hypoxia, cancer detection, skin lesion and ulcer identification, 
urinary stone analysis, enhanced endoscopy, and many potential others in development 
[14-25]. Supervised machine learning and artificial intelligence algorithms have 
demonstrated the ability to classify images after being allowed to learn features from 
training or example images. One such deep learning method, convolutional neural 
networks (CNNs), has demonstrated astounding performance at image classification tasks 
due to the capacity for robust handling of training sample variance and ability to extract 
meaningful features from large training data sizes [26, 27]. 
The need for an imaging modality that can perform diagnostic prediction could 
potentially aid surgeons with near real-time guidance during intra-operative cancer 
resection. If proven to be reliable and generalizable, this method could help provide intra-
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operative diagnostic information beyond palpation and visual inspection to the surgeon’s 
resources, perhaps enabling surgeons to achieve more accurate resections and biopsies, or 
as a computer-aided diagnostic tool for physicians diagnosing and treating these types of 
cancer. 
1.1.1 Preliminary Studies 
 Hyperspectral imaging has been applied successfully to a number of biomedical 
challenges. Preliminary research demonstrates that HSI has potential for providing 
diagnostic information for diseases, such as anemia and hypoxia, for example determining 
tissue oxygenation and altitude induced hypoxia [28]. Additionally, HSI has demonstrated 
potential for in-vivo and ex-vivo cancer detection, such as identifying residual cancer in 
the tumor bed from a multi-institute intraoperative brain cancer study and colon cancer 
identification [15, 18, 19, 22]. Moreover, HSI has shown advancements in identification of 
skin lesions, diabetic ulcers, and urinary stone subtyping [25, 29]. Because of the 
demonstrated ability of HSI for identifying diseases, we chose to implement it in our study 
for cancer detection in surgical specimens from head and neck cancer, a unique application 
of HSI that has not been explored before, and to construct an extensive patient database to 
address these problems. Before applying the methods to human surgical specimens, the 
work was first demonstrated by our lab in several animal models. 
 A previous Ph.D. student (G. Lu) also advised by Professor Fei developed the 
imaging protocol for SCC detection in a mouse model using HSI. Lu and Fei were the first 
to publish a comprehensive review on the use of HSI for biomedical application, which has 
been cited nearly 900 times [14], indicating the surge of research in the field. Specifically, 
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a subcutaneous cancer model was made using a xenograft of HNSCC cell line into mice, 
and a support vector machines (SVM) classifier was implemented with 89% accuracy 
(n=12 mice) when HSI are acquired through the skin on the back of the mouse [30]. 
Afterwards, intraoperative HSI were acquired after skin resection and tumor exposure in 
the same mouse model, and using an active-contour classifier achieved results of 97% 
accuracy for tumor detection, cross-validating with only 5 mice [31]. Next, a mouse model 
of neoplastic 4NQO-induced tongue carcinogenesis was adopted, and SVM classification 
of neoplastic versus normal tissue yielded an AUC of 0.84 for in-vivo HSI and 0.86 AUC 
for ex-vivo HSI, again using cross-validations [32].  Lastly, Lu et al. began the ex-vivo HSI 
head and neck cancer surgical specimen study in collaboration with Emory University 
Hospital Midtown. Prior to this thesis, Lu et al. published a single preliminary work on 
human, ex-vivo cancer detection using HSI classified with SVM in limited regions of 
interest (ROIs) from 6 thyroid and 20 HNSCC non-registered patients’ samples that 
achieved 86% accuracy for inter-patient validation and 91% accuracy for intra-patient 
validation, using cross-validations [33]. These works were done to establish the potential 
of HSI in a mouse model and to begin the process of evaluating HSI for ex-vivo human 
specimens. However, much more work remains to establish ground-truth registration for 
whole-tissue mapping and validation, complete investigation of more sophisticated and 
robust classification methods on a significantly larger dataset of patients, and to compare 
classification potential of HSI to other optical modalities and digitized histological images. 
1.1.2 Significance and Innovation 
 As discussed, in routine cases of resectable head and neck, complete removal of the 
cancer is required to achieve successful disease-free survival and reduce local disease 
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recurrence [8-10, 12, 13]. Hyperspectral imaging, a non-contact, non-ionizing, and label-
free optical imaging method, has demonstrated diagnostic potential that may aid surgeons 
with near real-time guidance during intra-operative cancer resection. If proven to be 
reliable and generalizable, we hypothesize the proposed method would add quantitative 
imaging to extend surgeons’ resources beyond normal palpation and visual inspection, 
becoming a candidate for clinical translation to the operating room.  
 The variability of HSI data is substantial both within and between patients and, 
therefore, must be calibrated to compare patients. Though classes of tissue may show 
significant differences on average, the large standard deviations of spectral signatures from 
classes of tissue require machine learning to make predictions about tissue class. Despite 
calibration, the machine learning algorithms implemented must be sufficiently robust to 
handle the variation of spectral signatures from different tissues of different anatomical 
sites that may occur within one type of carcinoma. To overcome these challenges, we 
propose utilizing deep learning with deep CNNs and hypothesize the results will solve 
these challenges to a clinically acceptable degree, performing well in a task where 
traditional, regression-based methods are limited. For this task, image registration is 
essential for creating an accurate ground truth to allow validation of deep learning for 
cancer detection in ex-vivo tissues, with potential for HSI to serve as intraoperative surgical 
guidance. Additionally, inspecting correct and incorrect classification results, we propose 
to analyze the weights and activations from the deep learning methods to reveal which parts 
of the optical spectra was used for making the decision; this will allow investigation inside 
the “black-box” of deep learning and correlation with cancer pathophysiology. Altogether, 
these results and developments will facilitate thorough investigation of HSI-based cancer 
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detection, and serve as a standard for ex-vivo gross-level imaging studies, within all areas 
of optical modalities. 
 Prior to this thesis study, for head and neck cancers, HSI has been demonstrated to 
have benefit in the animal model (n=12 mice), and was investigated in human surgical 
specimens with only a limited sample size (n=26 patients). This work aims to address the 
challenges and difficulties of cancer detection using human surgical specimens from head 
and neck cancers using a substantially large patient database (n=204), a thorough 
investigation of machine learning methods, and comparison of HSI to other optical imaging 
modalities. Evaluating HSI-based cancer detection on an extensive and comprehensive ex-
vivo patient database is an essential step to determine if the approach can be viable for 
clinical translation to intraoperative surgical guidance. 
 During surgical cancer resection, fresh frozen specimens are sent to the surgical 
pathology department to provide feedback on cancer margin status during surgery. 
Identifying cancer microscopically during intraoperative consultations can be challenging 
because of histological preparation and processing, time constraints, and the sheer volume 
of slides to make a final diagnosis. While we hypothesize that HSI could one day play a 
role supplying quantitative analysis to surgeons prior to resection, there is also a need for 
cancer detection in histopathological specimens. We hypothesize that a computer-aided 
diagnostic tool could be developed for assisting pathologists to quantitatively identify 
cancer is digitized histology slides made from surgical specimens. 
 To the best of our knowledge, this is the first work to identify head and neck cancer 
on histological images, which is only possible because of our extensive patient dataset. 
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Moreover, the results and developments of this work will establish a benchmark in the field 
for future work on computer aided diagnostics using histology. The major results and 
conclusions drawn from this thesis will help define the role and potential of artificial 
intelligence in the field of surgical guidance and digital pathology.  
1.2 Specific Aims 
 The objective of this work is to evaluate hyperspectral imaging (HSI) as a non-
contact, optical technique to further provide diagnostic information, for potential 
translation into the operating room. We hypothesize that label-free HSI will outperform 
autofluorescence, RGB composites, and fluorescent dye-based optical methods for the 
detection of head and neck cancer in ex-vivo fresh surgical tissue of human patients. In this 
thesis, we detail the HSI dataset obtained from 204 patients, a novel and comprehensive 
HSI database, and perform analysis using state-of-the-art deep learning methods, allowing 
thorough and complete investigation of cancer detection in ex-vivo surgical specimens of 
head and neck cancer. The results and outcomes of this comprehensive work demonstrate 
potential viability for clinical translation into intra-operative guidance systems. 
Specific Aim 1: Acquire a novel and extensive database of HSI from ex-vivo 
specimens obtained from H&N cancer patients undergoing surgery and develop and 
evaluate advanced image processing techniques. 
 (a) Construct a novel, comprehensive ex-vivo HSI database of 204 patients with 
head and neck cancer, including SCC and thyroid carcinomas. The dataset is investigated 
and detailed: patient demographics, clinical descriptors, and surgical pathology 
information. Imaging protocols to acquire reflectance broadband HSI, autofluorescence, 
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two dye-based fluorescence techniques, and standard RGB imaging. (b) A method for 
preparing accurate and reliable histopathological gold standards for HSI using a pipeline 
of rigid and deformable image registration is developed and evaluated. Serial sectioning of 
a few specimens is performed to understand variation of the cancer margin with depth. (c) 
Develop and analyze processing techniques with comparison of machine learning methods 
for the HSI data, including assessing image normalization techniques and performance 
degradation due to specular glare.  
 Impact: This aim establishes the data necessary for this investigation of HSI, which 
will draw conclusions about clinical potential. The processing and registration methods 
developed in this aim allow for inter-patient machine learning experiments and quantify 
the systematic error in using histology as the ground truth for gross-level ex-vivo tissue 
specimens. Investigation of specular glare and the variation of the cancer margin provide 
more information to facilitate thorough investigation of HSI-based cancer detection, and 
serve as a standard for future ex-vivo gross-level imaging studies with optical modalities. 
Specific Aim 2: Develop deep learning algorithms to classify head and neck 
cancer margins using HSI and optical imaging. 
 (a) Develop convolutional neural network algorithms for classification of optical 
spectral properties of ex-vivo tissue specimens, using HSI, autofluorescence, RGB 
composite imaging, 2NBDG dye, and proflavin dye-based imaging.  (b) Perform cancer 
detection in both whole tumor-only and normal-only tissues for baseline, ideal-case 
performance. Perform cancer detection at the registered tumor-normal margin and erode 
distances from the margin to identify how distance affects performance. The described 
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experiments will be performed in fully-independent patient groups for all 102 SCC patients 
and 82 thyroid cancer patients in the HSI database. Compare performance of optical 
imaging modalities. Additionally, intra-patient experiments will be performed, which 
simulates preliminary augmented surgical approach. (c) Investigate correct classification 
results to analyze CNN weights and activations from deep learning and correlate with 
cancer pathophysiology.   
 Impact: Expected results will demonstrate potential of HSI for intraoperative 
cancer detection and surgical guidance. Provide support for the hypothesis that HSI has a 
unique ability compared to optical imaging methods to capture full diagnostic, optical 
spectra that comprise biological properties of malignant neoplasms in multiple cancer types 
at difference anatomical locations. The comparison of optical imaging modalities for 
disease classification will guide which techniques have potential to be translated into intra-
operative guidance. Correlate CNN activation weights with theoretical optical features 
allows seeing inside the “black-box” of deep learning and provide physiological rationale. 
Specific Aim 3: Compare HSI outcomes to histology-based methods. Develop 
and evaluate deep learning classifiers for head and neck cancer detection on digitized 
histological images.  
 (a) Determine if HSI can provide sub-component classification for normal and 
cancerous tissues, similar to histological analysis, which provides more detail than just 
binary classification. (b) Using the digitized histological dataset of surgical specimens, 
develop CNN-based methods for classification. Implement and evaluate histological 
cancer detection for SCC and thyroid carcinoma in digitized whole-slide images. Develop 
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color and stain invariant approach for robustness. The objective is to create methods for 
(1) localizing the cancer within each slide and delineating with heat-maps, and (2) 
identifying slides with cancer from entirely normal slides. (c) Perform gradient tracing 
analysis to understand salient features from CNN-based decision making with clinical 
rationale. (d) Establish limitations of the proposed method.  
 Impact: This will be the first work to identify head and neck SCC on histological 
images using deep learning. Not only will this serve as a basis in the field for future work 
on SCC detection using histology, but it also provides a benchmark for comparison of the 
ability of HSI-based cancer detection methods, which use the exact same specimens. 
1.3 Thesis Overview 
 In this thesis work, the use of hyperspectral imaging was investigated for detection 
of excised human head and neck cancer specimens. Chapter 2 reviews the background and 
current literature available for hyperspectral imaging. Chapters 3-7 are reproductions of 
peer-reviewed, first-author journal manuscripts. Chapter 8 concludes the thesis with a 
summary of key findings, impact, and future research directions. 
 Chapter 2 is an extensive literature review on the studies utilizing HSI for cancer 
detection. It is a reproduction of the peer-reviewed manuscript, entitled “In-vivo and ex-
vivo tissue analysis through hyperspectral imaging techniques: Revealing the invisible 
features of cancer”, by Martin Halicek et al. 2019, which was published in the journal 
Cancers. 
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 Chapter 3 is a reproduction of the peer-reviewed manuscript, entitled 
“Hyperspectral imaging for head and neck cancer detection: Specular glare and variance 
of the tumor margin in surgical specimens”, by Martin Halicek et al. 2019, which was 
published in the Journal of Medical Imaging and describes machine learning, processing, 
and ground truth methods. It also contains excerpts from a conference proceedings by 
Martin Halicek et al. 2018 on image registration. 
 Chapter 4 is a reproduction of the peer-reviewed manuscript, entitled 
“Hyperspectral imaging of head and neck squamous cell carcinoma for cancer margin 
detection in surgical specimens from 102 patients using deep learning”, by Martin Halicek 
et al. 2019, which was published in the journal Cancers. This work details the complete 
investigation of HSI for SCC analysis, using all the SCC patients collected for this thesis 
divided into two cohorts, and compares the results of HSI with other optical imaging 
modalities. 
 Chapter 5 is a reproduction of the peer-reviewed manuscript, entitled “Tumor 
detection of the thyroid and salivary glands using hyperspectral imaging and deep 
learning”, by Martin Halicek et al. 2020, which was published in the journal Biomedical 
Optics Express. This work details the complete investigation of HSI for thyroid and 
salivary gland tumor analysis, using all the thyroid and salivary gland tumor patients 
collected for this thesis, and compares the results of HSI with other optical imaging 
modalities. 
 Chapter 6 is a reproduction of the peer-reviewed manuscript, entitled “Optical 
biopsy of head and neck cancer using hyperspectral imaging and convolutional neural 
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networks”, by Martin Halicek et al., which was published in the Journal of Biomedical 
Optics. It describes the use of HSI for sub-classification of normal tissue components and 
sub-classification of different thyroid tumors. 
 Chapter 7 is a reproduction of the peer-reviewed manuscript, entitled “Head and 
neck cancer detection in digitized whole-slide histology using convolutional neural 
networks”, by Martin Halicek et al. 2019, which was published in the Nature journal 
Scientific Reports. It describes the application of cancer detection in the digitized whole-
slide histological images prepared from the same tissue specimens used in the above HSI 
studies and previous chapters. 
 Chapter 8 is a summary of the key findings, limitations, future directions, and 
impacts of the research involved in this thesis work.  
 
Figure 1-1. Flowchart of the dissertation. 
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CHAPTER 2. LITERATURE REVIEW: HYPERSPECTRAL 
IMAGING FOR CANCER ANALAYSIS  
 In this first chapter, a current literature review of the state of hyperspectral imaging 
for cancer detection is provided. In contrast to conventional optical imaging modalities, 
hyperspectral imaging (HSI) can capture much more information from a certain scene, both 
within and beyond the visual spectral range (from 400 to 700 nm). This imaging modality 
is based on the principle that each material provides different responses to light reflection, 
absorption, and scattering across the electromagnetic spectrum. Due to these properties, it 
is possible to differentiate and identify the different materials/substances presented in a 
certain scene by their spectral signature. Over the last two decades, HSI has demonstrated 
potential to become a powerful tool to study and identify several diseases in the medical 
field, being a non-contact, non-ionizing, and a label-free imaging modality. In this 
literature review, the use of HSI as an imaging tool for the analysis and detection of cancer 
is presented. The basic concepts related to this technology are detailed. The most relevant, 
state-of-the-art studies that can be found in the literature using HSI for cancer analysis are 
presented and summarized, both in-vivo and ex-vivo. Lastly, we discuss the current 
limitations of this technology in the field of cancer detection, together with some insights 
into possible future steps in the improvement of this technology. 
2.1 Introduction 
 Hyperspectral imaging (HSI), also referred to as imaging spectroscopy, integrates 
conventional imaging and spectroscopy methods to obtain both spatial and spectral 
information of a scene [34]. Unlike conventional RGB (red, green, and blue) imaging, 
which only captures three diffuse Gaussian spectral bands in the visible spectrum (e.g., 
380–740 nm), HSI increases the amount of data acquired beyond the capabilities of the 
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human eye [35]. Hyperspectral (HS) sensors measure the aggregate signal of reflected, 
absorbed and emitted radiance at specific wavelengths of the material that is being 
observed. These sensors are capable of capturing a very large number of contiguous 
spectral bands (also called spectral wavelengths or spectral channels) across the 
electromagnetic spectrum (ES). Each pixel of an HS image, or average over a region of 
interest, has associated a specific vector of radiance values, commonly called spectral 
signature [34]. Image processing algorithms make use of these spectral signatures to 
automatically differentiate the materials observed by the sensor at each pixel [36]. These 
methods rely on the basis that different molecular compositions of each material present in 
nature have different responses to the incident light [34]. 
 HSI is a promising non-invasive and non-ionizing technique that supports rapid 
acquisition and analysis of diagnostic information in several fields, such as remote sensing 
[37, 38], archeology [39, 40], drug identification [41, 42], forensics [43-45], defense and 
security [46, 47], agriculture [48, 49], food safety inspection and control [50-52], among 
many others. Particularly, several studies can be found in the literature where HSI is 
applied to different medical applications [14, 53, 54]. It has been proven that the interaction 
between the electromagnetic radiation and matter carries useful information for medical 
diagnostic purposes [14]. As an alternative to other existing technologies for diagnosis, one 
of the strengths offered by HSI is being a completely non-invasive, non-contact, non-
ionizing and label-free sensing technique. In medical applications, this technology has been 
employed in several different areas such as blood vessel visualization enhancement [55, 
56], intestinal ischemia identification [57], oximetry of the retina [58-60], estimation of the 
cholesterol levels [61], chronic cholecystitis detection [62], histopathological tissue 
analysis, diabetic foot [63], etc. In recent years, medical HSI has started to achieve 
promising results with respect to cancer detection through the utilization of cutting-edge 
machine learning algorithms and increased modern computational power [14, 53]. 
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 In this literature review, the basis of the different HS acquisition systems is 
explained, as well as their applications to the different tissue sample analysis, followed by 
a brief presentation of the most common data processing approaches employed to process 
HS information. In addition, a brief introduction to the optical properties of cancer tissues 
and the current investigations performed in the literature to study and analyze in-vivo and 
ex-vivo cancer tissue samples using HSI are presented. 
2.2 Hyperspectral Imaging 
2.2.1 Hyperspectral Image Acquisition Systems 
 HSI sensors generate a three-dimensional (3D) data structure, called HS cube, 
where the spatial information is contained in the first two dimensions, while the third 
dimension encompasses the spectral information. Figure 2-1 shows the information 
structure of an HS cube. On one hand, each pixel of the HS image contains a full spectral 
signature of length equal to the number of spectral bands of the HS cube. On the other 
hand, a gray scale image of the captured scene can be obtained using any of the spectral 
bands that displays the spatial information provided by the image sensor at a particular 
wavelength. 
 
Figure 2-1. Hyperspectral imaging data. Basic structure of a hyperspectral imaging (HSI) 





Figure 2-2. Electromagnetic spectrum. HSI is commonly employed between the visible 
and the medium-infrared range. 
Depending on the type of sensor employed, HSI cameras will cover different 
spectral ranges. Figure 2-2 shows the partitioning of the entire electromagnetic spectrum 
(ES) and the range where HS images are commonly captured depending on the sensor type. 
Charge-coupled device (CCD) silicon-based sensors are sensitive in the visible and very 
near-infrared (VNIR) spectrum in the range between 400 and 1000 nm. The standard 
indium gallium arsenide (InGaAs) sensors are able to capture HS images in the near-
infrared (NIR) range, between 900 and 1700 nm, extending in some cases the upper range 
to 2500 nm. Other types of sensors can reach larger spectral ranges. For example, the 
mercury cadmium telluride (MCT) sensors are able to acquire HS images in the short-
wavelength infrared (SWIR) range, from 1000 to 2500 nm, being able also to reach 25,000 
nm in some specific systems [64]. 
HS cameras are mainly classified into four different types (Figure 2-3) depending 
on the methods employed to obtain the HS cube: whiskbroom (point-scanning) cameras, 
pushbroom (line-scanning) cameras, cameras based on spectral scanning (area-scanning or 
plane-scanning), and snapshot (single shot) cameras [50].  
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Figure 2-3. Hyperspectral camera types and their respective acquisition and data storage 
methods. (a) Whiskbroom camera; (b) Pushbroom camera; (c) Hyperspectral (HS) camera 
based on spectral scanning; (d) Snapshot camera. 
Whiskbroom cameras (Figure 2-3a) are characterized by capturing one single pixel 
at one time containing all its spectral information. The rest of the pixels of the scene are 
captured by scanning both spatial dimensions (x and y). Whiskbroom cameras have the 
main disadvantage of being very time-consuming during the image acquisition. However, 
they can achieve very high spectral resolutions, allowing researchers to perform a more 
detailed analysis of the spectral signature of the pixel that is captured.  
 18 
Closely related to the previous camera type, pushbroom cameras (Figure 2-3b) offer 
a faster scanning solution compared to whiskbroom, but also obtain high spectral 
resolution. In this case, the camera captures one line of pixels of the scene (y-axis) at one 
time. The other spatial dimension (x-axis) is obtained by moving the field-of-view (FOV) 
of the camera in that direction. Pushbroom cameras are the most common systems in 
remote sensing field and other industrial sectors due to their high spectral resolution, 
showing reduced capturing times with respect to the whiskbroom cameras. The main 
disadvantage of spatial scanning cameras is the presence of spatial aliasing if movement 
artifacts occur during the acquisition period [64]. 
On the other hand, HS cameras based on spectral scanning (Figure 2-3c) are able 
to obtain the entire spatial information (x-axis and y-axis) of the scene for a certain 
wavelength at one time, performing a scanning in the spectral dimension (λ-axis). These 
cameras can achieve high spatial resolutions and fast acquisition times; however, the 
spectral resolution is typically lower when compared to the spatial scanning (whiskbroom 
and pushbroom) cameras. One of the main disadvantages of spectral scanning cameras is 
that they are not suitable for capturing moving objects due to the time required to perform 
the spectral scanning, which would induce spectral aliasing artifacts. LCTF (Liquid Crystal 
Tunable Filter) and AOTF (Acousto-Optic Tunable Filter) HS cameras employ optical 
filters electronically controlled to filter each wavelength and generate the complete HS 
cube by performing a spectral scanning.  
Finally, there is an emerging type of HS camera that can provide hyperspectral 
video, having the lowest acquisition time and allowing the acquisition of moving objects 
without performing any spatial or spectral scanning. Snapshot cameras (Figure 2-3d) 
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capture the entire scene in a single shot that contains both the spectral and spatial 
information [65]. The main disadvantage of snapshot cameras is that the spectral and 
spatial resolutions are much lower with respect to the other camera types. 
In summary, the order of spectral resolution from highest to lowest is line scanning 
and point scanning being about equal, followed by spectral scanning, and snapshot. The 
order of spatial resolution from highest to lowest is spectral scanning, line scanning and 
point scanning being about equal, and snapshot. The order of fastest to slowest acquisition 
times is snapshot, spectral scanning, line scanning, and point scanning. The use of high 
spectral resolution HS cameras for cancer analysis allows researchers to study in detail the 
optical properties of the tissues, identifying the most relevant spectral channels that are 
involved in a certain application. On the other hand, the use of high spatial resolution HS 
cameras permits the analysis of samples by combining the spectral and the morphological 
properties of the tissue. Finally, HS snapshot cameras are the most suitable option for real-
time analysis situations, mainly when the analysis of in-vivo tissue is performed. In 
conclusion, the HS sensor type and acquisition system selected are highly application 
dependent. 
2.2.2 Hyperspectral Image Processing Algorithms 
An extensive literature is available on the classification of HS images [66]. 
Traditionally, HSI has been widely employed in the remote sensing field, so the majority 
of algorithms developed to classify HS images are related to this field [67]. However, more 
recently, HSI is progressively being used in other fields, such as drug analysis [68, 69], 
food quality inspection [70], or defense and security [71], among many others. That is why 
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the algorithms that were developed targeting remote sensing application have been adapted 
to classify different types of scenes. 
Pixel-wise classification methods assume that each pixel is pure or a mix of pure 
pixels and can be assigned to a certain material based on its spectral information [72-74]. 
Pixel-wise classification algorithms can be divided into two types: supervised classifiers 
and unsupervised classifiers (also called clustering or segmentation algorithms). 
Furthermore, in recent years, the use of deep learning (DL) approaches to classify HS data 
has become increasingly common, achieving excellent results when compared with 
traditional machine learning (ML) algorithms [75]. When applied to medical HSI data, 
these algorithms face two main challenges: the high dimensionality and the limited number 
of samples. However, these challenges are not necessarily present in other HSI domains, 
but are more prevalent in medical HSI because of substantial inter-patient spectral 
variability. 
The basis of supervised classification algorithms relies on training an algorithm on 
a set of spectral signatures with known class labels and using this trained model to assign 
new labels to unknown spectral signatures in a HS image. The training process of 
supervised algorithms must be performed with a library of spectral signatures where each 
type of signature has been identified with a certain membership class, with the goal that 
this library is sufficiently representative for generalization purposes. Moreover, regression-
based, statistical ML methods based on linear discriminant analysis, decision trees, random 
forest (RF) [75, 76], artificial neural networks (ANNs) [77-79], and kernel-based methods 
have been widely used to classify HS images. In particular, there are several types of 
kernel-based regression methods in the literature [80], where the support vector machine 
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(SVM) classifier is the most commonly used algorithm. In the HSI field, SVMs provide 
good performance for classifying this type of data when a limited number of training 
samples is available [80]. Due to its strong theoretical foundations, good generalization 
capabilities, low sensitivity to the problem of dimensionality and the ability to find optimal 
solutions, SVMs are usually selected by many researchers over other traditional, 
regression-based ML classification paradigms for classifying HS images [14]. As a 
relevant example, a variant of the SVM classifier, called fuzzy SVM classifier, was 
employed in the development of an emotion recognition system based on facial expression 
images [81]. In the medical field, SVMs have been used to detect multiple sclerosis in 
subjects, employing stationary wavelet entropy to extract features from magnetic 
resonance images used as inputs of the SVM classifier [82]. Furthermore, the same 
technique combined with a directed acyclic graph method has been used to diagnose 
unilateral hearing loss in structural MRI [83], demonstrating that the SVM algorithm is a 
reliable candidate to work with a variety of medical image modalities. Other relevant 
algorithms employed in HS classification problems with high dimensionality are linear and 
partial regression methods, such as partial least squares (PLS) and linear discriminant 
analysis (LDA), which are suitable for multivariate linear regressions with a large number 
of predictors; however, these perform well with small sample size, but may have problems 
generalizing to larger patient datasets [14].  
On the other hand, the goal of the unsupervised classifiers is to divide an image into 
a certain number of similar groups (also called clusters), where each group shares 
approximately the same spectral information and provides the correspondent cluster 
centroid [84]. Each cluster centroid represents a spectrum corresponding to a material in 
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the scene, while the membership functions provide the weights for these spectra. Unlike 
the supervised classifiers, unsupervised methods do not require a training process using 
labeled samples. For that reason, they cannot provide the identification of the class that 
each pixel belongs to, only relative clustering with no information about the material’s 
nature. Although unsupervised clustering does not provide any discriminant features by 
itself, it could be used to delineate the boundaries of the different spectral regions presented 
in an HS image. Unsupervised algorithms, such as the K-means algorithm [85, 86] and the 
Iterative Self-Organizing Data Analysis (ISODATA) technique [87, 88], are the most 
common clustering algorithms employed in the literature using HS data [66]. Hierarchical 
clustering is an unsupervised method of cluster analysis that seeks to obtain a hierarchy of 
clusters [89]. Several hierarchical clustering algorithms have been employed to classify HS 
images, such as Hierarchical Matrix Factorization [90], Hierarchical K-Means [91], and 
Hierarchical Spherical K-Means [92]. Some works based on HS analysis for medical 
applications use unsupervised clustering as part of the classification algorithms, such as 
those for colon tissue cell classification [93] or laryngeal cancer detection [94]. 
Deep learning (DL) techniques have been used for many applications of remote 
sensing data analysis, such as image processing, pixel-wise classification, target detection, 
and high-level semantic feature extraction and scene understanding [95]. Computationally, 
DL generates predictive models that are formed by several stacked processing layers with 
‘neurons’ that can activate with learned weights to discriminate different representations 
of data with multiple levels of abstraction. DL architectures can extract intricate features 
in large datasets through an iterative, error backpropagation approach that determines the 
gradients that lead to successful changes of internal parameters [96]. While conventional 
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machine learning techniques are limited in their ability to process data in its input form, 
DL methods can learn new mathematical representations from the input data required for 
detection or classification. These multiple levels of representation are obtained by non-
linear modules that modify the representation at one level (starting with the raw input) into 
a representation at a higher, slightly more abstract level, where very complex functions can 
be learned [96].  
Many DL frameworks have been applied to HS images in the literature. Of 
particular interest, convolutional neural networks (CNNs) [97, 98] have been employed to 
process and classify HS remote sensing data, improving upon the results obtained with 
conventional SVM-based algorithms [99, 100]. CNNs have also been employed to extract 
high-level spatial features from HS data in a spectral–spatial feature extraction algorithm 
for HS image classification [101]. In the medical field, DL is emerging in recent years as 
a powerful tool in the field of translational bioinformatics, imaging, pervasive sensing, and 
medical informatics [102]. As an example, deep neural networks (DNNs) and CNNs have 
been employed to classify electrocardiogram signals [103-105], detect retinal vessels [106-
108], classify colorectal polyps [109, 110], and cancer analysis [111, 112]. On the other 
hand, despite so much promise using DL techniques, the use of DL for medical HSI is 
recent [113] because of the large amounts of training data required, and currently there are 
not many medical HSI databases available. 
2.3 Cancer Optical Properties 
 The measured optical spectra of biological tissues from 400 to 1000 nm cover the 
visible and NIR regions and can be broken down at the molecular level, which greatly 
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contributes to the reflectance values measured in certain ranges. The hemoglobin (Hb) 
absorption and reflectance spectra vary substantially between the oxygenated and 
deoxygenated states, and Hb is a major spectral contribution of biological tissue in the 
range of 450 to 600 nm [114]. Deoxygenated Hb shows a single absorbance peak around 
560 nm, while oxygenated Hb shows two equal absorbance peaks around 540 and 580 nm 
[115]. The region of the NIR spectrum from 700 to 900 nm corresponds with the scattering 
dominant optical properties of collagen [116]. The NIR region is referred to as the 
scattering dominant region for biological tissues, mainly composed of fat, lipids, collagen, 
and water. The molecular contributions of absorbance at wavelengths in the typical HSI 
range are shown in Figure 2-4. The relationship of absorbance is inverse to reflectance 
measured by HSI systems. For a more detailed summary of the optical properties of 
biological tissue, the interested reader is directed to the canonical review by Jacques [117]. 
 
Figure 2-4. A few representative major molecular contributions to the absorbance at 
wavelengths of light typical for HSI investigations of biological tissue [117]. Reproduced 
with permission from [117]; published by IOP Publishing (2013). 
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Deal et al. investigated the contributions of normal and neoplastic colonic 
autofluorescence, which is the reflectance observed from the endogenous fluorescent 
molecules in biological tissue, using excitation wavelengths from 360 to 550 nm and 
emission at 555 nm, separated with a long-pass emission filter and dichroic beamsplitter 
[118]. Investigating neoplastic tissues, colorectal adenocarcinoma and adenomatous 
polyps, demonstrated that some autofluorescent molecules, such as elastin and 
nicotinamide adenine dinucleotide (NADH), had a significantly different abundance 
compared to normal colonic tissues, while other molecules, such as collagen, flavin adenine 
dinucleotide (FAD), and protoporphyrin IX (PPIX), showed no change between normal 
and neoplastic tissues. However, the authors acknowledge the limitation of performing 
their experiments with pairs of healthy and cancer from only nine patients and that non-
neoplastic normal tissue from a diseased colon may vary molecularly from normal healthy 
colon tissue in a subject devoid pathology. 
 Monte-Carlo (MC) methods applied to medical HSI use simulations of photons 
with random parameter perturbations to simulate the interaction of light and biological 
tissues. Herrmann et al. developed an MC simulation of HS illumination in the visible and 
NIR regions to study reflectance signals of a multi-layer model in silico with different 
blood volume and oxygen saturations per layer [119]. The authors confirmed the 
absorbance peaks of water at 1000 nm and reflectance ratios at 580/800 nm for Hb. 
Interestingly, the authors also contend that blood volume fractions of 5% and 10% are 
detectable at depths of up to 1 mm in the simulated biological tissue, but changes beyond 
this depth are likely not resolvable. Additionally, it is possible to correlate in vivo measured 
reflectance values from various cancers and healthy tissues to extract meaningful optical 
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tissue properties associated with distinct molecular components, such as collagen, keratin, 
and Hb, using an inverse-MC approach, which has been previously reviewed for its 
application to cancer diagnosis [120]. 
2.4 Medical Hyperspectral Imaging for Cancer Analysis 
In the previous sections, the basis of the HSI technology, the main algorithms 
employed to process this type of data and the optical properties of cancer tissue have been 
described. The following section is devoted to detail the state-of-the-art methods and 
primary research on the use of HSI within the medical field, focusing on cancer analysis.  
The primary research performed in the literature related to the use of HSI for cancer 
analysis can be categorized first by organ systems, next the type of tissue samples and 
experimental design (ex vivo, in vivo), and finally the type of subjects (human, animal). 
Moreover, in vitro studies will not be included in this review of state-of-the-art works for 
cancer detection.  
While it is possible to detail the investigations of HSI for cancer analysis altogether, 
HSI systems are not standardized, as different technologies were used in the following 
studies. Indeed, most of the studies work in the VNIR spectral region, employing CCD 
sensors. However, in some studies, the NIR region is also explored, requiring the use of 
InGaAs sensors. Halogen or xenon lamps are generally used as illumination systems for 
HSI applications, and sometimes optical fibers are used for light transmission to avoid the 
high temperatures produced by these types of light sources or to concentrate the light into 
a certain area. The main characteristics of the systems and analysis methods employed in 
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each study are presented in this literature review, sorted by the year of publication within 
each section. 
2.5 Head and Neck Cancer 
2.5.1 Clinical Need for HSI of Head and Neck Cancer 
Head and neck (H&N) cancers are the sixth most common cancer worldwide [139]. 
Approximately 90% of the cancers at origin sites of the upper aerodigestive tract, which 
includes the oral cavity, nasal cavity, pharynx, and larynx, are squamous cell carcinoma 
(SCC). There are several well studied risk factors for H&N SCC, including consumption 
of tobacco and alcohol and oral infection with human papilloma virus (HPV) [140]. 
Patients with SCC typically present it at an advanced stage (stage 3 or 4 disease) [141]. 
The mainstay treatment for SCC is surgical cancer resection. The single largest predictor 
of patient outcomes for SCC resection is the successful removal of the entire SCC from the 
surgical wound bed, referred to as negative margins. The presence of positive or close (less 
than 2 mm of tissue clearance) margins after surgery greatly increases the likelihood for 
locoregional disease recurrence and additional surgeries [142]. Surgeons rely on intra-
operative pathologist consultations with the surgical pathology department to ensure that 
negative margins are obtained through the use of frozen-section (FS) microscopic analysis 
of the resected specimens. Despite this, in the literature it is reported that up to 20% of 
patients will have a final diagnosis of positive or close margins despite having negative FS 
intraoperatively. Because of the difficulties in treating this challenging form of cancer, the 
estimated five-year survival rate of SCC is only 40 to 60% with treatment [143]. There 
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exists a great need to provide more near-real-time information and guidance to the 
operating head and neck surgeon. 
2.5.2 In-Vivo Animal Head and Neck Cancer 
Head and neck SCC was studied in-vivo using HS images from mice with SCC. 
The studies were performed in the VNIR range between 450 and 950 nm using a CRI 
system (Perkin Elmer Inc., Waltham, Massachusetts), which is comprised of a Xenon 
illumination source, LCTF, and a 16-bit CCD camera capturing images at a resolution of 
1040 by 1392 pixels and a spatial resolution of 25 µm per pixel. Lu et al. published several 
works in this field, where the tensor decomposition, PCA and KNN methods were 
employed to perform a feature extraction and automatic classification, achieving a 
sensitivity of 94% and a specificity of 91% in the discrimination of tumor and normal tissue 
[30]. Furthermore, the group also studied the tumor margin during the surgical procedures 
performing an in-vivo/in-vitro registration between the in-vivo HS images and the 
histological images to validate the results [144].  
On the other hand, their research has analyzed which pre-processing techniques are 
more suitable to compensate the variations of the environmental conditions during the 
acquisition inside an operating theatre [31, 145]. In the work published in 2015, a method 
based on the mRMR (maximal Relevance and Minimal Redundancy) algorithm was 
proposed to address the problem of glare that usually appears in the HS images, improving 
the sensitivity and specificity results to 94% and 98%, respectively. In addition, other 
techniques were studied, such as the use of a minimum-spanning forest (MSF) algorithm 
for an automatic classification and segmentation of the in-vivo HS images [146]. Figure 
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2-5 shows the results from the MSF algorithm applied to an HS image of an in-vivo mouse 
xenografted with a line of human head and neck SCC, obtaining an accurate identification 
of the head and neck tumor with respect to the gold standard. 
 
Figure 2-5. Result of the tumor identification using the Minimum-Spanning Forest method 
developed in [146]. (a) Synthetic RGB image of the original mouse; (b) Corresponding 
gold standard image; (c) Classification result obtained. Reproduced with permission from 
[146]; published by IEEE (2015). 
2.5.3 Ex-Vivo Human Head and Neck Cancer 
Active research into the application of HSI for H&N cancers is led by our group 
under professor Baowei Fei. Currently, all experiments explore H&N cancers including 
SCC and thyroid cancer in ex-vivo surgical tissue specimens and use the previously 
described CRI Maestro HS acquisition system in the VNIR spectral range, from 450 to 950 
nm, with a spatial resolution of 1392×1040 pixels (25 µm per pixel), capturing 91 spectral 
bands. 
In 2017, several works were published in this area with the goal of discriminating 
cancerous and non-cancerous tissue. Fei et al. achieved an accurate delineation of the 
boundaries between the normal and cancerous tissue using head and neck ex-vivo samples 
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compared with the histopathological results (Figure 2-6) [147]. The ensemble linear 
discriminant analysis (LDA) was employed to perform the classification, achieving an 
average accuracy, sensitivity and specificity of 90%, 89% and 91%, respectively, using 
oral cavity samples and an average accuracy, sensitivity and specificity of 94%, 94% and 
95%, respectively, using thyroid samples. Autofluorescence, fluorescence with 2-deoxy-2-
[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG) and proflavine images 
were also classified and compared with the HSI results, demonstrating that HSI offered 
better results over the other alternative reflectance-based imaging modalities (an 
improvement of more than 7% of accuracy).  
 
Figure 2-6. Preliminary results obtained in the tumor margin delineation for head and neck 
cancer [147]. After hyperspectral image acquisitions (top-left), the tissue was processed 
histologically, and tumor margins were outlined on the pathology image (bottom right) by 
a pathologist, which was used to validate the results of the classification (top-right). The 
average spectral curves are shown at the bottom left for each type of tissue, i.e., tumor, 
normal, and tumor with adjacent normal tissue. Reproduced from [147]; Creative 
Commons BY 4.0; published by SPIE (2017). 
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In addition, Lu et al. increased the number of patients (N=25) and performed a 
comparison using different machine learning classification approaches, reinforcing the 
conclusion obtained from the other study, where the ensemble LDA outperformed other 
traditional machine learning algorithms [33]. In this study, both intra-patient and inter-
patient classifications were performed, as well as different classifications using different 
spectral regions within the VNIR range (450–600 nm, 605–850 nm, 855–900 nm, and 450–
900 nm). Finally, the authors contend that the use of the entire spectral range (from 450 to 
900 nm) provides the best accuracy results. 
Recently, one of the first studies performed in the HS literature regarding the use 
of deep learning methods to classify HS images with the goal of distinguishing cancerous 
and non-cancerous tissue was performed by Halicek et al. [113]. The authors developed a 
CNN classifier to process the ex-vivo tissues from 50 different patients and compared the 
deep learning method with traditional machine learning approaches, demonstrating that 
CNNs outperform the traditional classifiers in this case. Additional works by Halicek et al. 
have not been summarized because the manuscripts are reproduced in full for this thesis in 
the following chapters and discussed in detail. 
Lastly, several works have investigated NIR HSI for SCC detection in tongue 
specimens only, using leave-one-patient cross-validations in a dataset of 14 patients. 
Trajanovski et al. 2019 incorporated a U-net for semantic segmentation of SCC in 14 
tongue specimens and achieved 0.93 validation AUC scores [148]. Using the same 14 
specimens of tongue SCC, Brouwer de Koning et al. 2019 found 84% sensitivity for visible 
(400 to 950 nm) and 77% sensitivity for NIR (950 to 1,700 nm) HSI; interestingly, 
combining visible HSI with NIR did not provide additional benefit [149].  
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2.5.4 In-Vivo Human Aerodigestive Tract Cancer 
A few studies can be found in the literature using HSI to analyze in-vivo samples 
of human subjects. Mainly, the studies are related to the use of endoscopic systems attached 
to an HS camera. In 2011, Kester et al. developed a customized real-time snapshot HSI 
endoscope system based on an image mapping technique and light dispersion that is 
capable of operating at frame rates of 5.2 fps, obtaining HS cubes of 48 bands in the visible 
range between 450 and 650 nm, with a spatial resolution of 100 µm [23]. Using this system, 
they were able to capture in-vivo tissue, resolving a vasculature pattern of the lower lip 
while simultaneously detecting oxy-hemoglobin. Figure 2-7 shows an example of the 
spectral signatures obtained by the system and the developed acquisition system. 
 
Figure 2-7. HS image example of the lower lip of a normal human acquired with the image 
mapping spectroscopy (IMS) endoscope developed in [23]. (a) RGB representation; (b) 
Spectral signature of the normal tissue pixel and a vein pixel; (c) Clinical setup of the IMS 
endoscope; (d) Miniature imaging end of the IMS endoscope; (e) Fiber optics of the IMS 
endoscope inserted into the instrument channel. Reproduced from [23]; Creative Commons 
BY 4.0; published by SPIE (2011). 
Another study was published by Jayanthi et al. related to the use of diffuse 
reflectance spectroscopy for early detection of malignant changes in the oral cavity [150]. 
The system was able to capture HS information within the visible spectral range (from 400 
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to 700 nm) based on a snapshot light dispersion technique, obtaining 40 different bands. 
They used PCA for dimensionality reduction and LDA for automatic classification of the 
data. They achieved sensitivity and specificity results higher than 95% in the discrimination 
between different lesions, such as normal/healthy, hyperplastic, dysplastic and SCC 
tissues. 
In 2016, laryngeal cancer was investigated by Regeling et al. using a flexible 
endoscopy coupled to an HSI system that was able to obtain HS images composed of 30 
bands in the visual spectrum between 390 and 680 nm [94]. This system was employed to 
obtain in-vivo HS images that required substantial image pre-processing, such as 
registration due to the patient’s heartbeat and noise removal due to specular reflections 
[151]. The images were registered using a rigid image-to-image registration based on 
normalized cross-correlation; the noise was reduced using the minimum noise fraction 
transformation; and the glare was detected using a customized method. For classification, 
a random forest (RF) algorithm was applied to distinguish between healthy and cancerous 
tissues, achieving an overall accuracy of 88%. 
Also in 2016, Laffers et al. employed a rigid HS endoscopic system to capture HS 
images between 390 and 680 nm of the oral cavity and oropharynx from 85 patients [152]. 
However, in this study they only took into consideration three patients, one of them used 
for training the algorithm and the other two for validation purposes. The classification 
results obtained using the RF algorithm were sensitivities of 61% and 43%, and specificity 
of 100% in the two validation patients. These reduced sensitivity values could be mainly 
produced by the low number of patients involved in the training of the classification 
algorithm, which would not correctly handle inter-patient variability for the training phase. 
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Finally, tongue cancer of in-vivo human samples was studied in 2012 by Liu et al. 
using HSI [153] (Figure 2-8). The HS system utilized was based on an acousto-optic 
tunable filter (AOTF), capturing 81 bands in the VNIR spectral range comprised between 
600 and 1000 nm. They developed a classifier based on the sparse representation method 
and compared the results obtained using traditional machine learning algorithms such as 
SVM and RVM (Relevance Vector Machine) classifiers. Sensitivity and specificity results 
of 91% and 94%, respectively, were obtained, increasing the accuracy by more than 4% 
with respect to the other two methods. 
 
Figure 2-8. Delineation of the tongue tumor region in [153]. Expert labeling (left) and 
classifier prediction of tumor regions (right). Reproduced from [153]; Creative Commons 
BY 4.0; published by MDPI (2012). 
 
2.6 Cancer of Other Organ Systems 
2.6.1 Gastrointestinal Cancer 
2.6.1.1 Clinical Need for HSI of Gastrointestinal Cancer 
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There are strong indications for endoscopy of the upper digestive tract and 
colonoscopy of the bowel for early detection of digestive tract cancers, with regular 
screenings for higher risk individuals [121]. Gastric carcinomas, most frequently caused 
by infection with helicobacter pylori or dietary contributions, are the second leading cause 
of cancer death globally. For the approximately two-thirds of gastric cancer patients that 
are diagnosed with locally advanced or metastatic disease, with a five-year survival of only 
10%, the only curative therapy remains surgical resection [122]. Colorectal cancers, mostly 
adenocarcinomas, are thought to arise mainly from secondary risk factors of dietary and 
lifestyle origins, such as excessive caloric and fat intake, smoking, and physical inactivity 
[123]. Laparoscopic surgeries, performed in a way that is minimally invasive and guided 
by endoscopy, have been shown to be clinically equivalent in randomized controlled trials 
[124]. However, during this minimally invasive surgery, there is a loss of tactile feedback 
that surgeons often require, so there is a need to overcome this lost information [125]. HS 
imaging has been proposed as a solution to this problem with potential for more accurate 
digestive tract cancer resections. 
2.6.1.2 Ex-Vivo Human Gastric Cancer 
In 2011, Akbari et al. performed a study to identify gastric tumors in human ex-
vivo tissues using an HS system, which was capable of capturing images in the range 
between 1000 and 2500 nm, obtaining 239 spectral bands [126]. An integral filter and the 
normalized cancer index (NDCI) was applied to perform an automatic classification of the 
tumor tissue determining the boundaries between tumor and normal tissue using 
histopathological analysis to validate their results (Figure 2-9). From their experiments, 
they determined that the spectral regions between 1226 and 1251 nm and 1288 and 1370 
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nm are the most salient ranges for distinguishing between non-cancerous and cancerous 
gastric tissue.  
 
Figure 2-9. Gastric cancer detection acquisition system, cancer detection results using the 
NDCI and integral filter, and comparison with histopathological results obtained in [126]. 
(a) HS acquisition system setup; (b) RGB representation of the ex-vivo sample; (c) Cancer 
enhanced regions using an integral filter in the hyperspectral image (1057–2440 nm); the 
tissues are shown in a blue to red spectrum, where the red regions represent the tumor; (d) 
Cancer enhanced regions using NDCI; (e) Pathological sectioning and results; (f) Detected 
tumor using an integral filter; (g) Detected tumor using NDCI. Reproduced with permission 
from [126]; published by Wiley (2011). 
In 2013, Kiyotoki et al. collected HS images in the spectral range comprised 
between 400 and 800 nm from ex-vivo tissue gastric samples to perform a preliminary 
study of gastroduodenal tumors removed by endoscopic resection or surgery from 14 
different patients [127]. The system was able to obtain HS images comprised of 72 spectral 
bands with a spatial dimension of 640×480 pixels. Using these images, they were able to 
determine the optimal wavelength that allowed the most accurate classification between 
tumor and normal mucosa using the cutoff point method at the 726 nm wavelength. The 
sensitivity, specificity, and accuracy obtained in the test samples were 79%, 92%, and 86%, 
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respectively. This work was expanded upon in 2015 by the same group, increasing the 
number of patients to 96 and performing the selection of the optimal wavelength using the 
Mahalanobis distance, which in this case was 770 nm [128]. Sensitivity, specificity, and 
accuracy results obtained were 71%, 98%, and 85%, respectively, demonstrating that the 
increment in the number of patients to analyze did not decrease the accuracy of the method. 
Although the classification method employed to distinguish the different types of samples 
was quite basic, the studies revealed promising results in the use of HSI as a diagnostic 
tool for gastric cancer. 
Baltussen et al. performed a study of laparoscopic HS imaging using two HS 
cameras collectively sensing between 400 and 1700 nm to distinguish normal fatty tissue, 
healthy colorectal mucosa, and adenocarcinoma in order to provide more diagnostic 
information back to surgeons, given the loss of tactile feedback during endoscopic 
procedures [129]. The authors utilized 32 patient samples to perform a three-class detection 
using quadratic SVMs of fat, muscle, and tumor, and obtained a tissue-level accuracy of 
88% and a patient-level accuracy of 93%. One limitation of the presented HSI technique 
was focusing only on muscle and fat as normal tissues, but the authors acknowledge that 
future work should involve the entire specimen. 
2.6.1.3 In-Vivo Human Colon Cancer 
HS endoscopic systems have been used to study in-vivo colorectal tumors in the 
literature. One of the main studies in this field was performed in 2016, when Han et al. 
used a flexible hyperspectral colonoscopy system based on a motorized filter wheel, 
capable of obtaining 27 different bands in the range comprised between 405 and 665 nm, 
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to discriminate between malignant colorectal tumors and normal colonic mucosa in human 
patients [130]. They used a wavelength selection algorithm based on the recursive 
divergence method to identify the most relevant wavelengths in the spectral range 
employed, demonstrating that HSI can be used in-vivo for outlining the disease region and 
enhancing the microvascular network on the mucosa surface. 
2.6.2 Breast Cancer 
2.6.2.1 Clinical Need for HSI of Breast Cancer 
Breast conserving surgery, also known as lumpectomy, with adjuvant radiation 
therapy, is the recommended surgical approach over traditional mastectomy without 
radiation for women diagnosed with early breast cancer. Women diagnosed with stage I or 
II breast cancer showed increased overall survival and disease-survival rates when treated 
with lumpectomy and radiation compared to complete mastectomy without radiation 
therapy, and this result was seen for all age groups and cancer types [131]. Successful 
breast conserving surgery is directly dependent on complete removal of the tumor mass 
with adequate margins, meaning there is a buffer of healthy tissue on the free cut edge. 
There is evidence to suggest that conservatively around 20% of women who undergo 
partial mastectomy have a final, post-operative diagnosis of positive margin status, which 
requires additional surgeries, with some studies reporting higher figures [132]. 
Intraoperative biopsies along with pathologist consultations are necessary tools to guide 
surgeons, but the need remains to provide more intraoperative diagnostic information with 
one potential solution being HSI. 
2.6.2.2 In-Vivo Animal Breast Cancer 
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One of the first and most relevant works performed using HSI to study breast cancer 
was performed in 2007 by Panasyuk et al. [133]. In this work, a HS system based on LCTFs 
was used to acquire HS images in the visual spectral range, between 450 and 700 nm and 
composed of 34 bands, during intraoperative surgery of 60 rats affected by an induced 
breast cancer. They generated classification maps, where different types of tissue including 
tumor, blood vessels, muscle, and connective tissue were clearly identified. Furthermore, 
comparison to the histopathological examination of the tumor bed yielded a sensitivity of 
89% and a specificity of 94% for the detection of the residual tumor by HS imaging. One 
of the limitations of this work was the use of light-emitting diode (LED) illumination in 
the HS acquisition system, which produced a non-standard spectral signature because LED 
light does not provide a uniform, broadband spectrum, such as that obtained by halogen or 
xenon light sources. 
McCormack et al. performed a study of mouse models of breast cancer that aimed 
to evaluate the use of in-vivo HSI for microvessel oxygen saturation (sO2) monitoring 
during surgical procedures, studying also the response of the microvessels to different types 
of treatments [134]. The HS acquisition system was based on LCTFs and a halogen lamp, 
capturing images in the spectral range between 500 and 600 nm and composed of 26 bands 
because the absorption levels of both oxy and deoxy-hemoglobin are known to peak in this 
range.  
2.6.2.3 Ex-Vivo Human Breast Cancer 
Breast cancer has also been studied using ex-vivo samples with the goal of 
automatically delineating the regions of interest (ROI) in the samples and classifying the 
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tumor and normal tissue samples. In 2013, two studies were published with both previously 
mentioned goals using an HS system capable of obtaining images in the spectral range 
between 380 and 780 nm. The study conducted by Kim et al. performed an automatic ROI 
detection based on contrast and texture information achieving a true positive rate and a true 
negative rate of 97% and 96%, respectively, similar to the results obtained in a manual 
segmentation (99% and 96%) [135]. In the study performed by Pourreza-Shahri et al., the 
authors performed a feature extraction (using the Fourier coefficient selection features 
method) and a dimensional reduction (using the Minimum Redundancy Maximum 
Relevance method) to the HS images and then performed an automatic classification, using 
the SVM classifier with the radial basis function (RBF) kernel, of the tissue samples, 
differentiating between cancerous and non-cancerous tissue [136]. Sensitivity and 
specificity results of 98% and 99%, respectively, were obtained, demonstrating that HSI is 
a powerful imaging modality that has potential for use in the aided diagnosis of breast 
cancer. Lastly, Kho et al. utilized a U-Net CNN to perform breast cancer detection and 
segmentation with two HS cameras, one in the visible and one in the NIR regions, which 
achieved successful results when combining both spectra [137, 138].  
 
2.6.3 Brain Cancer 
2.6.3.1 Clinical Need for HSI of Brain Cancers 
Brain tumors are categorized based on their histology and molecular parameters 
[154], with malignant gliomas the prevailing form of primary brain tumors in adults, 
causing between 2 and 3% of cancer deaths worldwide [155]. Surgery is one of the major 
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treatment options for brain tumors alongside radiotherapy and chemotherapy. 
Nevertheless, the surgeon’s naked eye is often unable to accurately distinguish between 
tumor and normal brain tissue as brain tumors infiltrate and diffuse into the surrounding 
normal brain. During neurosurgeries, it is frequent that too much normal brain tissue is 
taken out (called safety margin) or that tumor tissue is unintentionally left behind (called 
residual tumor). Several studies have demonstrated that the residual tumor is the most 
common cause of tumor recurrence, and it is a major cause of morbidity and mortality [156, 
157]. In contrast, over-resection of brain tumor tissue has been shown to cause permanent 
neurological damages that affect patients’ quality of life [158].  
Several image guidance tools, such as intraoperative neuronavigation, 
intraoperative magnetic resonance imaging (MRI), intraoperative ultrasound (US) and 
fluorescent tumor markers (for example 5-aminolevulinic acid, 5-ALA), are commonly 
used to assist surgeons in the delineation of brain tumors. Conversely, these technologies 
present several limitations. Intraoperative neuro-navigation is affected by the brain shift 
phenomenon [159], where the preoperative image link to the patient is affected by the brain 
deformation produced after craniotomy and durotomy. MRI significantly extends the 
duration of the surgery (between 20 and 75 min per image), generating a limited number 
of images and requiring special operating rooms [160]. On the other hand, US is 
inexpensive, real-time and unaffected by brain shift [161-163]. However, the use of US 
can lead to resection of histologically normal parenchyma. Finally, although 5-ALA is able 
to identify the tumor boundaries, it produces relevant side effects on the patient and should 
only be used for high-grade tumors [164, 165]. Thus, HSI can be a potential solution to 
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intraoperative margin delineation of brain tumors, being a label-free and non-ionizing 
imaging modality. 
2.6.3.2 In-Vivo Human Brain Cancer  
The goal providing intraoperative detection and delineation of brain tumors has 
been investigated by the European project HELICoiD (HypErspectraL Imaging Cancer 
Detection). Several studies have been performed to develop the HSI technology and 
machine/deep learning algorithms for in-vivo identification of the brain tumor margins [15, 
166-169]. 
The main goal of which was to use HSI to generalize a methodology to discriminate 
between normal and malignant tissues in real time during neurosurgical procedures [168]. 
For this purpose, an intraoperative demonstrator was designed and built with the aim of 
acquiring intraoperative HS images and processing them in real time to assist 
neurosurgeons during resection [167]. This demonstrator captured HS images in the 
spectral range comprised between 400 and 1700 nm in approximately 2 min using two 
pushbroom cameras, one in the VNIR range (400 to 1000 nm) formed by 826 spectral 
bands with a high spatial resolution of 1004×1787 pixels and another HS camera in the 
NIR range (900 to 1700 nm) formed by 172 spectral bands with a low spatial resolution of 
320×479 pixels. The HELICoiD brain cancer database is publicly available and consists of 
labeled samples from 33 HS cubes from 22 different patients [168]. Ravi et al. [15] 
investigated dimensional reduction approaches to evaluate and compare with a proposed 
modification of T-distributed Stochastic Neighbors (t-SNE). These methods were 
employed to generate three-band images from the HS cubes in order to provide high 
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contrast images used as inputs of a semantic segmentation classifier. In addition, due to the 
high dimensionality of the VNIR data, a pre-processing chain was proposed to reduce HS 
cubes to 129 spectral bands, which demonstrated increased performance for SVM-based 
methods [169].  
In 2018, Fabelo et al. presented a classification algorithm for HS brain cancer 
detection using a chain of supervised classification methods combining SVM, PCA and 
kNN to combine spatial and spectral information, and the final result was obtained by 
majority voting with an unsupervised segmentation method, k-means, to delineate tumor 
boundaries [169]. The results were quantitatively and qualitatively evaluated following an 
intra-patient cross-validation method, achieving specificity and sensitivity results higher 
than 98%. Figure 2-10 shows the synthetic RGB representations of the HS cube and the 
corresponding thematic maps obtained when using this algorithm for normal brain and 
brain affected by cancer. In the thematic maps, the tumor tissue is represented in red color, 
the normal tissue in green, the hypervascularized tissue in blue and the background in 
black. The classification results obtained demonstrated the capabilities of HSI in the 
identification of different types of tumors, not only high-grade gliomas.  
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Figure 2-10. HELICoiD demonstrator set-up and normal and cancerous brain image results 
obtained from the database employed in [167]. (a) HELICoiD demonstrator. (b) Synthetic 
RGB images and classification maps of the normal brain HS images. (c) Synthetic RGB 
images and classification maps of the cancerous brain HS images, with the brain tumor 
outlined in yellow. For classification maps, predicted normal brain tissue (green), cancer 
(red), hypervascularized tissue (blue), and background (black). Reproduced from [167]; 
Creative Commons BY 4.0; published by MDPI (2018). 
 
Lastly, in Fabelo et a. 2019, one of the latest studies related to the use of HSI for 
brain cancer presented a comparison between the use of SVM-based algorithms and deep 
learning approaches [166]. These experiments were carried out using only the glioblastoma 
tumor samples available in the database, 26 HS images from 16 patients, and performed 
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leave-one-patient-out cross-validation. The results obtained using deep learning 
architectures were promising, improving the accuracy of the tumor identification by ~16% 
with respect to the SVM-based algorithm results. However, these studies require a higher 
amount of data in order to validate the results obtained so far and also a clinical validation 
of the system should be carried out to assess it.  
2.7 Discussion 
Several questions that remain unanswered as we look back at hyperspectral imaging 
for cancer detection and analysis can be asked again. The best HS sensor for the clinical 
adoption of HSI necessary to make the leap from basic research to clinical translational 
medicine is unknown and debatable. The sensor is likely to be task specific. We have 
reviewed that line-scanning pushbroom HS acquisition systems produce higher spectral 
resolutions, but spectral scanning HS cameras allow for higher spatial resolution. For 
example, in clinical cases where real-time is not a critical issue but a higher spectral 
resolution is required, a pushbroom HS camera is appropriate, but in cases where there is 
need for faster acquisition and where fewer spectral bands are required, spectral scanning 
or snapshot HS cameras would work well. Traditional, regression-based algorithms may 
yield optimal performance and accuracy using only spectral signatures as inputs when the 
HS sensor exhibits high spectral resolution. However, there are certain tasks that also 
require interpretation of spatial information, and these types of tasks may require the use 
of a CNN or other method for contextual spatial information along with the spectral 
signatures. 
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Regardless of the sensors and HS acquisition system implemented, it is yet 
unknown which wavelength range of the electromagnetic spectrum is optimal for each 
application, and this could very well be again task specific. Most of the works reviewed in 
this article have been performed in the range of 400 to 1000 nm, broadly. Currently, as 
discussed in the HS sensor section, we appear to be lower-limited to 400 nm in the short 
wavelength range, but in the NIR and IR (infrared) range, it is possible to extend beyond 
1000 nm, as some works have investigated. As reviewed in Section 2.3, the optical 
properties of biological tissue vary in spectra. It could be useful to have HS cameras below 
400 nm for tasks sensitive to FAD (flavin adenine dinucleotide) or NADH. On the other 
hand, some tasks might require extending into the SWIR range for fat, water, or collagen 
analysis. Additionally, with regards to the broad-band spectrum, different algorithms that 
have been previously deployed and validated on other parts of the spectrum may not be 
generalizable in different ranges. It may happen that some algorithms work better 
compared with others for certain parts of the spectrum. For example, deep learning may 
have the potential to learn and tolerate more noise in the input signals, so a spectral range 
that contains more noise, either organic or systemic from the sensor, could be handled 
better by a CNN [140]. However, deep learning can be prone to over-fitting if there is 
insufficient data, and false negatives or positives can sometimes be predicted with 
exceptionally high confidence that the prediction is correct, which can lead to difficulties 
in interpreting the results. Therefore, it is conceivable that there are scenarios where 
traditional methods, such as SVM, may suppose the best choice for some specific works. 
There has been a wide variety of works performed both ex-vivo and in-vivo, but 
there are challenges, both known and unknown, in moving from the former to the latter. 
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Mainly, it is unknown whether ex-vivo HS data correlates well with in-vivo data. If an 
algorithm is trained on ex-vivo data, there is no guarantee that the algorithm can be 
generalizable enough to apply to in-vivo data for testing or for clinical use. What is more, 
it cannot be assured that the same algorithms would work for the same task when moving 
from ex-vivo to in-vivo. For example, the in-vivo data collection could degrade the quality 
of the HS data or induce artifacts from the patient and surgical environment, and this could 
result in a certain family of algorithms being less effective than others. Therefore, if this 
phenomenon was observed, then entire datasets of large numbers of ex-vivo patient data 
need to be re-collected if the system is adopted for in-vivo clinical use. 
Currently, several systematic limitations of general HSI hinder its use in the 
operating theater or in the clinic. The most obvious one from a user perspective will be the 
size of the machinery and apparatus. The imaging time, which can be up to one minute, 
can be another limitation. With the increased imaging time, there is more room for artifact 
induction due to reasons such as patient movement or instrumentation movement. In 
addition, there are several potential problems when imaging biological tissue. Because the 
light sources are so close to the HS sensors and the biological tissue is often wet, there is a 
problem with specular glare. The human body is not topographically uniform, so imaging 
a small area with changes in elevation can create inconsistent illumination of the scene or 
cast shadows. Aside from inconsistencies with illumination, this could lead to issues with 
the HS camera focusing on multiple imaging planes. It is difficult to forecast the effects of 
this on large-scale HSI, and this could lead to issues with reproducibility or false 
negative/positive results because of insufficient HS quality to produce an accurate and 
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reliable result. A level of quality control is necessary where the algorithms can 
automatically detect if the scene is not correctly captured to make an accurate prediction. 
In conclusion, the reviewed studies present promising results for a wide variety of 
cancer detection applications based on medical imaging and for surgical guidance. 
However, currently we are limited in the field of HSI by technology restrictions and small 
datasets. The preliminary results warrant further research across all organ systems to 
determine if HSI has a place in the operating theater or in the clinic. Since HSI is non-
contact, non-ionizing, non-invasive, and label-free, it is an attractive imaging modality with 
great potential. Most importantly, like all future translational technologies, HSI needs to 
be evaluated to demonstrate that it can be reliable, reproducible, and generalizable before 
it takes its place in medicine. The following chapters of this thesis work will explore HSI 
and deep learning on sufficiently large patient datasets, performing the crucial comparisons 
with RGB imaging and other forms of optical imaging. 
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CHAPTER 3. HYPERSPECTRAL IMAGING OF HEAD & NECK 
CANCER EX-VIVO TISSUE SPECIMENS: REGISTRATION, 
SPECULAR GLARE, AND VARIANCE OF THE TUMOR 
MARGIN 
 In this chapter, the necessary pre-processing and machine learning approaches for 
SCC detection using HSI is evaluated with a subset of ex-vivo surgical specimens. 
Additionally, the registration method and effectiveness of histological ground truths for 
gross-level ex-vivo specimens are developed and evaluated. Several machine learning 
methods are investigated, including convolutional neural networks (CNNs) and a spectral-
spatial classification framework based on support vector machines (SVMs). Quantitative 
results demonstrate that additional data pre-processing and unsupervised segmentation can 
improve CNN results to achieve optimal performance when the training dataset is small. 
The methods are investigated in two paradigms: with and without specular glare. 
Classifying regions affected by specular glare degrade the overall performance, but the 
combination of the CNN probability maps and unsupervised segmentation using a majority 
voting method produces better results if the training data is limited. It is well known that 
different wavelengths of light used in HSI have different penetrate depths into biological 
tissue. Cancer margins may change with depth and create uncertainty in the ground-truth. 
Through serial histological sectioning, the variance in cancer-margin with depth is 
investigated and paired with qualitative classification results. Through compounding error 
of registration and depth variability, the validity of the ground truth may be limited to 1-2 
mm. This chapter focuses on the study of specular glare, registration, pre-processing, and 
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margin variation to provide better understanding of the potential of HSI for use in the 
operating room. 
3.1 Introduction 
 Head and neck cancer is the 6th most common cancer world-wide, with majority of 
cancers of the upper aerodigestive tract, comprising the oral and nasal cavities, pharynx 
and larynx being squamous cell carcinoma (SCC) [2]. Approximately two-thirds of SCC 
patients present with advanced disease, either stage III or IV [141]. Surgical resection is 
the primary management of SCC of the aerodigestive tract, potentially with concurrent 
chemo-radiation therapy depending on the extent of the disease [4]. The local recurrence 
rates for SCC cases depend on the successful removal of the cancer. For surgeries with 
negative cancer margins, the local recurrence rate is 12-18%, compared to local recurrence 
rates up to 30-55% if positive cancer margins are determined [8-10]. Moreover, positive 
cancer margins have a greatly reduced disease-free survival, with estimates ranging from 
7 to 52%, compared to disease-free survival rates of 39-73% for negative margins [12, 13]. 
Disease recurrence greatly affects likelihood for additional surgeries, reduced quality of 
life, complications from surgery, and increased mortality rates [11].  
 Hyperspectral imaging (HSI) is a non-contact optical imaging modality capable of 
acquiring a single image of potentially hundreds of discrete wavelengths. Preliminary 
research demonstrates that HSI has potential for providing diagnostic information for 
various diseases [14]. Preliminary studies from our group show that HSI combined with 
machine learning may yield diagnostic information with potential applications for surgical 
use in head and neck cancers [33, 170-172]. Fabelo et al. have demonstrated the need and 
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utility of HSI for in-vivo brain cancer detection and developed a visualization system that 
could lead to near-real-time guidance by using and machine learning-based classification 
algorithm [166, 167, 169]. Moreover, the use of deep learning techniques to process the 
same dataset was study, demonstrating that they outperforms the traditional machine 
learning methods [166]. Many applications of HSI for gastrointestinal procedures have 
been explored, including anatomical organ identification, anastomosis and ischemia 
classification, and cancer detection [173]. Recently, the implementation of HSI for guided 
colorectal surgery as a replacement for tactile information lost in laparoscopic surgeries 
has been explored in an ex-vivo study, and Baltussen et al. demonstrated that HSI could 
distinguish between normal healthy colon wall and colorectal adenocarcinoma [129]. 
Much work has been explored in head and neck HSI as well. Salmivuori et al. detailed the 
assistance of HSI in ill-defined, cutaneous basal cell carcinomas of the head and neck, and 
the authors contend that HSI offers clinical utility in more accurately assessing margins 
[174]. Farah et al. demonstrated that narrow band imaging (NBI) at green (400–430 nm) 
and blue (525–555 nm) visible light could reveal the extent of oral SCC under white light 
[175]. Non-encoding portions of RNA called micro-RNA function to regulate the 
expression of DNA [176]. Moreover, Farah et al. obtained micro-RNA and mRNA 
expression levels from both the primary tumor core and near-tumor normal tissues; it was 
determined that NBI spatially correlated with tumor-like expression levels in detecting the 
abnormality in near-tumor normal tissues [177, 178].  
 Machine learning methods, including support vector machines (SVMs) and 
convolutional neural networks (CNNs), the latter being an implementation of artificial 
intelligence, have demonstrated near human-level ability for image classification tasks [26, 
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27]. These experiments have been conducted on gross-level HSI acquired of ex-vivo tissues 
specimens from patients undergoing surgical cancer resection. However, HSI uses 
wavelengths of light that can penetrate different depths into biological tissue, so it is 
possible that the superficial cancer margin may change with depth and create uncertainty 
in ground truth, which is used to obtained evaluation metrics for these experiments. 
 Selected previous works from our group performing head and neck SCC detection 
in ex-vivo samples from the upper-aerodigestive tract used only single class tissue 
specimens (purely tumor or normal tissues) to demonstrate classification potential with 
HSI [113, 179]. Lu et al. 2017 incorporated tumor-involved cancer margin specimens from 
head and neck SCC, but these methods were implemented on selected ROIs of normal and 
tumor near the margin [33]. Therefore, the AUCs reported for head and neck SCC detection 
thus far from our group ranges from 0.8 to 0.95, but these results may be limited to ROIs 
or single class tissues. Similarly, Manni et al. 2019 used ROIs from tumor-margin 
specimens from 7 patients with tongue SCC and obtained an AUC of 0.92 [180]. 
Weijtmans et al. 2019, developed a deep learning architecture that separately extracts 
spectral and spatial features from HSI, a dual-streamed approach, also validated on 7 
patients with tongue SCC; the proposed model performed better with both feature streams 
(AUC of 0.90) compared to individually [181]. A few works have investigated SCC 
detection at the actual cancer margin; Halicek et al. 2018 performed SCC detection at the 
cancer margin, upon which the proposed method in this paper expands, but this previous 
work was limited by ignoring regions of specular glare [182]. Trajanovski et al. 2019 
performed semantic segmentation with deep learning of entire ex-vivo tissue specimens 
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with excellent validation performance (AUC of 0.93) on gross specimens of the cancer 
margin from 14 tongue SCC samples [148].  
 This study aims to investigate the ability of HSI to detect SCC in surgical specimens 
from the upper aerodigestive tract using several distinct machine learning pipelines. 
Additionally, another objective of this work is to investigate the limiting factors of HSI-
based SCC detection, including specular glare, noise and blur, and uncertainty in the 
ground truth due to changes in superficial cancer margin with depth, all of which must be 
thoroughly explored to understand the potential of HSI in the operating room. A 
preliminary version of this work was presented at the 2019 SPIE Medical Imaging 
Conference [182]. The new contributions of this journal paper include a proposed 
algorithm combining deep learning and unsupervised machine learning, additionally five 
testing patients have been serially sectioned to reveal changes in the cancer margin. This 
work expands upon previous cross-validation experiments with CNN-only methods on our 
H&N dataset to include multiple machine learning pipelines involving CNNs and other 
state-of-the-art methods. The proposed methods are tested on five HSI from five SCC 
patients, and the accuracy of the corresponding ground truths from these five tissues are 
discussed in detail along with potential directions for incorporating the outcomes of this 
work to improve future studies with HSI for cancer detection. 
3.2 Methods 
3.2.1 Experimental Design 
 In collaboration with the Otolaryngology Department and the Department of 
Pathology and Laboratory Medicine at Emory University Hospital Midtown, head and neck 
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cancer patients undergoing surgical cancer resection were recruited for our hyperspectral 
imaging studies. Written and informed consent was obtained from all patients before 
acquiring surgical tissue specimens for inclusion in our study, which was used for research 
purposes only and de-identified by a clinical research coordinator. The experimental 
methods and protocols were approved by the Institutional Review Board at Emory 
University. In previous studies, we have evaluated the efficacy of using HSI for optical 
biopsy of head and neck tissues [147, 170]. Excised tissue samples of head and neck 
squamous cell carcinoma (HNSCC) and normal tissue were collected from the upper 
aerodigestive tract sites, including tongue, larynx, pharynx, and mandible. Three tissue 
samples, with approximate size of 10×10×3 mm, were collected from each patient: a 
sample of the primary tumor specimen, a normal tissue sample, and a sample at the tumor-
involved cancer margin with adjacent normal tissue; these specimens were scanned with a 
HSI system [33, 113].  
 In this study, we selected 26 tissue specimens from 12 patients with moderate to 
poorly differentiated primary SCC of the upper aerodigestive tract for this analysis, 
including primary origin sites of the larynx, pharynx, tongue, floor of mouth, alveolar 
ridge, buccal mucosa, and maxillary sinus. The patients were divided into two groups, 
cross-validation and testing groups. The first 7 patients and corresponding 21 tissues 
samples were collected early in the course of this project that met the criteria of having the 
ideal distribution of tumor, tumor-normal and normal tissues, and were used for evaluating 
quantitative results, expanding from previously published results with this group of patients 
[172]. Additionally, 5 tumor-involved margin tissue specimens from 5 patients acquired at 
the end of the data collection period were selected to comprise the testing group. These 
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tissue specimens were selected because they had approximately equal amounts of cancer 
and normal tissue in each specimen and were verified by the collaborating pathologist as 
of interest to undergo serial histological sectioning through the depth of the tissue. These 
5 patients’ tissues were classified using models trained from the first 7 patient cross-
validation group (following a leave-one-patient-out cross-validation method), and these 5 
patients’ results are presented qualitatively to compare with the variability in the superficial 
cancer margin. 
3.2.2 Hyperspectral Imaging 
 Hyperspectral images were acquired of ex-vivo surgical specimens using a 
previously described CRI Maestro imaging system (Perkin Elmer Inc., Waltham, 
Massachusetts), which captures images that are 1,040 by 1,392 pixels and a spatial 
resolution of 25 µm per pixel [113, 145, 170, 183]. Each hypercube contains 91 spectral 
bands, ranging from 450 to 900 nm with a 5 nm spectral sampling interval. The HS data 
were normalized by a standard white-dark calibration normalization, which involved 
subtracting the inherent dark current from the measured spectra and dividing by a white 
reference spectra for all wavelengths sampled for all pixels [145, 170]. Figure 3-1 shows 
the RGBs, grayscale images at representative bands, and spectral signatures of the patients’ 
HSI data. The grayscale images at selected bands highlight the choice of the cutoffs due to 
noise at the ends of the broadband spectrum. The HSI was used to construct RGB 
composite images by implementing a Gaussian function centered on each color component 
of the spectrum: red (625 to 700 nm), green (520 to 560 nm), and blue (450 to 490 nm). 
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Figure 3-1. Two representative tissue specimens from different patients. Left: spectral 
signatures of SCC and normal ROIs are shown for both patients in (a) and (b). The HSI-
RGB composite images and selected spectral bands are shown to highlight the noisy band 
cutoffs during pre-processing. Binary ground-truth masks including glare regions, 
generated by only removing patches centered on specular glare is shown; binary ground-
truth mask excluding glare regions, generated by sufficient area to extract 25×25 patches 
and avoiding specular glare (white: SCC, and normal: grey). 
3.2.3 Histological Imaging 
 To obtain a ground-truth labelling for the tissue specimens imaged with HSI, tissues 
were inked after imaging to preserve orientation, fixed in formalin, paraffin embedded, 
sectioned from the top of the imaging surface, haemotoxylin and eosin (H&E) stained, and 
digitized using a Hamamatsu Photonics NanoZoomer at 40x objective (specimen-level 
pixel size, 0.23 μm). The ex-vivo tissue sections were reviewed by a board-certified 
pathologist with expertise in H&N pathology, and the cancer margins were annotated 
directly on the slide using digitized histology in Aperio ImageScope (Leica Biosystems 
Inc, Buffalo Grove, IL, USA).  
 There exists the possibility for substantial deformation of the histological images 
during processing relative to the HSI setup. The registration challenges are explored using 
a deformation-based image registration pipeline of the histological image with known 
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registration landmarks, and an error of 0.5 mm for SCC tissues was calculated [184]. For 
the cross-validation group patients in this work, the histological images were automatically 
registered using this deformable registration pipeline to produce the HSI ground truth. 
However, to calculate the error of histology ground truths for HSI in millimeters, a more 
accurate registration is needed than the automated approach. For the testing group patients, 
since each had 6 histological slices, we manually registered each histological image using 
mutual landmarks to the HSI that were serially sectioned to reduce error. 
3.2.4 Deformable Registration Pipeline 
 A binary mask is created from the HSI RGB composite image. A binary mask is 
also created from the histological image. These two binary masks are used as the input of 
the registration algorithm that was implemented with MATLAB (MathWorks Inc, Natick, 
MA, USA). A flowchart of the proposed registration method is shown in Figure 3-2. For 
samples with needle-bored holes, the average target registration error (TRE) was calculated 
from the center of the needle-bored hole after registration. An affine registration is 
performed using rotation, translation, and scale to produce a non-reflective similarity 
transformation [185]. This step is necessary to get the histology mask approximately 
aligned to the neighborhood of the HSI mask. If the affine registration is not sufficient by 
visual inspection, an optional control-point registration is applied using control-point pairs 
selected from the tissue edges of the masks. The control-point registration is implemented 
by a local weighted mean of inferred second degree polynomials from each neighboring 
control-point pair to create a transformation mapping [144, 186].  
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 Demons registration is based on an analogy to Maxwell’s demons, in which every 
pixel in an image is an effector with a force, referred to as a demon, in total used to create 
a deformation field. A free-form deformation is made from the individual displacements 
of the complete grid of effectors (demons) in an image, and a Gaussian filter is applied to 
smooth the image and to create a regular displacement field [187]. The displacement field 
is determined by points scattered along the contours of binary masks. This process is 
performed iteratively, and the displacement of each effector at each iteration is calculated 
using optical flow, which represents small displacements derived from diffusion model 
behavior [187, 188].  
 The demons registration method was applied in the deformable registration pipeline 
[187]. After the affine and control-point based registration, the transformed histology mask 
is registered to the HSI mask using deformable demons registration with an accumulated 
field smoothing value of 0.5 for five pyramid levels with one thousand iterations per 
pyramid level [187].  
 To evaluate the efficacy of the proposed registration methods, 17 tumor-margin 
tissue samples from 11 HNSCC and 6 thyroid cancer patients were registered. Dice 
similarity coefficient (DSC) was calculated by measuring the overlap of the histological 
and HSI mask. Target registration error (TRE) was calculated using both needle-bored 
holes in samples when available and tissue landmarks visible between gross and histology 
to obtain an average Euclidean distance representing error [144]. The TRE and DSC were 
calculated for each tissue sample, and averages were obtained for both groups. 
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Figure 3-2. Flowchart of the proposed registration method for histological cancer margins 
to HSI of surgical tissue specimens. 
3.2.5 HSI Binary Ground-Truth 
Specular glare is detected in each spectral band by fitting a gamma distribution to 
the pixel intensities of that band. Next, the top 1% of intensities are identified in this 
distribution, and any pixels with intensities of these bins are identified as specular glare. 
There were two types of specular glare observed: near-infrared (NIR) and visible, which 
usually were spatially independent. Visible glare occurs between 450 to 790 nm, and NIR 
glare occurs after 800 nm, which can be seen in the selected bands in Figure 3-1. A pixel 
was identified as a specular glare pixel and removed if there was glare identified using the 
distribution method in any spectral band from 490 to 790 nm. This range was selected 
because bands before and after this range were removed during pre-processing. NIR glare 
is observed beyond this range, so it is not relevant. 
Binary masks are constructed from the histological images and used to construct 
the ground truth for HSI in two methods. The first method is to investigate only ideal 
quality pixels, which is constructed by avoiding HSI regions with a large amount of 
specular glare. For the ground-truth mask avoiding glare, only regions that contain 
sufficient area to extract 25×25 spatial patches without any specular glare are included. 
The second method is to investigate the degrading effect of specular glare on classification 
accuracy. For the ground-truth mask including glare regions, the entire tissue area is 
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included for patch-making, but the top 1% of glare pixels are identified by fitting a gamma 
distribution to pixel intensities, such that no patches are centered on a glare pixel. A binary 
mask of the specular glare pixels was generated, and patches were produced automatically 
using this mask in the regions around the specular glare. Figure 3-1 shows an example of 
the two masks generated from two different patients. Both masks will be used for 
evaluating quantitative testing results and are referred to as ‘ground-truth mask excluding 
glare’, and ‘ground-truth mask including glare’, respectively. The specular glare pixels are 
represented by the black pixels within the first mask in the middle. The automatic patch-
making process can be seen to avoid the regions of specular glare shown in the second 
mask on the right of Figure 3-1. 
3.2.6 Effect of Sectioning Depth on Cancer Margin Ground-Truth  
HSI uses wavelengths of light in the visible and near-infrared spectrum that can 
penetrate different depths into biological tissue. It possible that the cancer margin may 
change with depth and create uncertainty in the classification results because of the variable 
penetration of the HSI broad-band spectrum. To investigate this, additional histological 
sectioning was performed on 5 tumor-involved margin tissue specimens (see Figure 3-3).  
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Figure 3-3. Representative tissue specimen that underwent serial histological sectioning to 
evaluate cancer margin variation with tissue depth. Left to right: HSI-RGB composite 
image; first histological slice (the green outlined area is the pathologist annotation of the 
SCC region); combined merged image of the 6 binary masks from the 6 histological images 
(cancer shown in white, normal in gray); merged image of the SCC contours from the 6 
histological images. The two rightmost images are used to depict the total variation of the 
cancer margin. 
During histological sectioning, it is standard procedure to discard the first sections 
until the first good quality section is obtained that contains the entire perimeter of the tissue 
specimen. The five specimens used for additional histological sectioning were retroactively 
enrolled for serial sectioning, so it was unknown what initial depth of tissue was discarded 
in the first sections before the first to obtain the first good quality slice. In discussion with 
the pathology laboratory technician, who performed the histological sectioning, and 
through observation of specimen sectioning, it was estimated that approximately 100-200 
microns were discarded on average during initial sectioning before obtaining the first high-
quality, tissue-encompassing slide.  
To produce serial histological sectioning further into the depth of the tissue 
specimens, the thickness of the remaining paraffin embedded tissue was estimated. The 
microtome used for this study produced slices at 5 microns, so the number of additional 
sections was documented and the distances of additional depth could be measured. From 
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the sectioned surface, which corresponds to the top of the tissue that was optically imaged, 
five more sections were obtained, up to 300 microns further into the depth of the tissue, by 
discarding non-included slices. The extent of the additional serial sections were obtained 
for 100 to 300 microns beyond the first good quality slice; the exact values for the five 
tissue specimens’ total additional sectioning depths were 100 microns, 150 microns, 200 
microns, and 300 microns, depending on the unique tissue specimen. Therefore, the 
combined total estimate of additional sectioning is approximately 200 to 500 microns into 
the tissue depth from the original HS image surface. Penetration depth depends on the 
tissue composition and wavelength of light. This sectioning depth was investigated because 
it represents the effective penetration depth for biological tissue in the shorter wavelengths 
of HSI used, which correspond to the most relevant features for HSI classification, such as 
hemoglobin between 550 to 600 nm [189-191]. 
3.2.7 Machine Learning Techniques 
3.2.7.1 Data Pre-processing 
A further pre-processing chain was applied to the data mainly to reduce the noise 
in the spectral signatures (Figure 3-4) and compared with the standard white-reference 
calibration. The machine learning methods detailed below were tested with and without the 
following pre-processing steps. The proposed pre-processing chain is based on 4 steps: 
image calibration, operating bandwidth selection, noise filtering, and data normalization. 
In the first step, the previously described method to normalize the data using white 
reference and dark current is performed. Next, the spectral bands are truncated between 
490-790 nm, so the final HS cube contains only 61 bands, which will be used for 
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classification. Spectral bands outside this range were noisy because they were too close to 
the detectable limits of the HS camera. In the third step, a smoothing filter is applied to the 
data in order to reduce the spectral noise. A moving average with a span of 10 spectral 
bands was used as the smoothing filter, implemented as a sliding low-pass filter with 
coefficients equal to the reciprocal of the span. Finally, each pixel’s spectral signature is 
normalized between 0 and 1, using a function to map the minimum and maximum to these 
values.  
 
Figure 3-4. Block diagram of the proposed pre-processing chain. 
3.2.7.2 Convolutional Neural Networks 
A deep convolutional neural network was used to detect SCC in the ex-vivo 
specimens of the upper aerodigestive tract, implemented using TensorFlow in Python on a 
NVIDIA Titan-XP GPU [26, 27, 172, 192]. In summary, an Inception-V1-style 3D CNN 
was designed and trained using leave-one-patient-out cross-validation [27]. The 3D 
convolutional kernels that comprised the modified 3D inception V1 modules were of sizes 
1×1×1, 3×3×3, and 5×5×5, and in total, the CNN architecture contained 2 inception 
modules, 3 convolutional layers, and 2 fully connected layers using the 3D patch input size 
of 25×25×91 (height × width × spectral bands) for un-processed HSI patches and 
25×25×61 for pre-processed HSI patches. The total number of HSI samples in the cross-
validation group was 647,000 normal HSI pixels and 877,000 cancer HSI pixels, calculated 
from the binary masks excluding glare, from the 21 tissue specimens from 7 patients. Each 
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HSI pixel served as the center for an image patch (height × width × spectral bands). Drop-
out was employed to avoid over-fitting in the CNN models.  
In total, the CNN described was separately trained using 4 different scenarios using 
the information from two versions of the binary ground truth masks and the two proposed 
processing methods, which produces different models: first, CNN trained without specular 
glare patches (trained separately both with and without added pre-processing of spectral 
data), and second, CNN trained with specular glare patches (trained separately both with 
and without added pre-processing of spectral data). The 95% confidence intervals were 
calculated using a bootstrapping method by sampling 1000 pixels from each class with 
replacement from each patient and calculating the area under the curve (AUC) of the 
receiver-operator characteristic; the method was performed 1000 times for each patient and 
the 2.5 and 97.5 percentiles were reported. The saved, trained models from the patients 
from the previous work were used to classify the HS images of the 5 testing group patients 
that underwent serial histological sectioning for surgical margin variation with depth 
evaluation. The probabilities of all models were averaged per patient to obtain qualitative 
probability heat-maps, scaled from 0 to 1, where 0 represents normal class and 1 represents 
high probability that the tissue belongs to the cancer class.  
3.2.7.3 HELICoiD Algorithms 
The results of the CNN classification method and the generated probability maps 
were compared to the results obtained by a machine learning pipeline previously developed 
for intraoperative detection of brain cancer using HSI [15, 167, 193-195]. In summary, a 
spatial-spectral classification algorithm, here referred to as HELICoiD (Figure 3-5a), was 
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implemented using a classification map obtained by a SVM classifier that is spatially 
homogenized by employing a combination of a one-band-representation obtained from the 
first principal component analysis (PCA) decomposition through a K-nearest Neighbors 
(KNN) filtering method (Figure 3-5a, part A). After that, the result of the KNN filtering is 
merged with an unsupervised segmentation map generated by a hierarchical K-means 
(HKM) algorithm through a majority voting (MV) method [169]. The result of this 
algorithm is a classification map that includes both the spatial and spectral features of the 
HS images. In addition, for this application, the KNN filtering is applied again to the MV 
probabilities and the PCA one-band-representation to homogenize the results (Figure 3-5a, 
part B).  
 
Figure 3-5. Block diagrams of the proposed classification frameworks. (a) HELICoiD 
algorithm with the additional KNN filter. (b) Pipeline of the mixed algorithm. 
A component of the HELICoiD algorithm was isolated and referred to as spatial-
SVM, which uses both the spectral and spatial components of HSI for machine learning 
through a combination of PCA+SVM+KNN. This spectral-spatial implementation of SVM 
is performed with and without the additional pre-processing pipeline to be used as a 
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surrogate for direct comparison to the CNN with and without pre-processing. Furthermore, 
a pipeline that combines the CNN architecture with the entire HELICoiD algorithm was 
proposed. In this case, the spatial-spectral stage of HELICoiD (PCA+SVM+KNN) is 
replaced by the CNN architecture trained with the pre-processed data (Figure 3-5b). Both 
HELICoiD and CNN+HELICoiD algorithms use the pre-processed HS data as input. 
In summary, we present 6 algorithms for investigation of HSI machine learning: 
the CNN (with and without pre-processing), the spatial-SVM (with and without pre-
processing), the HELICoiD algorithm, and finally the CNN+HELICoiD algorithm. These 
6 machine learning algorithms were tested first on the group of experiments using the 
binary ground truth masks that exclude specular glare, and again the experiments were 
performed with the binary ground truth masks that include specular glare. The 6 algorithms 
were compared using box plot distributions of the values and median AUC with 95% 
confidence intervals, and, a paired, one-tailed t-test on the classification results was used 
to determine statistical differences with a 0.05 threshold for significance. The quantitative 
classification results of 7 patients are reported in Table 3-2, obtained by using leave-one-
patient-out cross-validation. In addition, like the CNN method, the saved, trained models 
from these patients were used to classify 5 tissue specimens that were imaged with HSI 
and underwent serial histological sectioning for cancer margin variability evaluation. The 
probabilities of all models were averaged per patient to obtain qualitative probability heat-
maps, scaled from 0 to 1, where 0 represents normal class and 1 represents high probability 




3.3.1 Deformable Registration from Histology to HSI 
Seventeen patient tissue samples were registered according to the described methods, 
divided into two groups: HNSCC (n=11) and thyroid (n=6). As a representative patient, 
Figure 3-6 shows a glossal SCC cancer margin with a needle-bored hole for TRE 
evaluation. 
 
Figure 3-6. Results of affine and deformable demons registration of the cancer-normal 
margin on glossal SCC tissue sample with needle-bored holes. The cancer margin is 
outlined by a head & neck pathologist. The transformed margin from affine registration is 
outlined in yellow, and the margin from demons registration is outlined in green. The fixed 
HSI mask (green) and moving histology mask (magenta) overlap area is shown white. The 
TRE for this sample is evaluated using needle-bored holes shown on the masks in the center 
column. The deformation fields of the registration methods are shown on the right. 
Affine registration alone of the representative tissue samples is insufficient to 
establish the cancer margin on the HSI, but the Demons-based method achieved successful 
alignment. Table 3-1 shows the complete experimental results. For the HNSCC group only, 
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Demons registration produced better matched images (TRE of 0.43 ± 0.16 mm) with more 
consistent results between tissue samples compared to affine registration alone (TRE of 
0.51 ± 0.23 mm). Moreover, the result for HNSCC Demons registration was statistically 
significant (p=0.02) compared to affine, using a one-tailed, paired Student’s t-test. In 
addition, for HNSCC, the proposed deformable pipeline had a better image overlap 
compared to affine alone, DSC of 0.98 versus 0.93, which was also statistically significant 
(p<0.001). 
 
Table 3-1. Targeted registration error (TRE) and Dice similarity coefficient (DSC) for the 
registration between hyperspectral images and digitized histological images.   
Group Registration Method TRE (mm) DSC (%) 
HNSCC Affine 0.51 ± 0.23 93 ± 2 
N=11 Deformable Demons 0.43 ± 0.16* 98 ± 2* 
Thyroid Affine 0.92 ± 0.45 91 ± 2 
N=6 Deformable Demons 0.98 ± 0.42 98 ± 2* 
*Statistically significant compared to affine registration (p<0.05) 
 
The efficacy of both registration methods, affine and Demons, differed significantly 
for the thyroid group. On average the error for Demons registration of thyroid samples 
(TRE of 0.98 ± 0.42 mm) was comparable with affine registration alone (TRE of 0.92 ± 
0.45 mm). However, the proposed deformable pipeline had a better image overlap for 
thyroid samples compared to affine alone, DSC of 0.98 versus 0.91, which was statistically 
significant (p<0.001). However, Demons registration did not show an advantage over 
affine registration for the thyroid samples.  
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Using a one-tailed, unpaired Student’s t-test, the results of average error for HNSCC 
Demons registration were compared to thyroid sample Demons registration, and the result 
was statistically significant (p<0.001). This indicates that the registration of thyroid 
samples induces a substantially larger amount of error when compared to HNSCC samples, 
most likely due to less structural integrity of the glandular thyroid tissue. 
3.3.2 Comparison of Machine Learning Methods with Specular Glare 
Quantitative results from the leave-one-patient-out cross-validation, using both the 
ground-truth regions that include glare pixels and the sub-sampled masks that include only 
ideal quality regions that exclude glare, show that the CNN-based classifier group 
outperformed the SVM-based classifier group using the average area under the curve 
(AUC) of the receiver operator characteristic (ROC), as shown in Table 3-2 and Figure 
3-7. The results are reported using seven-fold cross-validation to validate on all 7 patients.  
Table 3-2. Results of inter-patient cross-validation of SCC versus normal, obtained using 
the leave-one-patient-out method. Average AUCs reported with bootstrapped 95% 
confidence interval. 
Ground Truth Classifier Average AUC [95% CI] 
Excluding Glare spatial-SVM 0.71 [0.68, 0.74] 
 CNN 0.86 [0.82, 0.89] 
 spatial-SVM (Pre-processed HSI) 0.82 [0.80, 0.84] 
 CNN (Pre-processed HSI) 0.84 [0.81, 0.86] 
 HELICoiD (Pre-processed HSI) 0.82 [0.79, 0.84] 
 CNN+HELICoiD (Pre-processed HSI) 0.82 [0.79, 0.85] 
Including Glare spatial-SVM 0.69 [0.67, 0.71] 
 CNN 0.73 [0.71, 0.76] 
 spatial-SVM (Pre-processed HSI) 0.76 [0.74, 0.77] 
 CNN (Pre-processed HSI) 0.78 [0.76, 0.81] 
 HELICoiD (Pre-processed HSI) 0.79 [0.77, 0.81] 
 CNN+HELICoiD (Pre-processed HSI) 0.81 [0.80, 0.83] 
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When classification is performed of only ideal quality pixels (obtained from the sub-
sampled mask; see Figure 3-1), the results indicate that additional pre-processing of the 
spectral signature and addition of the HELICoiD method and KNN filtering do not 
significantly improve the results compared to only using the CNN, see Figure 3-7a. The 
average AUCs for the CNN groups are 0.86, 0.84, and 0.82 for the CNN, CNN with pre-
processed input data, and CNN+HELICoiD method, respectively. The average AUCs for 
the SVM-based groups are 0.71, 0.82, and 0.82 for the spatial-SVM without and with 
preprocessed input data, and HELICoiD method, respectively. The 95% confidence 
intervals overlap for all groups except for basis spatial SVM, as shown in Table 3-2. 
Additionally, all methods have a similar interquartile range and median distribution, see 
Figure 3-7. 
 
Figure 3-7. Results of inter-patient cross-validation of SCC versus normal, obtained using 
the leave-one-patient-out method. Top: average AUCs reported with 95% confidence 
interval. Bottom: box plots with the range in black, 75th and 25th percentile in blue, and 
median in red. 
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However, when the classification is performed over the entire HS image tissue area, 
which includes classification of specular glare pixels that contain more noise and 
variability, the CNN+HELICoiD method outperforms other methods tested with an 
average AUC of 0.81 for classification. This classification scheme including specular glare 
pixels represents a more realistic application of HSI. The CNN algorithm alone with or 
without pre-processing has an average AUC of 0.78 and 0.73, respectively, both which 
constitute a statistically significant decrease in performance compared the 
CNN+HELICoiD method (𝑝 = 0.03 and 0.04, respectively). The average AUC values 
range from 0.69 to 0.79 for the SVM-based groups, and the HELICoiD algorithm 
significantly outperforms the spatial SVM (𝑝 = 0.01). The additional pre-processing 
pipeline, described in Figure 3-4, only offers a statistically significant increase in 
performance for the spatial-SVM algorithm (𝑝 = 0.02), not the CNN (𝑝 = 0.1); see Table 
3-2 for complete results with 95% confidence intervals. In summary, from cross-validation 
experiments, the best classification method was using the CNN as the input for the 
HELICoiD+KNN filtering method, and for comparison, using the spectral-spatial 
SVM+PCA+KNN for input to the HELICoiD algorithm instead of the CNN component 
yielded slightly lower results that were not statistically significant.  
3.3.3 Variance of the Tumor Margin with Depth 
For generalization and application, HS images from five tissue specimens from five 
patients with SCC comprised the hold-out testing group and were classified using the saved 
models that were trained and cross-validated using the 7 patient cross-validation group. 
The testing patients were classified by all cross-validation models and averaged to obtain 
qualitative probability heat-maps. Qualitative investigation of the five, testing patients, 
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classified with the CNN trained with pre-processed data alone, and the 
CNN+HELICoiD+KNN filtering method is shown in Figure 3-8. As shown in Figure 3-8, 
the CNN+HELICoiD+KNN technique performs better on the 5 testing patients, in 
agreement with the quantitative metrics from the cross-validation group. The SCC 
probability heat maps are shown with binary masks depicting the uncertainty and variation 
in the cancer margin with depth. Depending on the tissue, as demonstrated, the margin 
changes by about 1 mm depending on sectioning depth. Therefore, our qualitative results 
can be interpreted within the range of uncertainty of the ground-truth to provide more 




Figure 3-8. Representative results of binary cancer classification of the 5 testing patients. 
From left to right: HSI-RGB composite; histological ground truth showing variation in 
cancer margins with cancer area outlined; heat maps for cancer probability for CNN-
HELICoiD+KNN and HELICoiD+KNN techniques. The extremes in the superficial cancer 
margin are overlaid on to the heat maps. 
3.4 Discussion 
In this work, we presented and quantified the combination of two state-of-the-art 
machine learning-based classification methods for HSI of ex-vivo head and neck SCC 
surgical specimens. In summary, there are two methods for generating SCC prediction 
probability maps: the first uses a CNN, and the second uses a combination of 
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SVM+PCA+KNN. After generation of the predicted cancer probabilities on a pixel level, 
the probability map is combined with a HKM unsupervised segmentation layer through a 
majority voting algorithm that determines the class belonging of the region of interest. 
Therefore, two distinct methods are compared using leave-one-patient cross-validation to 
obtain quantitative evaluation metrics. Additionally, the methods are tested on a group of 
HSI obtained from 5 SCC patients that underwent serial histological sectioning to evaluate 
the variation in the cancer margin with penetration depth of the light wavelengths. 
The quantitative results of this paper suggest that when working with ideal quality 
pixels, such as the spectral signatures generated from flat surface tissue surfaces with no 
glare, the CNN techniques and spatial-spectral machine learning algorithms will perform 
with no significant difference and that no additional pre-processing is necessary. The 
average AUCs for these methods using the pre-processed input data range from 0.82 to 
0.86 with overlapping confidence intervals. However, when the pixels classified contain 
noise, for example due to sloping of the tissue edges or specular glare from completely 
reflected incident light, additional spectral smoothing and additional HELICoiD+KNN 
filtering of the classifier improve classification results of the CNN. The best performing 
method tested was CNN+HELICoiD+KNN with an average AUC of 0.81 [0.80, 0.83]. 
These tested methods outperform the traditional spectral-spatial machine learning methods 
employed in this study. Therefore, the HELICoiD+KNN techniques using both the CNN 
and SVM+PCA+KNN for cancer probability maps performed best for the 7 cross-
validation patients, so both were employed on the 5 patients testing set. One major 
limitation of the approach used in this paper was the small sample-size, and therefore, the 
proposed ML models could be prone to overfitting and lack generalization to larger testing 
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datasets. To investigate potential overfitting in this experiment, we analyzed the training 
and cross-validation accuracies for the CNN trained with pre-processed HSI data. The 
average training accuracy was 85%, and the average cross-validation accuracy with 
confidence interval was 79% [78, 81] for excluding glare and 74% [73, 76] for including 
glare. This result indicates that our models did not suffer substantially from overfitting. 
Excluding glare, the CNN alone without pre-processing performs best. It is 
hypothesized that CNN and deep learning methods should be expected to outperform 
traditional ML techniques because a substantially large dataset should allow learning of 
variance, tolerance of noise, and remove the need for pre-processing. Also, the 
CNN+HELICoiD method performs only slightly better than the original HELICoiD; this 
could be produced because the CNN probability maps are out-weighted by the PCA and 
KNN filtering that are applied afterwards. After the inclusion of specular glare, the results 
change relative to each method, with the CNN with pre-processing out-performing the 
CNN without pre-processing. This outcome could be the result of the classification 
problem becoming more challenging compared to excluding glare, so the dataset is now 
too small for the CNN to perform well without pre-processing. Expanding the training 
dataset with more patients with specular glare and large amounts of noise may allow 
original CNN methods to outperform other techniques. 
In order to test the general application of the proposed methods, HSI from 5 testing 
group patients with SCC were classified using the models that were trained and cross-
validated using the 7 patient group. To qualitatively investigate these results, histological 
images of the 5 ex-vivo tissue specimens were obtained down to about 0.3 mm to determine 
how the superficial cancer margin may change with depth. As shown in Figure 3-8, the 
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CNN+HELICoiD+KNN technique performs best on the 5 patient SCC testing group, 
which was the same result obtained from the 7-fold quantitative cross-validation 
experiment.  
The 5 patients’ tumor-involved margin specimens were classified with the CNN 
trained with the fully pre-processed image patches that were extracted from the complete 
binary ground-truth mask including specular glare pixels. These probability maps are 
shown in Figure 3-8, and the CNN map is also used as the input for the HELICoiD+KNN 
filtering technique. In the top three rows of Figure 3-8, there are regions of glare with tissue 
specimens that are classified incorrectly as normal with the CNN, but the CNN+HELICoiD 
correctly classifies these regions of interest as SCC. It is also possible to observe that the 
CNN+HELICoiD method tends to over-predict SCC at regions of normal tissue near the 
cancer margin. We hypothesize that the CNN+HELICoiD technique outperforms the 
patch-based CNN alone because it can incorporate more local and regional spatial and 
spectral information to overcome the degrading effect of specular glare. Therefore, future 
work could involve the application of a fully-convolutional CNN for SCC detection on 
tissues with specular glare. This algorithm requires more data necessary for training as it 
produces labels that are end-to-end, a full pixel classification map for a full HSI input, so 
it would require the entire HSI dataset acquired for this project. 
An additional aim of this investigation was to determine the variation of the 
superficial cancer margin through the depth of the tissue. From the 5 testing patient tissue 
specimens, it can also be seen that the superficial cancer margin of the ex-vivo tissue 
specimens can vary from the extreme near and far margins in range of 1 to 2 mm. These 
results allow interpretation of the cancer prediction probability maps with observed 
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variation in the ground truth. However, additional possible uncertainty may exist in the 
histological ground-truth. For example, if the angle of the sectioning plane is skewed from 
the tissue plane, then the ground-truth could be warped, which could lead to errors that 
cannot be corrected by deformable registration. In a previous work, we explored a pipeline 
of affine and deformable demons-based registration for alignment of the histological 
ground-truth to gross-level images of specimens, and it was determined via needle-bored 
control points that target registration error was 0.4 ± 0.2 mm [184]. The combination of 
these two main sources of uncertainty in the histological ground-truth for the ex-vivo tissue 
specimens allows for error propagation of up to 2.5 mm in the binary mask. This would 
greatly affect the results of pixel-wise evaluation metrics such as accuracy, sensitivity, and 
specificity.  
 Future work includes development and implementation of a new performance 
evaluation method to handle this margin uncertainty, for instance evaluating primary tumor 
clearance at several millimeter increments from the ideal tumor margin. Currently, the 
standard for surgeons’ opinions on margin adequacy is 5 mm for head and neck SCC, with 
margins between 1 to 5 mm defined as ‘close margins’ [196]. However, some studies 
suggest that outcomes may be similar for margin of 2.2 to 5 mm [197]. It is evident that 
the question of margin adequacy is still being determined, and surgeons would be interested 
in performance of optical imaging methods at different margin distances. Therefore, the 
proposed, new error metric should extend to about 2 to 3 mm. Figure 3-9 demonstrates how 
the cancer-margin could be systematically eroded and used to determine accuracies at 
several distances from the cancer margin to better provide surgeons and physicians with a 
method for interpreting results for HSI studies, given the conclusions of this paper on the 
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uncertainty of the cancer-margin. The outcomes of this work suggest the use of this new 
error metric for future studies.  
 
Figure 3-9. Proposed evaluation metric demonstrates millimetric, systematic cancer-
margin erosion that could provide performance updates at several distances from the cancer 
margin to provide physicians with an easily interpretable method for understanding results 
of HSI studies. 
 Another avenue of future work involves the rethinking of the definition of normal 
tissues in the tissue specimens of the tumor-involved margin. In oral SCC, it has been 
studied that normal tissue directly adjacent to the primary SCC is molecularly distinct from 
normal tissues farther from the SCC, and additional resection to this extended margin may 
lead to increased disease-free survival and reduced local recurrence [177, 178]. Moreover, 
this result was obtained by investigation that NBI at 400–430 nm and 525–555 nm reveals 
changes in normal tissue that correlate to significantly different levels of micro-RNA 
epigenetic regulation compared to primary tumor and normal tissue that are not visible 
under white-light alone [175, 177, 178]. Therefore, it may be possible to extract micro-
RNA expression levels to determine a molecular ground-truth for certain tissues employed 
in this study, as Liu et al. have demonstrated that micro-RNAs can be reliably obtained 
from formalin-fixed paraffin embedded tissue samples [198]. 
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3.5 Conclusion 
 This chapter investigated the effects of specular glare, noise, blurring, and tissue-
edge sloping artifacts on hyperspectral imaging-based cancer detection. It explored the 
potential of hyperspectral imaging and machine learning for the detection of head and neck 
cancer in a limited subset of tissue specimens. According to the experimental results, the 
CNN seems to be more robust against the environmental conditions of the acquired images 
and provides better classification results even without data pre-processing. Additionally, 
another objective was to evaluate the general efficacy on example test cases with 
uncertainty in the ground truth as the superficial cancer margin varies with penetration 
depth. This was tested by serially sectioning the tissue samples in the testing group to reveal 
the variation of the cancer margin through the depth of the tissue. This determined that the 
validity of the top section alone as the ground truth may be limited to 1-2 mm, suggesting 
an alternative approach for obtaining performance metrics should be developed. All the 
above factors were necessary to explore and understand the potential of HSI in the 
operating room. This chapter lays the foundation for the systematic limitations of the 
proposed experimental design that will be detailed in the following chapters, which will 
detail deep learning methods employed in sufficiently large patient datasets for training, 
validation, and testing to understand the potential role of HSI for clinical translation.  
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CHAPTER 4. HEAD & NECK SCC DETECTION IN 102 
PATIENTS WITH HSI 
 This chapter details the work of using HSI for SCC detection on all SCC tissues 
collected in our dataset. Surgical resection of head and neck (H&N) squamous cell 
carcinoma (SCC) may yield inadequate surgical cancer margins in 10 to 20% of cases. This 
chapter investigates the performance of label-free, reflectance-based hyperspectral 
imaging (HSI) and autofluorescence imaging for SCC detection at the cancer margin in 
excised tissue specimens from 102 patients and uses fluorescent dyes for comparison. Fresh 
surgical specimens (n = 293) were collected during HNSCC resections (n = 102 patients). 
The tissue specimens were imaged with reflectance-based HSI and autofluorescence 
imaging and afterwards with two fluorescent dyes for comparison. Deep learning tools 
were developed to detect SCC with new patient samples (inter-patient) and machine 
learning for intra-patient tissue samples. The performance was estimated in mm increments 
circumferentially from the tumor-normal margin. In intra-patient experiments, HSI 
classified conventional SCC with an AUC of 0.82 up to 3 mm from the cancer margin, 
which was more accurate than proflavin dye and autofluorescence (both p < 0.05). Intra-
patient autofluorescence imaging detected human papilloma virus positive (HPV+) SCC 
with an AUC of 0.99 at 3 mm and greater accuracy than proflavin dye (p < 0.05). The inter-
patient results showed that reflectance-based HSI and autofluorescence imaging 
outperformed proflavin dye and standard RGB images (p < 0.05). In new patients, HSI 
detected conventional SCC in the larynx, oropharynx, and nasal cavity with 0.85–0.95 
AUC score, and autofluorescence imaging detected HPV+ SCC in tonsillar tissue with 0.91 
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AUC score. This work demonstrates that label-free, reflectance-based HSI and 
autofluorescence imaging methods can accurately detect the cancer margin in ex-vivo 
specimens within minutes. This non-ionizing optical imaging modality could aid surgeons 
and reduce inadequate surgical margins during SCC resections. 
4.1 Introduction 
 Surgery is often the primary treatment for head and neck squamous cell carcinoma 
(HNSCC) [199]. Primary surgery is the modality of choice for resectable oral cavity 
cancers and late stage disease of the larynx and hypopharynx [200]. Management of locally 
advanced SCC may also require a multimodal approach with adjuvant chemoradiation 
therapy [199, 201]. Nearly 90% of cancers of the upper aerodigestive track of the head and 
neck are SCC [2, 139]. Depending on the extent of the disease, radiation therapy or 
chemotherapy alone may be the primary curative modality selected, such can be the case 
with unresectable, recurrent, or metastatic cancers and also with cases known to be 
susceptible to chemoradiation [199, 200]. Human papilloma virus (HPV) is an identified 
cause of SCC, and the most common location for HPV positive (HPV+) SCC is the 
oropharynx, with nearly 60% of oropharyngeal SCC cases being HPV+ [199, 202]. 
Approximately two-thirds of patients with HNSCC present with stage III or IV advanced 
disease [141]. Adequate surgical removal of the primary SCC is vital to successful patient 
outcomes, improved quality of life, survival, and reduced recurrence [140, 196]. Surgeons 
can use pre-operative imaging, such as CT or MRI, for planning, but during the surgery, 
surgeons rely on experience, visual cues, and tactile palpation to determine the extent of 
the disease. Excised samples and tissue biopsies can be sent for pathological analysis and 
consultation to determine if the cancer has been sufficiently resected [196, 203, 204].  
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 Intraoperative pathologist consultations (IPCs) can be time-consuming and may not 
fully reflect the extent of the disease due to limitations in tissue sampling and preparation. 
While the overall accuracy of frozen-sections in IPCs is upwards of 97%, the accuracy for 
challenging cases, such as positive and close margins, ranges from 71 to 92%, with 
sensitivities reported as low as 34 to 77% [203-207]. These errors can compound, leading 
to reported positive margins in up to 12% and close margins in up to 19% of HNSCC 
surgeries, despite having negative frozen sections during IPC [203-207]. For example, in 
oral cavity SCC, up to 30% of patients have positive margins after surgery [201, 208]. 
 The task of surgical guidance for SCC resections in the head and neck has been 
explored with increasing volume in the past five years using several imaging modalities 
coupled with machine learning [209]. Some methods propose using fluorescently-tagged 
monoclonal antibodies that require intravenous administration but have specific optical 
signatures in the near-infrared (NIR) spectrum, with successful outcomes of studies with 
21 patients [201, 208], and other methods utilize topical fluorescent dyes for targeting SCC 
[33, 210]. Label-free optical imaging methods that utilize only narrow bands in the blue 
and green visible spectrum have also demonstrated success at delineating oral SCC margins 
in-vivo in studies with 20 patients [177, 178]. 
 Hyperspectral imaging (HSI) is an emerging technology in biomedicine [14] and 
has been used for cancer detection studies both ex-vivo and in-vivo [211, 212]. HSI has 
been utilized for brain cancer detection in-vivo using machine learning algorithms and an 
optimized, clinical workflow for neurosurgeons [166, 168]. Additionally, HSI has been 
proposed for laparoscopic cancer detection in colorectal surgeries with demonstrated 
potential [22, 129].  
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 Our group reported proof-of-concept studies on HSI for the detection of head and 
neck SCC in fresh surgical specimens from human patients [33, 147]. In our previous pilot 
studies with HSI, manually selected regions of interest (ROIs) were classified, and image 
preprocessing was used to remove specular glare pixels before tissue classification [33, 
210]. In our other works [113, 172, 179], deep learning algorithms were developed for HSI 
tissue classification in both whole primary-tumor specimens and at the SCC cancer-normal 
margin, but only in limited sample sizes from 21 to 29 patients employing cross-validation. 
Previous works from other groups focus on SCC detection in excised tongue SCC 
specimens, using both proof-of-concept ROI-based detection of SCC in 7 specimens [180] 
and tumor semantic segmentation of the entire cancer-margin specimens [148] with 
promising results in leave-one-patient-out cross-validation experiments of 14 patients. 
 In this large study of 293 tissue specimens from 102 patients with SCC, we develop 
deep learning methods to classify the whole tissue specimens instead of ROIs and thus 
further investigate the full potential of label-free HSI-based imaging methods for SCC 
detection. This is the first work to conduct fully-independent training, validation, and 
testing directly of the SCC tumor margin with a large patient dataset (N = 102 patients), 
divided into conventional, keratinizing SCC with variants (N = 88) and HPV+ (N = 14) 
SCC cohorts. The tissues represent a variety of anatomical sites to give an accurate 
assessment of the feasibility of label-free, non-contact, and non-ionizing HSI-based 
imaging modalities for SCC detection. Additionally, this is the first study to investigate 
and quantify HSI-based methods for HPV+ SCC detection directly. It is hypothesized that 
deep learning algorithms can be developed to enable label-free HSI-based methods, namely 
reflectance-based HSI and autofluorescence imaging, to perform with substantial accuracy 
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to provide meaningful information to guide complete surgical resections. Furthermore, it 
is hypothesized that label-free HSI-based methods will outperform the fluorescent dye-
based methods due to lack of target specificity with sufficient signal-to-noise in SCC 
tissues. The results of this study will inform if HSI and other fluorescence imaging 
modalities can be expected to provide specific benefits to cancer margin detection during 
SCC resection surgeries. 
4.2  Materials 
4.2.1 Head and Neck SCC Patient Dataset 
 Patients with head and neck SCC undergoing routine surgery at the Emory 
University Hospital Midtown (EUHM) were recruited by providing informed, written 
consent to the research coordinator, who de-identified the patient data. All methods and 
procedures were approved by the Emory University Institutional Review Board (IRB) 
under the Head and Neck Satellite Tissue Bank protocol. Fresh, ex-vivo surgical specimens 
were collected from the surgical pathology laboratory, making sure not to impede routine 
clinical service. Three tissue samples from each patients’ gross tissue specimen were 
collected: a tissue specimen of the primary tumor (T), an all normal tissue (N), and a 
specimen at the tumor-involved cancer margin (TN). The specimens were transported to 
an imaging laboratory to perform gross-level optical imaging of the ex-vivo specimens for 
SCC detection [33, 113, 210]. The median sizes (height × width) of the tissues were 9×6 
mm, 10×7 mm, and 9×5 mm for the T, TN, and N tissues, respectively, with an approximate 
tissue depth of 2 to 3 mm. In total, 293 tissue specimens were collected from 102 patients 
with head and neck SCC to be included in this study. 
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 A pathologist with expertise in head and neck cancer categorized the tissue samples 
collected for this study into two groups per cancer subtype: Conventional SCC with 
variants and HPV+ SCC. The conventional SCC group (N = 88 patients) was comprised of 
conventional, keratinizing SCC (N = 85), adenosquamous carcinoma (N = 1), basaloid SCC 
(N = 1), and spindle cell SCC (N = 1). The HPV+ SCC group consisted of 14 patients that 
were all identified as p16 marker positive using immunohistochemistry, and one was a 
neuroendocrine SCC. Table 4-1 shows the breakdown of tissue samples for different 
locations of primary tumors along with other patient characteristics and cancer properties. 
For this study, we defined the oral cavity as broadly consisting of non-tongue structures 
inside the oral cavity: Oral mucosa (N = 3), gingiva (N = 5), floor of mouth (N = 12), 
retromolar trigone (N = 4), maxillary (N = 2), and mandibular surfaces (N = 9). Although 
it is not the clinical standard, tongue specimens were presented separately because it was 
the single largest anatomical site in this study, and the excised specimens we acquired from 
the tongue were typically very distinct, both optically and anatomically, with thick surface 
epithelium and large amounts of skeletal muscle, compared with the rest of the oral cavity 
cases. The pharynx consisted of cases originating in the oropharynx (N = 12 total; 10 HPV+ 
and 2 HPV-), hypopharynx (N = 4), and N = 3 cases of HPV+ tonsillar SCC. One patient’s 





Table 4-1. Demographics and cancer properties for the patients recruited for this study. 
Values are reported for the two cohorts, conventional SCC with variants and p16+ SCC, 
separately and combined. Percentages for conventional are out of 88 patients, HPV+ out 
of 14 patients, and combined out of 102 patients. TNM staging was not available for one 
patient in the HPV+ cohort. All cases were M0. Tobacco history represents current or past 
smoking or chewing tobacco history. 
Property 
Conventional SCC 
(N = 88) 
HPV+ SCC 
(N = 14) 
All SCC 
(N = 102) 
No. % No. % No. % 
Demographics       
Mean Age (y.o.) 64.5 - 58.1 - 63.6 - 
Male 59 67% 12 86% 71 70% 
Female 29 33% 2 14% 31 30% 
Tobacco History 58 66% 5 36% 63 62% 
Primary Location       
Oral Cavity 35 40% 0 0% 35 34% 
Tongue 19 22% 0 0% 19 19% 
Oropharynx 2 2% 13 93% 15 15% 
Hypopharynx 4 5% 0 0% 4 4% 
Larynx 19 22% 0 0% 19 19% 
Nasal Cavity 4 5% 0 0% 4 4% 
Maxillary Sinus 5 6% 0 0% 5 5% 
Unknown 0 0% 1 7% 1 1% 
Cancer Stage       
pT1 3 3% 2 14% 5 5% 
pT2 7 8% 6 43% 13 13% 
pT3 16 18% 2 14% 18 18% 
pT4 62 70% 3 21% 65 64% 
Avg. T Size (cm) 4.4 - 3 - 4.2 - 
N+ 53 60% 5 36% 58 57% 
Histologic Grade       
G1 8 10% - - 8 8% 
G2 60 71% - - 60 59% 
G3 16 19% - - 16 16% 
IPC (Averages)       
IPC/Surgery 2.1 - 2.0 - 2.1 - 
Time/IPC (min) 41 - 42 - 41 - 
Tissues/Surgery 3.5 - 2.6 - 3.4 - 




4.2.2 Hyperspectral Imaging 
 The HSI were acquired of the gross-level surgical specimens using a Maestro 
spectral imaging system (Perkin Elmer Inc., Waltham, Massachusetts), which captured 2D 
images at full spatial resolution using a 16-bit charge coupled device and stepped through 
the spectral bands using a liquid crystal tunable filter [33, 113, 210]. The spatial resolution 
of the HS sensor was 1040 by 1392 pixels, which corresponds to a specimen-level 
resolution of 25 µm per pixel. The HSI were captured from 450 to 900 nm in 5 nm spectral 
bands to produce a hyperspectral data cube (hypercube) with 91 spectral bands. The 
average imaging time for acquiring a single HSI at this resolution was about one minute. 
The hyperspectral data were normalized in each spectral band individually by subtracting 
the inherent dark current (imaging with a closed camera shutter) and dividing by a white 
reference disk. An RGB composite image was generated from the normalized hypercube 
by applying a Gaussian kernel in each color region. Figure 4-1 shows a representative 
patient tissue specimen and average spectral signatures of SCC and normal tissues. 
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Figure 4-1. A representative cancer-involved tissue specimen of conventional, keratinizing 
SCC of the mandibular gingiva. (a) From left to right: RGB image made from HSI. The 
histological image, which serves as the ground truth, has SCC annotated in green. HSI 
single band at 550 nm. Fluorescence imaging modalities of the same specimen; (b) Spectral 
feature saliency from CNN gradients of correctly classified HSI for conventional SCC and 
normal upper aerodigestive tract tissues. Left: Full spectra from 450 to 900 nm of SCC and 
normal tissues. Symbol colors represents the relative, scaled importance of the spectral 
feature for making the correct prediction of cancer or normal from the HSI (0 is low 
saliency; 1 is high saliency). Right: Spectral cutout from 520 to 580 nm, corresponding to 
the hemoglobin range. The double asterisk (**) indicates that statistically significant 
differences (p < 0.01) were observed in reflectance values between SCC and normal for all 
spectral bands (450 to 900 nm). The most important spectral feature for correctly predicting 
SCC in HSI was the oxygenated hemoglobin peak at 560 and 565 nm. 
 
4.2.3 Fluorescence Imaging 
 To compare the ability of HSI for cancer margin detection, several optical imaging 
modalities were acquired afterwards: A second label-free and two dye-based methods [33, 
210]. Figure 4-1 shows a representative patient tissue specimen of all imaging modalities 
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and the histological ground truth. Autofluorescence imaging is a label-free imaging 
modality that captures the light emission from intrinsic fluorophores in biological tissue 
that are stimulated to fluoresce by external excitation. The autofluorescence images were 
produced by an excitation light source of 455 nm and a long-pass filter of 490 nm. The 
autofluorescence images were acquired from 500 to 720 nm in 10 nm increments to 
produce a hypercube of 23 spectral bands, and this imaging protocol was also used for the 
fluorescent dyes. 
 In addition to the two label-free modalities (HSI and autofluorescence), two dye-
based fluorescence imaging modalities were acquired for SCC detection [33, 210]. A 
fluorescently tagged glucose molecule, 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl) 
amino]-D-glucose (2-NBDG), is a dye that produces a stronger signal measured from 
regions with higher metabolic glucose uptake, often associated with cancer regions. The 
tissue specimens were incubated for 20 minutes in a 160 µM 2-NBDG solution (Cayman 
Chemical, Ann Arbor, MI, USA) at 37 degrees Celsius, after which tissues were rinsed in 
1× phosphate buffered solution (PBS) before imaging.  
 Proflavin dye images were acquired last before fixing the tissues [33, 210]. 
Proflavin is a DNA-binding fluorescent dye that has demonstrated utility for nuclear 
morphology visualization in a mouse model of oral carcinogenesis [213]. The effect of 
proflavin staining allows greater signal-to-noise in non-keratinizing tissues, as keratin is 
also a target of the dye [213, 214]. The tissue specimens were incubated for 120 seconds 
in a 0.01% proflavin solution (Sigma Aldrich, St. Louis, MO, USA) at room temperature, 
after which tissues were rinsed in PBS.  
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4.3 Methods  
4.3.1 Histological Ground Truth and Registration 
 After acquiring the HSI, the fresh, ex-vivo tissue specimens were inked to preserve 
the optical imaging orientation, fixed in formalin, and paraffin embedded. Using a 
microtome, only the first, high-quality top section corresponding to the surface that was 
optically imaged was obtained, stained with hematoxylin and eosin, and digitized using 
whole-slide scanning at 40× objective [215]. The digital histology images from each 
specimen were annotated to outline the cancerous and normal areas by a board-certified 
pathologist with expertise in H&N cancer [33, 210].  
 The digital histology ground truth served as the gold standard for the optical 
imaging modalities. The histology ground truth image was registered in a semi-automated 
fashion according to a previously established pipeline of deformable registration to the 
gross-level HSI [184]. This registration was subject to errors in tissue-deformation, 
uncertainty in the cancer margin with depth, and off-plane slices that in total were estimated 
to be about 1 mm [184]. Moreover, the variation in photon penetration depth from the 
optical imaging modalities and the variation in the cancer margin throughout the depth of 
the tissue specimens was also estimated to create another 1 to 2 mm of error in the margin, 
according to our previous work [216]. Therefore, a systematic and objective method for 
calculating classification performance was implemented by removing the area near the 
cancer margin in millimeter increments and reporting all values [216]. The regions near 
the cancer margin are both included and excluded from performance calculations because 
the tissue near the margin can be degenerated or have undergone pre-cancerous 
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transformation. Here the registered cancer margin is referred to as the ‘actual TN’ margin, 
and mm increments estimated from the TN margin are identified. The ‘actual TN’ margin 
calculates performance metrics for all tissues right up to the pixels that comprise the 
interface of tumor and normal. For distance calculations for example, ‘TN at 1 mm’ 
represents that evaluation metrics are calculated from all distances up to 1 mm from the 
margin. The ‘TN margin at 2 mm’ is also reported, which calculates performance up to 2 
mm from the margin. 
4.3.2 Intra-Patient Experiments 
 Intra-patient experiments used a patient’s known cancer and normal specimens to 
train a machine learning algorithm and simulated a personalized approach for SCC 
detection on-the-fly in the operating room. For intra-patient experiments, linear 
discriminant analysis (LDA) was used in ensemble to train, validate, and test the SCC data 
from the same patient. Each SCC patient with all tissue types (meaning a purely normal 
specimen, a specimen containing only primary tumor, and a specimen of the cancer margin) 
was included and divided into each cohort, conventional SCC (N = 41) and HPV+ SCC (N 
= 6). Despite collecting 102 patients for this study, only 47 fit this distribution of all three 
tissue types exactly. Independently, an ensemble LDA of 500 learners was trained and 
validated in 5 folds from each patient’s tumor and normal samples. After each patient’s 
model development, the patient’s tumor-normal margin specimen was used as the testing 
data. The LDA method was selected because our previous work demonstrated that it 
outperformed other regression-based machine learning algorithms [33]. Training time for 
5 cross-validated folds of one patient’s model was about one to three minutes, depending 
on the size of regions selected for training, which is reasonable for simulating training of a 
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patient’s data for HSI during surgery. All statistical analyses were performed using a 
paired, one-tailed t-test. 
4.3.3 Inter-Patient Experiments 
 To explore the ability of HSI and fluorescence imaging modalities to detect SCC 
on patients fully-independent from algorithm development, two experiments were 
performed. The first experiment consisted of training the CNN on primary tumor (T) and 
all normal (N) tissues, while testing on T and N tissues from other patients. The second 
experiment consisted of training on primary tumor (T) and all normal (N) tissues, while 
testing only tumor-involved cancer margins (TN) tissues from other patients.  
 To perform these experiments, within each SCC cohort, patients were randomly 
divided into 5 folds, each fold served as the fully-independent testing group, while training 
and validation was performed on the patients in the remaining 4 folds, which allows test-
level performance metrics for all patients in our dataset. For the conventional SCC cohort, 
each model from each fold was trained and validated on approximately 25,000 patches 
from 110 tissue specimens from 70 patients, and the independent testing group from each 
fold was approximately 50 tissues from 20 patients. This was performed once for each fold, 
until the entire cohort dataset, comprised of 70,000 patches from 255 tissue specimens from 
88 patients was used as the testing group. For the HPV+ SCC cohort, training/validation 
was performed in the same fashion in 5 folds, until the entire cohort dataset of 16,000 
patches from 38 tissue specimens from 14 patients was used as the testing group. All 
statistical analyses were performed using a paired, one-tailed t-test. 
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4.3.4 Convolutional Neural Network 
 For inter-patient experiments, a convolutional neural network (CNN) was 
developed to quickly and efficiently classify cancerous and normal tissues at the cancer 
margin. Due to the uniqueness of HSI data, the inception-v4 CNN architecture [217] was 
customized in several key ways to optimize the CNN to hypercube data in image-patches 
that were 25×25×C, where C is the number of spectral bands of each HS optical modality. 
The full CNN architecture schematic is presented in detail in Figure 4-2. The CNN was 
developed in TensorFlow on an Ubuntu machine running NVIDIA Titan-XP GPUs [192]. 
The early convolutional layers were modified to handle the selected patch-size and create 
smaller inception blocks that would allow for faster training and classification using the 
CNN. Training was performed up to 50 epochs; one epoch of training data ran for up to 1 
hour using HSI; and deployment of the fully-trained CNN on a single GPU to classify a 
new HSI scene with hundreds of patches required only 25±10 seconds. The relative 
saliency of spectral features for correctly predicting SCC or normal in HSI, shown in Figure 
4-1b and Figure 4-7, were extracted from the CNN using the class-activated gradients per 
the grad-CAM algorithm [218]. 
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Figure 4-2. Schematic of the customized Inception V4 CNN architecture with added 
squeeze-and-excitation layers. The CNN was modified to operate on the 25×25×91 patch-
size selected. The receptive field size and number of convolutional filters is shown at 
bottom of each inception block. The convolutional kernel size used for convolutions is 
shown in italics inside each convolution box. 
4.3.5 Image Processing and Reconstruction 
 For all experiments, the 10 pixels, corresponding to 0.25 mm, at the edge of each 
tissue were discarded for performance calculations. Since the imaging protocol for tissue 
specimens required using a flat imaging surface, the tissue free edges created false 
curvature where the tissue was too thin to provide an adequate imaging signal. 
Implementation of the inter-patient CNN experiments involved a patch-based approach 
using a sliding window of size 25×25×91 and an overlap of 13 pixels. The overlapping 
regions of image-patches were averaged to produce a smoother result for calculation of the 
performance metrics of the inter-patient experiments. 
4.3.6 Evaluation 
 To evaluate performance of the machine learning algorithms employed in the 
experiments for detecting SCC, the area under the curve (AUC) of the receiver operator 
 95 
characteristic (ROC) curve was calculated. The AUC score was selected because it 
describes the accuracy at all possible thresholds of identifying the positive class and is not 
susceptible to errors when the classes are imbalanced. For each experiment, the optimal 
operating point on the ROC was calculated for the validation group data. This validation 
group threshold was used as the threshold for the testing group to best distinguish between 
cancer and normal, objectively. Using this threshold, the overall accuracy was calculated. 
Sensitivity, the ratio of true positives to total positive predictions, and specificity, the ratio 
of true negatives to total negative predictions, were also calculated and presented. 
4.4 Results 
4.4.1 Surgical Specimens Results 
 The accuracy of pathologist assistants in the surgical pathology department was 
calculated on their ability to identify the desired tissue specimen type (T, TN, or N) for 
research purposes. To obtain this performance, the label (prediction) given by the 
pathologist assistant (T, TN, or N) was compared to the ground-truth label from histology. 
This value is reported only to give an estimate of the difficulty of the task of positive margin 
and primary tumor specimen identification. It is important to note that these specimens 
were for research purposes only and do not attempt to reflect the accuracy of the clinical 
service in determining SCC during intraoperative guidance. The accuracy for identifying 
tissue specimens correctly was normal specimens with 92% accuracy, tumor-normal 
margin tissues with 95%, and primary tumor-only specimens with 60% accuracy. Figure 
4-3a shows the breakdown by tissue specimen type. The most common reason for the 
misidentified tissue specimens was normal tissue in the primary tumor specimen. To 
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calculate the accuracy, sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) of the specimen identification in surgical pathology, the 
TN tissues and predictions were separated into T and N components for calculation of 
true/false positives/negatives. For example, a true TN predicted as all T would count as 
both a true-positive and a false-positive; alternatively, a true T predicted as TN, would 
count as both a true-positive and a false-negative. The specificity and PPV were both 82%, 
the lowest metrics obtained, as the most common misidentification was tumor-margins as 
tumor-only, and overall an accuracy of 88% was determined for tissue type identification. 




Figure 4-3. Accuracy of ex-vivo tissue samples acquired. (a) The types of tissue samples 
acquired were all normal (N), primary tumor (T) specimen, or specimen at the tumor-
normal (TN) margin. Accuracies shown are for the desired tissue type in the column. (b) 
The performance metrics when TN tissues and predictions were separated into T and N 
components for calculation of accuracy, sensitivity, specificity, PPV, and NPV. For 
example, a true TN predicted as all T would count as both a true-positive and a false-
positive; alternatively, a true T predicted as TN, would count as both a true-positive and a 
false-negative. Therefore, the 139 true TNs and 5 false predicted TNs are double counted, 
so the specimen total is now 437 instead of 293 specimens. 
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4.4.2 Intra-patient Results of Tumor-Involved Cancer Margins 
 The results of reflectance-based HSI intra-patient (N = 47) accuracy ranged from 
80 to 90% for conventional SCC and 82 to 97% for HPV+ SCC. The results of reflectance-
based HSI intra-patient AUC were 0.75 to 0.82 for conventional SCC and 0.77 to 0.91 for 
HPV+ SCC. Table 4-2 shows the complete results for HSI and the fluorescence imaging 
modalities. The accuracy for both SCC cohorts peaked at 3 mm from the cancer margin, 
but the number of patients decreased with increasing distance from the cancer margin 
because not all distances up to 3 mm could be estimated from all tissue specimens. For the 
conventional SCC cohort (N = 41), HSI outperformed autofluorescence, proflavin, and 2-
NBDG at nearly all distances from the cancer-margin and significantly outperformed 
proflavin and autofluorescence (p ≤ 0.05) close the margin (Figure 4-4a,b). The results for 
the HPV+ SCC cohort (N = 6) are not as conclusive as the conventional cohort because the 
limited number of tissue samples causes a discontinuous trend, with autofluorescence 
imaging being among the top performing modalities in terms of accuracy and AUC (Figure 
4-4c,d), and the AUC obtained for autofluorescence imaging detection of HPV+ SCC was 
0.99 at 3 mm, which was greater than other modalities (p > 0.05). In terms of accuracy, 
autofluorescence imaging significantly outperforms proflavin at 2.5 mm from the cancer 
margin (p < 0.05). Therefore, the label-free methods, HSI and autofluorescence, perform 




Table 4-2. Accuracy (Acc.) and area under the curve (AUC) results for all modalities 
performed using intra-patient experiments for conventional SCC and HPV+ p16-positive 
cohorts. Bolded values represent the greatest value in the column for each patient cohort. 
Imaging Modality SCC Cohort 
1mm 2mm 3mm 
AUC Acc. AUC Acc. AUC Acc. 
HSI 
SCC, Conventional 0.77 85% 0.80 88% 0.78 90% 
SCC, HPV+ 0.79 88% 0.69 88% 0.91 97% 
Autofluorescence 
SCC, Conventional 0.67 85% 0.72 85% 0.73 87% 
SCC, HPV+ 0.81 89% 0.84 95% 0.99 98% 
Proflavin 
SCC, Conventional 0.73 82% 0.76 85% 0.73 89% 
SCC, HPV+ 0.85 88% 0.82 94% 0.93 97% 
2-NBDG 
SCC, Conventional 0.76 84% 0.79 87% 0.80 89% 
SCC, HPV+ 0.74 90% 0.69 95% 0.70 97% 
 
Figure 4-4. Results from intra-patient training and testing with LDA using HSI, 
autofluorescence, proflavin, and 2-NBDG. Results for Conventional SCC are shown in (a) 
AUC and (b) accuracy. Results for HPV+ SCC are shown in (c) AUC and (d) accuracy. 
Statistically significant results between imaging modalities are indicated by a colored 
asterisk. Sample size (N) is reported above plots to indicate that not all distances in mm 
can be estimated from each tissue specimen, so sample size decreases as the distance 
estimated increases, which causes noticeable jumps in the plots. 
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4.4.3 Inter-patient Results of Tumor vs Normal 
 For the conventional SCC cohort (N = 88), the results of the inter-patient 
experiments using only one-class specimens of the tumor-only (T) or normal-only (N) 
yielded similar median and average AUC scores for HSI and autofluorescence of 0.92 and 
0.93 (median) and 0.87 and 0.86 (average). Both of HSI and autoluorescence outperformed 
the fluorescent dye-based techniques, 2-NBDG and proflavin, which had 0.88 and 0.87 
(median) and both with 0.85 average AUC scores (all differences not significant with p > 
0.05). Figure 4-5c,d shows the median and average AUCs for all imaging modalities for 
the conventional SCC cohorts. For the HPV+ SCC cohort (N = 14), autofluorescence 
imaging yielded a median AUC of 0.86 and average AUC of 0.74, which was significantly 
more accurate than proflavin or RGB imaging (both p < 0.05). For tonsillar HPV+ SCC 
tissues (N = 3), the average SCC detection was 0.89 AUC score (Figure 4-6b,d). The grad-
CAM algorithm [218] was used to show that the salient spectral features necessary for 
distinguishing SCC from normal across all anatomical sites encompassed both the visible 
and NIR spectrum (Figure 4-1b and Figure 4-7). In particular, it can be observed that 
normal tissues have more absorption and salient spectral features in the NIR range, 
indicating that normal tissues have greater fat, collagen, and water content than cancer 
[116]. The most important spectral feature for correctly predicting SCC with HSI was the 
oxygenated hemoglobin peak at 560 and 565 nm, which is correlated with increased 
metabolic activity. Additionally, the spectral signatures and spectral feature saliency maps 
are shown separated by anatomical location in Figure 4-7. 
 100 
 
Figure 4-5. Median and average AUC results from inter-patient classification (a value of 
0.5 corresponds to random guess). AUC values for the conventional SCC cohort: (a) 
Median AUC values for TN margin tissue specimens; (b) average AUC shown with SEM 
for TN margin specimens with statistical significance, shown as (*) for p<0.05 and (**) 
for p<0.01; (c) median AUC values for T and N whole tissue specimens; (d) average AUC 
shown with SEM for T and N whole specimens; (e) Average AUC at 2mm from the SCC 
margin using HSI across different anatomical sites; (f–h) representative patient examples 
of conventional SCC at the maxillary gingiva, nasal cavity, and larynx, respectively. From 
left to right: RGB made from HSI, histology ground truth, and predicted cancer heat-map. 




Figure 4-6. Median and average AUC results from inter-patient classification (a value of 
0.5 corresponds to random guess). AUC values for the HPV+ SCC cohort: (a) median AUC 
values TN margin specimens; (b) median AUC values T and N whole specimens; (c) 
average AUC of TN margin specimens with SEM; (d) average AUC of T and N whole 
specimens shown with SEM and statistical significance; , shown as (*) for p<0.05 and (**) 
for p<0.01; (e) Average AUCs of HPV+ SCC in tonsillar tissues; (f) Representative patient 
example of HPV+ SCC in tonsillar tissue from the oropharynx. From left to right: RGB 
made from HSI, histology ground truth, and predicted cancer heat-map. The white and 
green contours outline the SCC area. 
4.4.4 Inter-patient Results of Tumor-Involved Cancer Margins 
 The results of the inter-patient experiments with HSI in the conventional SCC 
cohort (N = 88) revealed that testing on specimens of the tumor-only (T) or normal-only 
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(N) yielded median and average AUCs greater than testing at the tumor margin (TN) at 
distances up to 2 mm from the margin, 0.92 and 0.87 compared to 0.85 and 0.77, 
respectively (Figure 4-5a–d). As can been seen in Figure 4-5b, for all distances HSI and 
autofluorescence outperform 2-NBDG, proflavin, and RGB imaging in average AUC 
score. Both HSI and autofluorescence significantly outperformed proflavin dye imaging at 
distances 1 mm (both p < 0.05) and 2 mm (both p < 0.01) from the cancer margin. HSI and 
autofluorescence significantly outperform RGB imaging in AUC at the actual cancer 
margin and 1 mm from the margin (all p < 0.05). Table 4-3 shows the full results from 
conventional SCC with HSI at distances from the cancer margin. 
Table 4-3. Performance results from the best label-free HSI methods from the inter-patient 
experiments for each patient cohort by distance from margin (shown with ± SEM). In the 
conventional SCC cohort, reflectance-based HSI is presented. Additionally, the HSI results 
are separated by anatomical location. For the HPV+ SCC cohort, autofluorescence is 
presented, which all came from the pharynx. 





Accuracy Sensitivity Specificity 
Conventional SCC 
Reflectance-based HSI 
     
TN Actual 0.75 0.68 ± 0.02 60 ± 2% 60 ± 4% 54 ± 3% 
TN 1mm 0.81 0.73 ± 0.02 66 ± 2% 60 ± 4% 61 ± 4% 
TN 2 mm 0.85 0.77 ± 0.03 64 ± 3% 65 ± 4% 59 ± 5% 
Conventional SCC 
Reflectance-based HSI 
     
Oral Cavity, TN 2mm 0.81 0.79 ± 0.04 63 ± 5% 71 ± 8% 49 ± 8% 
Tongue, TN 2mm 0.78 0.64 ± 0.07 61 ± 7% 57 ± 9% 53 ± 9% 
Nasal Cavity, TN 2mm 0.98 0.93 ± 0.06 79 ± 11% 69 ± 17% 73 ± 24% 
Max. Sinus, TN 2mm 0.95 0.78 ± 0.18 58 ± 19% 93 ± 5% 52 ± 18% 
Larynx, TN 2mm 0.86 0.85 ± 0.05 79 ± 5% 69 ± 11% 71 ± 9% 
Hypopharynx, TN 2mm 0.84 0.78 ± 0.13 42 ± 9% 20 ± 14% 99 ± 1% 
Oropharynx, TN 2mm 0.95 0.95 ± 0.001 95 ± 4% 49 ± 49% 78 ± 22% 
HPV+ SCC 
Autofluorescence 
     
TN Actual 0.63 0.55 ± 0.05 60 ± 4% 45 ± 6% 65 ± 6% 
TN 1mm 0.63 0.56 ± 0.07 65 ± 5% 49 ± 8% 62 ± 8% 
TN 2 mm 0.77 0.68 ± 0.09 63 ± 7% 64 ± 8% 60 ± 9% 
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 The conventional SCC cohort was separated into the anatomical sites described in 
Table 4-1, and the highest average AUCs at 2mm from the cancer margin were observed 
in the nasal cavity (0.93), larynx (0.85), and oropharynx (0.95), while specimens from the 
tongue performed the lowest (Figure 4-5e). Representative tissue specimens from the oral 
cavity, nasal cavity, and larynx are classified with HSI and shown in Figure 4-5f–h. 
 
Figure 4-7. Spectral feature saliency from CNN gradients of correctly classified HSI (per 
grad-CAM) for conventional SCC and normal upper aerodigestive tract tissues separated 
by anatomical location. (a): Spectral signatures with spectral feature importance for normal 
tissues from the maxillary sinus, nasal cavity, oral cavity, tongue, larynx, and pharynx. 
Color of symbol represents the relative importance of the spectral feature for assigning the 
correct label of the class (0 – blue, low saliency; 1 – red, high saliency). (b): Spectral 
signatures with spectral feature importance for primary conventional SCC tissues from the 
maxillary sinus, nasal cavity, oral cavity, tongue, larynx, and pharynx. 
 For the HPV+ SCC cohort (N = 14) inter-patient experiments, autofluorescence 
imaging yielded the best results compared to the other imaging modalities at 2 mm from 
the cancer margin with 0.68 average AUC and 0.77 median AUC (Figure 4-6a,c; not 
significant, p > 0.05). For tonsillar HPV+ SCC tissues (N = 3), the average SCC detection 
with autofluorescence imaging at 2 mm from the cancer margin was 0.91 AUC (Figure 
4-6e). A representative tissue specimen from HPV+ SCC is classified with 
autofluorescence imaging in Figure 4-6f. Table 4-3 shows the full results from HPV+ SCC 
with autofluorescence imaging at distances from the cancer margin. 
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4.5 Discussion 
 The results of this large study of 293 tissue specimens from 102 patients with SCC 
show that label-free, reflectance-based hyperspectral imaging and autofluorescence 
imaging both outperform the fluorescent dye-based imaging methods, i.e., proflavin and 2-
NBDG, and this technology could aid in the detection of SCC. The fluorescent dyes 
employed are not specific enough to target SCC with a high signal-to-noise ratio in ex-vivo 
tissue specimens because of the large inter-patient variability. Proflavin allows 
visualization of nuclear structures, but is washed out by excessive keratin. The regional 
metabolic uptake of 2-NBDG to localize cancerous areas was not evident or demonstrated 
by the results of this ex-vivo study. Label-free HSI techniques may yield potential but the 
best machine learning protocols for training HSI classifier is undetermined. It may be task 
specific, but the results of this study show that with a large SCC HSI database, deep 
learning algorithms can be trained with high fidelity to work across a large number of 
anatomical sites in the upper aerodigestive tract.  
 IPC analysis with frozen sections remains the current standard for intraoperative 
guidance, but it is time and labor intensive. Across all 102 patients with SCC recruited for 
this study, an average number of 2.1 IPCs were performed per surgery, each taking about 
41 minutes in total. On average, each surgery typically investigated 3.4 tissues, each of 
which take about 25 minutes to report final diagnosis. The average imaging time for HSI 
was about 1 minute with up to 35 seconds for HSI classification using the CNN, which is 
significantly less than IPC.  
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 Detection of SCC for surgical purposes is a challenging task, whether performed 
by a surgeon, pathologist, or computer-aided optical imaging modality. In the literature, 
the accuracy of detecting positive or close margins in frozen sections ranges from 71 to 
92% with sensitivity from 34 to 77% [203-207]. As sampling and tissue preparation is the 
main source of error, careful sectioning of small biopsies and vigilant communication is 
recommended to reduce errors during IPCs [196]. Nonetheless, significant need for 
guidance remains, with up to 20% to 30% of cases reported with close or positive margin 
results after SCC resections [203-207]. To this end, to put the SCC detection ability of HSI-
based methods into context, we present the pathologist assistant accuracy of 88% for 
research purposes-only tissue identification. Since current practice is imperfect, the 
potential benefit of HSI for SCC detection should be evaluated on two criteria: firstly, to 
establish no potential harm; and secondly, to assess HSI-based intraoperative information 
that has clinical utility in achieving negative margins, especially considering the time 
advantage. 
 The results presented in this study using 293 specimens from 102 patients can be 
compared to previous pilot studies from our group. Lu et al. 2017 reported results from a 
small (N = 24) proof-of-concept study using manual ROIs that showed that training and 
testing on the same patient with HSI yielded an intra-patient accuracy of 89–94% and intra-
patient AUC of about 0.96 [33]. Our objective and systematic approach yielded equivalent 
results using nearly double the intra-patient cohort (N = 47) for distances 1 mm beyond the 
cancer margin, 85–90% accuracy for conventional SCC and 88–97% accuracy for HPV+ 
SCC, across all anatomical tissue sites. Moreover, the AUCs obtained from 0.82 to 0.91 
for conventional and HPV+ SCC cohorts at 2.25 mm from the cancer margin, importantly, 
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are not limited by the selection of manual ROIs and include specular glare pixels. 
Therefore, slightly lower results are to be expected, but provide a more realistic 
performance estimate for HSI-based methods in the operating room. The experimental 
results of this study were a median AUC of 0.92 for HSI and 0.93 for autofluorescence for 
all conventional SCC T vs N tissues using the most patient data in an HSI study to date. 
The previous proof-of-concept work by Lu et al. reported an accuracy of 85% for T versus 
N tissues only, an accuracy of 76% for manual ROIs near the cancer-margin, and an overall 
average AUC of 0.88 for all tissues (T, TN, and N) for SCC at comparable tissues and 
anatomical sites. In comparison, in this study, for larynx, nasal cavity, and oropharyngeal 
SCC, we achieved AUC scores of 0.85, 0.93 and 0.95 with accuracies above 79%. 
 The optical imaging modalities in this study were all acquired using HSI 
technology, including proflavin, 2-NBDG, and autofluorescence, and all were saved as 
hypercubes for CNN training. Moreover, even RGB images were generated from HSI, and 
recent work has suggested that CNNs can recover the full HSI spectrum from RGB 
composites constructed from HSI [219]. Therefore, it is possible that the results from these 
modalities benefitted from being HS data, which is one possible explanation for not 
observing more statistically significant differences. The results of this study are promising 
at tissue sites that perform with high AUCs in both SCC cohorts. However, the results 
suggest that HPV+ SCC requires more data to perform well with deep learning. Therefore, 
the results of this study support the hypothesis that label-free HSI methods significantly 




 In summary, this chapter investigated HSI for SCC detection using all 293 
specimens from 102 patients with SCC in the dataset acquired for this thesis, and it was 
demonstrated that HSI may offer utility for intraoperative SCC detection. This study was 
published as the first comprehensive report on a large SCC dataset that could be used to 
train a deep learning model that can predict SCC across multiple anatomical locations with 
high fidelity. There is a critical need to provide rapid information in the operating room for 
guidance during SCC resection, with errors reported up to 10–30% of missed positive and 
close margins in current practice. Our results show that AUCs upwards of 0.80 to 0.90 may 
be obtained for SCC detection with HSI-based methods in less than 2 minutes for SCC 




CHAPTER 5. THYROID & SALIVARY TUMOR DETECTION IN 
82 PATIENTS WITH HSI 
 This chapter details the work of using HSI for thyroid and salivary gland tumor 
detection on all such tissues collected in our dataset. The performance of hyperspectral 
imaging (HSI) for tumor detection is investigated in ex-vivo specimens from the thyroid 
(N=200) and salivary glands (N=16) from 82 patients. Tissues were imaged with HSI in 
broadband reflectance and autofluorescence modes. For comparison, the tissues were 
imaged with two fluorescent dyes. Additionally, HSI was used to synthesize three-band 
RGB multiplex images to represent the human-eye response and Gaussian RGBs, which 
are referred to as HSI-synthesized RGB images. Using histological ground truths, deep 
learning algorithms were developed for tumor detection. For the classification of thyroid 
tumors, HSI-synthesized RGB images achieved the best performance with an AUC score 
of 0.90.  In salivary glands, HSI had the best performance with 0.92 AUC score. This study 
demonstrates that HSI could aid surgeons and pathologists in detecting tumors of the 
thyroid and salivary glands. 
5.1 Introduction 
 Thyroid cancer incidence has significantly increased worldwide from 1970 to 2012, 
despite the fact that mortality from thyroid cancer has decreased [220]. Surgery is the 
standard treatment for thyroid cancers, and the 5-year survival rate for localized or regional 
thyroid cancers (excluding anaplastic variant) is above 90% [221]. The most common 
malignant tumor of the thyroid is papillary thyroid carcinoma (PTC), comprising 70% of 
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thyroid cancers, and there are several variants of PTC, including conventional, follicular, 
tall-cell, and oncocytic [222]. The initial diagnosis of thyroid tumors is with fine-needle 
aspiration (FNA) biopsy and histological evaluation of the specimen [222]. Follicular 
tumors are another cytological type of thyroid neoplasms, which include follicular 
adenoma, a benign tumor, and follicular thyroid carcinoma (FTC), the malignant form. The 
requisite diagnostic criterion for follicular carcinoma versus adenoma is definitive 
invasiveness; no cytological features can provide the diagnosis of FTC, so FNA is therefore 
useless is making the distinction [223]. Medullary thyroid carcinoma (MTC) is a rare form 
of thyroid cancer, comprising only 4% of thyroid cancers, that occurs sporadically in most 
cases, but can be associated with a familial germline mutation [224]. 
 During thyroid tumor resections, intraoperative frozen section (FS) analysis and 
pathologist consultation can be useful for determining extent of the disease and, according 
to recent American guidelines, may occasionally confirm malignancy and escalate 
treatment from partial to total thyroidectomy [225]. For example, in thyroid tumors, 15-
30% of preoperative FNA biopsies may be indeterminate [226]. It remains controversial in 
thyroid tumor surgeries whether the practice of intraoperative FS can provide relevant 
diagnostic information, as it can be prone to misdiagnosis [226]. In 4% cases with benign 
intraoperative FS reports, clinically significant malignancy was found, compared to 6.8% 
in cases where no FS was performed [227]. This translates to a sensitivity of 22% for 
identifying malignancy in patients with benign FNA [227]. In the literature, it is suggested 
that the practice of intraoperative FS may lead to over or under treatment of thyroid tumors 
[226]. 
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 Salivary tumors involve the salivary glands, which are a system of exocrine glands 
in the mouth that produce saliva to initiate digestion. The major salivary glands are the 
parotid, the submandibular, and the sublingual salivary glands [228]. The classification of 
benign and malignant salivary tumors is complex, with over 20 distinct entities according 
to the most recent standard proposed by the World Health Organization [228-230]. Overall, 
more than 80% of primary tumors of the salivary glands arise in the parotid gland, which 
is the largest salivary gland [228, 230]. Pleomorphic adenoma is the most common benign 
tumor of the salivary glands (60%) and typically occurs in the parotid glands [230]. 
Mucoepidermoid carcinoma is the most common malignant neoplasm of the parotid gland 
[228]. Adenoid cystic carcinoma is a malignant tumor that can occur with equal likelihood 
in the submandibular and parotid glands [228]. Polymorphous low-grade adenocarcinoma 
(PLGA) is a rare malignant tumor, commonly found in minor salivary glands of the hard 
or soft palate [231]. In surgical resection of salivary tumors, the sensitivity of intraoperative 
FS for detecting malignant parotid gland tumors with benign FNA was only 33%, 
suggesting difficulty in diagnosing low grade tumors [232]. Moreover, FS for salivary 
tumors carries the risk of tumor seeding and may not provide definitive diagnosis [233]. 
Nonetheless, the combination of preoperative FNA and intraoperative FS leads to high 
diagnostic accuracy overall for salivary tumors [234].  
 With the goal of image-guided surgery, hyperspectral imaging (HSI) is an emerging 
technology in biomedicine that has been used for cancer detection studies both ex-vivo and 
in-vivo [14, 211, 212]. HSI has been explored for brain cancer detection in-vivo [166, 168]. 
Additionally, HSI has been proposed for laparoscopic cancer detection in colorectal 
surgeries with demonstrated potential [22, 129]. The ability of HSI to identify ideal 
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transection margins for colorectal tissues has been demonstrated after devascularization by 
blocking vascular anastomoses [235]. Our group reported HSI studies of head and neck 
cancer using ex-vivo human surgical specimens [33, 113, 179, 236]. 
 In order to leave the parathyroid glands intact during surgery, Barberio et al. 
demonstrated that HSI may be beneficial in detecting parathyroid glands from thyroid 
tissue during thyroidectomy [237]. For surgeries of salivary tumors, one challenge is 
leaving the facial nerve intact, which runs through the parotid gland and can cause facial 
paresis if injured. Wisotzky et al. showed that HSI can identify the facial nerve in the 
parotid gland [238]. The submandibular and sublingual salivary glands are surrounded by 
an anatomical variety of normal tissues in the oral cavity. Previous work from our group 
has demonstrated that HSI can distinguish amongst normal tissues in the oral cavity, such 
as stratified squamous epithelium, normal salivary gland, and skeletal muscle [179]. 
 In this large study of 82 patients, we perform tumor detection in 200 thyroid tissue 
specimens from 76 patients in inter-patient testing experiments, and salivary gland tumor 
detection was investigated using 16 salivary gland tissue specimens from 6 patients. This 
is the most comprehensive study to date of tumor detection in thyroid and salivary glands 
to thoroughly assess the feasibility of label-free, non-contact, and non-ionizing HSI-based 
imaging modalities for computer aided tumor detection. The outcomes of this work will 
help guide future HSI and autofluorescence studies and determine the specific benefits that 





 In this study, ex-vivo tissue specimens from the thyroid and salivary glands were 
imaged with optical imaging modalities; histological sections were prepared from the 
specimens for ground truths; patients were categorized and used to train, validate, and test 
deep learning algorithms; and performance was calculated to compare the methods. 
5.2.1 Ex-vivo Surgical Specimen Dataset 
 For this study, 216 surgical specimens were acquired from 82 patients undergoing 
routine resection of thyroid tumors or salivary gland tumors at the Emory University 
Hospital Midtown, who were recruited by giving written, informed consent to an 
institutional research coordinator. Table 5-1 shows the categorization of patients and tissue 
specimens. All patient data were de-identified by the research coordinator. The Institutional 
Review Board (IRB) of Emory University approved all research protocols and imaging 
methods. Three types of fresh, ex-vivo surgical specimens were obtained from the surgical 
pathology department during clinical service. We aimed to acquire a sample of normal 
tissue (N), tissue from the primary tumor (T), and a specimen of the tumor-involved margin 
that contains both tumor and normal tissue (TN), all of which were confirmed by 
histopathological analysis. The size of the tissue specimens was approximately 10×6×2 
mm on average. Additionally, the final clinical pathology report was made available after 
de-identification. 
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Table 5-1. Number of patients and tissue specimens for this study. Patients are divided by 
cohort and sub-group. The tissue specimens are categorized into tumor (T), tumor-normal 
margin (TN), and normal (N). 
Group Patients 
Number of Tissue Specimens 
T TN N 
Thyroid Tumor Cohort     
 Papillary Thyroid Carcinoma (PTC) 54 41 38 59 
 Medullary Thyroid Carcinoma (MTC) 
& Insular Carcinoma 
6 4 6 8 
 Follicular Adenoma & Carcinoma 13 14 10 12 
 Poorly Differentiated Carcinoma 3 4 2 2 
Salivary Tumor Cohort     
 Parotid Gland Tumor 3 2 3 3 
 Other Salivary Gland Tumor 3 4 2 2 
Total 82 69 61 86 
 
 The tissue samples collected for this study were categorized by an experienced 
pathologist into six groups according to tumor subtype, divided into two broad cohorts: 
thyroid tumors and salivary gland tumors. The thyroid tumor cohort was comprised of 200 
tissue specimens from 76 patients. The malignant tumors included in this cohort were PTC 
(N=54), MTC (N=5), insular carcinoma (N=1), follicular carcinoma (N=8), and poorly 
differentiated thyroid carcinoma (N=3). The benign tumors of the thyroid were follicular 
adenoma (N=5). The only thyroid cohort tissues excluded from this study were six patients 
with benign thyroid hyperplasia/goiter.  
 The cohort of salivary gland tumors was comprised of 16 tissue specimens from 6 
patients. Two patients had benign pleomorphic adenoma (N=2) of the parotid gland. Four 
patients had malignant tumors of the salivary glands: mucoepidermoid carcinoma (N=1), 
salivary duct carcinoma of the parotid gland (N=1), PLGA of the hard palate (N=1), and 
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adenoid cystic carcinoma (N=1). The patient demographics and relevant cancer properties 
are shown in Table 5-2. 
Table 5-2. Patient demographics and cancer properties for the patients recruited for this 
study. Intraoperative pathologist consultations (IPCs) using intraoperative frozen section 
(FS) analysis are also reported. 
 Property  Number Percentage 
Demographics   
 Average Age (years) 49.7 - 
 Male 28 34% 
 Female 54 66% 
 Tobacco History 26 32% 
Ethnicity   
 White 47 57% 
 Black 19 24% 
 Asian 6 7% 
 Other / Unknown 10 12% 
Primary Location / Tumor Type   
Thyroid Gland   
 Papillary Carcinoma 54 66% 
 Follicular Carcinoma 8 10% 
 Follicular Adenoma 5 6% 
 Medullary Carcinoma 5 6% 
 Poorly Differentiated Carcinoma 3 4% 
 Insular Carcinoma 1 1% 
Salivary Gland   
 Pleomorphic Adenoma 2 2% 
 Adenoid Cystic Carcinoma 1 1% 
 Mucoepidermoid Carcinoma 1 1% 
 Adenocarcinoma (PLGA) 1 1% 
 Salivary Duct Carcinoma 1 1% 
Cancer Stage   
 pT1 19 23% 
 pT2 19 23% 
 pT3 26 32% 
 pT4 9 11% 
 Avg. T Size (cm) 3 - 
 N+ Status 33 40% 
IPC (Averages)   
 Surgeries with IPC 19 23% 
 IPC/Surgery 1.6 - 
 Tissues/Surgery 1.1 - 
 Time/IPC (min) 19.1 - 
 Time/Tissue (min) 17.3 - 
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5.2.2 Optical Imaging Modalities 
 To assess the ability of HSI for tumor detection, several other optical imaging 
modalities were acquired for comparison, including both label-free and fluorescent dye-
based methods. It was hypothesized that HSI would outperform fluorescence methods due 
to lack of sufficient target specificity in 2-NBDG and proflavin. In the following sections, 
the image acquisition systems are described for hyperspectral reflectance imaging, HSI-
synthesized RGB multiplex imaging, autofluorescence imaging, and two fluorescent dye-
based imaging techniques: 2-NBDG and proflavin. 
5.2.2.1 Hyperspectral Imaging 
 A CRi Maestro HS system (Perkin Elmer Inc., Waltham, Massachusetts) was used 
to acquire HSI of the ex-vivo specimens. The HS system performs spectral scanning from 
450 to 900 nm using a Xenon light source and liquid crystal tunable filter (LCTF) with 5 
nm spectral resolution [33, 239]. The image size of the HSI was 1040×1392×91 pixels 
(height×width×spectral bands), and the corresponding specimen-level spatial resolution 
was 25 µm per pixel. Acquisition time for an HSI was approximately one minute.  
 The raw HS data (Iraw) were normalized band-by-band (λ) by subtracting the 
inherent dark current of the sensor and dividing by a white reference disk for all pixels 
(x,y), according to the following equation. 
𝐼𝑛𝑜𝑟𝑚(𝑥, 𝑦, 𝜆) =
𝐼𝑟𝑎𝑤(𝑥, 𝑦, 𝜆) − 𝐼𝑑𝑎𝑟𝑘 𝑐𝑢𝑟𝑟𝑒𝑛𝑡(𝑥, 𝑦, 𝜆)




The average spectral signatures after white-dark calibration are shown for all groups 
included in this paper by cohort in Figure 5-1. 
 
 
Figure 5-1. Average hyperspectral signatures for the tissues in the thyroid cohort (a) and 
the salivary cohort (b). 
5.2.2.2 HSI-Synthesized RGB Images 
 A multiplex image is a synthetic composite image generated from a hyperspectral 
image. For this work, several three-band (RGB) multiplex images were synthesized from 
the normalized reflectance HSI hypercubes. The first synthetic RGB was generated from 
the HSI by applying a Gaussian kernel in each color region, which is referred to as HSI-
synthesized Gaussian RGB composite. The second RGB image was constructed from 
human color perception curves originally proposed by Judd et al. 1951 and expanded by 
Vos 1978 [240]. For some tissues, a standard RGB image was also captured for comparison 
by an RGB camera. Figure 5-2 shows a representative surgical tissue specimen of thyroid 
cancer from an RGB-captured camera, HSI-synthesized Gaussian RGB multiplex, and 
HSI-synthesized RGB with human eye perception. 
 117 
 In this paper, we use HSI to simulate three-band images using RGB multiplex 
imaging. However, the sensors of RGB cameras typically employ the Bayer filter [241, 
242] for adapting RGB color spectrums similar to human-eye. While the spectrum of blue 
and green are typically consistent, different RGB camera sensor types have differing 
sensitivity to the red channel components between 400 and 500 nm [241, 242]. Therefore, 
for a subset of thyroid tumor specimens, the component of red channel response between 
400 and 500 nm was manipulated to simulate if this would have an effect on performance 
from the HSI-synthesized human eye RGB multiplex images. 
 
Figure 5-2. A representative specimen of thyroid cancer. (a) Left to right: RGB image from 
standard RGB camera; HSI-synthesized RGB human-eye multiplex image made from 
reflectance HSI using Vos et al. 1978 method; HSI-synthesized Gaussian RGB multiplex 
image made from reflectance HSI. (b) Spectral signatures of human-eye color perception 
of red (R), green (G), and blue (B) colors proposed by Vos et al. 1978. (c) Gaussian kernels 
used for generating Gaussian RGB multiplex images. 
5.2.2.3 Autofluorescence imaging 
 Autofluorescence imaging uses the emission from intrinsic fluorophores in 
biological tissue that are stimulated to fluoresce by external excitation light at specific 
wavelengths. The autofluorescence images were captured using a 455 nm excitation source 
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and a 490 nm long-pass filter using the CRi Maestro imaging system. The long-pass filter 
removes any of the external light from the source that would be reflected into the image 
and allows capturing images of emission-only photons, according to Stokes’ theorem. The 
autofluorescence images were acquired from 500 to 720 nm in 10 nm increments to 
produce a hypercube with 23 spectral bands and final size of 1040×1392×23 pixels. 
5.2.2.4 2-NBDG Imaging 
 A fluorescently tagged glucose molecule, 2-deoxy-2-[(7-nitro-2,1,3-
benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG), is a dye that targets cancer regions by 
producing a stronger signal measured from regions with higher metabolic glucose uptake. 
After the hyperspectral and autofluorescence imaging methods described above, the tissues 
were incubated for 20 minutes in a 160 µM 2-NBDG solution (Cayman Chemical, Ann 
Arbor, MI, USA) at 37 degrees Celsius, quickly rinsed in 1× phosphate buffered solution 
(PBS) to remove excess dye, and fluorescence imaging was performed using the CRi 
Maestro. The images were acquired with the same excitation light source at 455 nm and a 
long-pass filter at 490 nm from 500 to 720 nm in 10 nm increments, producing a hypercube 
that has 23 spectral bands. 
5.2.2.5 Proflavin Imaging 
 The second dye used for fluorescence imaging was proflavin dye, which is 
unaffected by previous 2-NBDG dye because it has a significantly stronger optical signal 
comparatively. Proflavin fluorescent dye binds to DNA and thus allows visualization of 
nuclear morphology, which can improve the ability of machine learning based cancer 
detection methods [213]. Keratin is also a target of proflavin dye, but this should not affect 
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the glandular tissues involved in this study [213, 214]. For proflavin imaging, the tissue 
samples were incubated for 2 minutes in a 0.01% proflavin solution (Sigma Aldrich, St. 
Louis, MO, USA) at room temperature, and the tissues were rinsed in PBS before imaging 
with the CRi Maestro. The images were acquired with an excitation light source at 455 nm 
and a long-pass filter at 490 nm from 500 to 720 nm in 10 nm increments, producing a 
hypercube that contains 23 spectral bands. 
5.2.3 Histological Ground Truth 
 The ground truths for the optical imaging modalities were achieved using digitized 
histology imaging. After acquiring all images, the tissue specimens were inked at the top, 
bottom, left and right edges, and back surface of the tissue to identify tissue orientation in 
histological sections. Tissues were then fixed in formalin, paraffin embedded, and 
sectioned with a microtome, and 5 μm slices were made from the surface that was optically 
imaged. The first high quality slice was kept to serve as the histology ground truth, 
processed with hematoxylin and eosin staining, and digitized using whole-slide scanning 
at 40× objective [243]. A board-certified pathologist with expertise in head and neck 
pathology annotated the tumor and normal areas on the digital histology images.  
 A binary mask was made of the contoured digital histology images, which served 
as the ground truth for the optical imaging modalities. Due to tissue deformations during 
histological processing and slide preparation, the histology ground truth masks needed to 
be registered to the gross-level optical images. The digital histology slide was registered in 
a semi-automated method according to a previously established pipeline of affine, land-
mark, and deformable registration to the gross-level HSI [184, 216]. The transformation 
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was applied to the binary histology mask, and thus a ground truth mask was generated 
matching the gross-level optical images of the tissue specimens. 
5.2.4 Experimental Design 
 The deep learning experimental designs involved training, validation, and testing. 
However, for the two cohorts, thyroid tumors (N=76 patients) and salivary tumors (N=6 
patients), there were different designs of the data partitioning, which was required because 
of the significant differences in sample size. Therefore, the thyroid cohort is used to 
produce fully-independent inter-patient results. However, the salivary cohort is used to 
produce intra-patient training and testing, as described below in detail. 
5.2.4.1 Thyroid Tumors 
 Tumor detection of the thyroid gland was performed in fully-independent patients, 
divided across 5 folds. Each fold served as the fully-independent testing group, while 
training and validation was performed on the patients in the remaining 4 folds, as depicted 
in Figure 5-3. This design was selected to allow test-level performance metrics for all 76 
thyroid patients. 
 
Figure 5-3. Schematic depicting the experimental design of fully-independent training, 
validation, and testing paradigms for the 76 patient thyroid tumor cohort. 
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5.2.4.2 Salivary Gland Tumors 
 Tumor detection in the limited sample size of salivary gland tumors was performed 
using intra-patient experiments. Training and validation was performed on the patients’ 
primary tumor (T) and normal (N) tissues, and testing was performed on the tumor-normal 
(TN) margin tissue. Figure 5-4 shows a schematic diagram of the training and testing 
paradigm. The salivary gland cohort was separated into tumors of the parotid gland (N=3 
patients) and other salivary glands (N=3), as shown in Table 5-1. 
 
Figure 5-4. Flow diagram of intra-patient experiments of the salivary gland, with 
representative tumor of the parotid gland. Intra-patient T and N tissues were used for MLP 
(multilayer perceptron) training, and TN tissue specimens were used for testing. The 
histological ground truth is shown with tumor contour in green. The predicted tumor heat-
map overlay onto the RGB image is shown with tumor predictions (red) and normal 
predictions (green). Areas of specular glare in the heat-map are not classified, and the 
ground-truth tumor contour is in blue. 
5.2.5 Convolutional Neural Network 
 For thyroid tumor detection using 200 tissue specimens from 76 patients, a 
convolutional neural network (CNN) was developed for the effective classification of 
thyroid tissue into tumor and normal using a patch-based approach. The inception-v4 CNN 
architecture [217] was selected because it is one of the top performing CNNs on standard 
tasks like Image-Net, yet has a manageable number of hyperparameters. HSI data has 
several unique challenges due to data size. Therefore, the CNN required modification for 
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HS data pre-processed into image-patches of size 25×25×C pixels, where C represents the 
number of spectral bands. The first convolutional layers were modified for the smaller 
patch-size necessitated by HS data, and the operating resolution in the modular inception 
blocks was reduced to allow more efficient training and classification using the CNN. 
Additionally, squeeze-and-excitation modules were added to increase the performance of 
the CNN [244]. The implemented CNN architecture schematic is detailed in Figure 5-5.  
 
Figure 5-5. Schematic diagram of the modified inception v4 CNN architecture. The CNN 
was customized to operate on the 25×25×91 patch-size selected. The receptive field size 
and number of convolutional filters is shown at bottom of each inception block. The 
convolutional kernel size used for convolutions is shown in italics inside each convolution 
box. Squeeze-and-excitation modules were added to the CNN to increase performance. 
 Image patches (25×25×C) were generated using a sliding window approach with a 
stride of 13 pixels, and the data pre-processing of HSI was performed in MATLAB 
(MathWorks, Inc., Natrick, MA). All deep learning programming was done in the 
TensorFlow python software package [192] on an Ubuntu machine and accelerated with 
CUDA execution on Titan-XP NVIDIA GPUs (Nvidia Corp., Santa Clara, CA). The CNN 
loss function was cross-entropy, the optimizer utilized was Adadelta with an initial learning 
rate of 1.0, and validation performance was calculated every 2 epochs of training data. 
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Training each CNN model was performed for 14 epochs of 8× augmented (reflections and 
rotations) training data, which took about 23 hours to train. Deployment of a fully-trained 
CNN model on a single GPU to classify a new thyroid tissue specimen, which consisted of 
hundreds of patches, was 20 ± 8 seconds (avg. ± st. dev.) for all imaging modalities. The 
heatmaps were produced by averaging the results of overlapping pixel regions in image-
patches, since the 25×25 patches were produced with a stride of 13 pixels, which was used 
to produce a smoother and less coarse final result. 
5.2.5.1 Multilayer Perceptron 
 For salivary gland tumor detection of 16 tissue specimens from 6 patients, a 
simplified artificial neural network, called a multilayer perceptron (MLP), was used for 
intra-patient detection with spectral information only. The MLP consisted of a 91 unit 
spectral vector input, a single hidden layer with 128 neurons, and an output layer of 2 nodes 
(normal or tumor). This simplified MLP was applied only to the salivary gland tumor 
cohort and selected to limit overfitting in this small dataset. The salivary gland cohort was 
separated into parotid gland tumors (N=3 patients) and other salivary gland tumors (N=3 
patients).  
 The spectral signatures of tissue were extracted by local averaging of 5×5 pixel 
blocks to reduce noise. Image pre-processing was used to remove the specular glare pixels 
from both training and testing. For each group, the normal (N) and tumor-only (T) 
specimens’ spectra were used for training (85%) and a subset for validation (15%), and the 
tumor-normal (TN) margin tissue spectra was used for testing. For the parotid group and 
other salivary gland group separately, all patients’ training samples were combined into 
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one training group (6 tissues), and the three TN test specimens were classified. Training 
was performed on the order of a few minutes, and testing was produced in about one 
second. 
5.2.6 Performance Evaluation 
 The principal evaluation metric used for this study was area under the curve (AUC) 
of the receiver operator curve (ROC). The AUC score was selected because it is robust to 
class imbalances within tissues and provides an estimate of performance at all possible 
thresholds of separating the normal and tumor classes. Additionally, the accuracy, 
sensitivity, and specificity were calculated and reported using the tumor probability 
threshold from the validation data. All results were calculated on a tissue specimen level 
and averaged. Additionally, for the final testing results of both cohorts, the 10 pixels at the 
edge of tissue, corresponding to 0.25 mm, were excluded from performance calculations. 
The imaging protocol for ex-vivo tissue specimens was performed using a flat imaging 
surface, so the tissue edges created unnatural curvature where the tissue was too thin to 
provide an adequate imaging signal. Statistical significance was calculated for the test 
results using Student’s t-test and a 0.05 p-value threshold. 
5.3 Results 
5.3.1 Thyroid Tumor Detection 
 Tumor detection for the thyroid cohort with all cancer types combined (N=76) 
demonstrated that the HSI-synthesized RGB multiplex images generated from the HSI 
were the best performing results in terms of average AUC scores with 0.89 and 0.90 for 
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HSI-synthesized Gaussian RGB multiplex and the HSI-synthesized human-eye RGB 
multiplex, respectively. HSI performed with an average AUC score of 0.86. Full results of 
thyroid tumor detection by AUC score, accuracy, sensitivity, and specificity for all imaging 
methods are shown in Table 5-3 and separated by cancer type.  
Table 5-3. Performance results of the optical imaging modalities for the thyroid tumor 
cohort (average ± SEM). The best performing modality for each groups’ evaluation metrics 
is bolded. 
    AUC Accuracy Sensitivity Specificity 
HSI 
All Thyroid Tumors (N=82) 0.86 ± 0.02 78 ± 2% 80 ± 3% 74 ± 3% 
PTC (N=54) 0.86 ± 0.02 76 ± 2% 79 ± 3% 71 ± 4% 
MTC & Insular Ca. (N=6) 0.81 ± 0.09 85 ± 5% 85 ± 5% 72 ± 11% 
Follicular Ad. & Ca. (N=13) 0.90 ± 0.04 80 ± 4% 80 ± 7% 82 ± 5% 
Poorly Diff. Ca. (N=3) 0.90 ± 0.08 81 ± 15% 73 ± 23% 96 ± 4% 
Auto-
fluorescence 
All Thyroid Tumors (N=82) 0.85 ± 0.02 76 ± 2% 83 ± 2% 68 ± 3% 
PTC (N=54) 0.81 ± 0.03 72 ± 2% 79 ± 3% 62 ± 4% 
MTC & Insular Ca. (N=6) 0.86 ± 0.06 80 ± 5% 83 ± 7% 78 ± 6% 
Follicular Ad. & Ca. (N=13) 0.95 ± 0.02 87 ± 3% 93 ± 3% 81 ± 5% 
Poorly Diff. Ca. (N=3) 0.98 ± 0.01 95 ± 1% 95 ± 3% 93 ± 1% 
2-NBDG Dye 
All Thyroid Tumors (N=82) 0.86 ± 0.02 78 ± 2% 75 ± 3% 80 ± 3% 
PTC (N=54) 0.84 ± 0.02 76 ± 2% 72 ± 3% 79 ± 3% 
MTC & Insular Ca. (N=6) 0.84 ± 0.05 80 ± 5% 74 ± 8% 72 ± 10% 
Follicular Ad. & Ca. (N=13) 0.92 ± 0.03 84 ± 4% 82 ± 6% 89 ± 4% 
Poorly Diff. Ca. (N=3) 0.91 ± 0.08 79 ± 11% 81 ± 15% 89 ± 11% 
Proflavin 
Dye 
All Thyroid Tumors (N=82) 0.83 ± 0.02 75 ± 2% 68 ± 3% 80 ± 3% 
PTC (N=54) 0.82 ± 0.02 73 ± 2% 66 ± 4% 77 ± 4% 
MTC & Insular Ca. (N=6) 0.70 ± 0.08 71 ± 4% 60 ± 9% 71 ± 8% 
Follicular Ad. & Ca. (N=13) 0.91 ± 0.03 81 ± 4% 73 ± 7% 93 ± 2% 





All Thyroid Tumors (N=82) 0.89 ± 0.02 79 ± 2% 77 ± 2% 82 ± 3% 
PTC (N=54) 0.87 ± 0.02 77 ± 2% 76 ± 3% 79 ± 4% 
MTC & Insular Ca. (N=6) 0.95 ± 0.03 88 ± 4% 91 ± 4% 82 ± 8% 
Follicular Ad. & Ca. (N=13) 0.90 ± 0.02 77 ± 3% 67 ± 6% 91 ± 2% 





All Thyroid Tumors (N=82) 0.90 ± 0.02 79 ± 2% 80 ± 2% 79 ± 3% 
PTC (N=54) 0.88 ± 0.02 78 ± 2% 80 ± 3% 76 ± 4% 
MTC & Insular Ca. (N=6) 0.96 ± 0.02 88 ± 3% 93 ± 3% 85 ± 6% 
Follicular Ad. & Ca. (N=13) 0.92 ± 0.02 76 ± 3% 68 ± 7% 86 ± 4% 
Poorly Diff. Ca. (N=3) 0.99 ± 0.01 91 ± 3% 92 ± 3% 93 ± 5% 
 
 The average and median AUC scores are presented in Figure 5-6A and B across all 
thyroid tumor types with statistical significance. Combining all thyroid tumors, both 
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implementations of three-band, HSI-synthesized RGB multiplex imaging (average AUC 
score of 0.89 for Gaussian-RGB multiplex and 0.90 for human-eye RGB multiplex) 
outperformed autofluorescence (0.85 AUC score), 2-NBDG (AUC score of 0.86), and 
proflavin (0.83 AUC score) to a degree of statistical significance (all p<0.05). Additionally, 
HSI-synthesized human-eye RGB multiplexing also significantly outperformed HSI 
(p<0.05). For the PTC sub-group (N=54), both HSI-synthesized RGB multiplex images 
statistically outperformed autofluorescence, 2-NBDG, and proflavin (all p<0.05). For the 
MTC group (N=6), both HSI-synthesized RGB multiplex images significantly 
outperformed 2-NBDG and proflavin (all p<0.05). For the follicular tumor group, 
autofluorescence outperforms the other methods in AUC score, but the difference is not 
significant (p>0.05). Lastly, poorly differentiated thyroid carcinomas were classified with 
the highest AUC score from HSI-synthesized human-eye RGB multiplex imaging, but not 
significantly (p>0.05). 
 
Figure 5-6. Average and median AUC scores from thyroid tumor detection. (a) average 
AUC scores for thyroid tumor detection across all tissue specimens grouped by tumor 
subtype; statistical significance (*, p<0.05) is shown above. (b) median AUC scores of 
tumor subtype detection. 
 The different imaging modalities and respective probability heat-maps for tumor 
detection are shown in Figure 5-7 for all groups of thyroid tumors. As can be seen, HSI 
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shows the most consistent heat-maps around regions of specular glare, compared to the 
HSI-synthesized RGB multiplex methods. As shown in Figure 5-6B, the median AUC 
scores show that HSI (0.95) and the two HSI-synthesized RGB multiplex methods (0.95 
and 0.96) have approximately equivalent median performance for combined thyroid 
tumors.  
 
Figure 5-7. Representative tissue images and corresponding classification heat-maps from 
all modalities from patients with thyroid carcinoma. Columns from left to right: histology, 
HSI with heat-map, HSI-synthesized Gaussian-RGB multiplex with heat-map, HSI-
synthesized  human-eye RGB multiplex with heat-map, autofluorescence with heat-map, 
2-NBDG dye image with heat-map, Proflavin dye image with heat-map. Rows from top to 
bottom: papillary thyroid carcinoma (PTC), medullary thyroid carcinoma (MTC), 
follicular thyroid carcinoma, and poorly differentiated thyroid carcinoma. The contours in 
white (in heat-maps) and green (on histology) outline the cancerous regions. Predicted 
tumor heat-maps range from dark blue (predicted normal) to dark red (predicted cancer). 
 The median AUC scores are substantially greater than the averages, which indicates 
that the distribution of performance results tends to be more accurate than the average 
reflects. Histogram analysis of percent difference of the HSI and HSI-synthesized RGB 
multiplex imaging methods shows that HSI-synthesized RGB outperforms HSI in a 
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relatively small number of tissue specimens, which causes the average AUC scores for 
HSI-synthesized RGB multiplexing to be greater than HSI. Figure 5-8A and C show the 
histograms of percent difference in tissues from HSI to both Gaussian-RGB multiplex and 
the human-eye RGB multiplex, respectively. Additionally, Figure 5-8B and D show the 
tissue specimens with the largest differences in AUC scores compared to HSI, where HSI-
synthesized RGB multiplexing still works quite well.  
 
Figure 5-8. Differences in AUC score performance comparing HSI against HSI-
synthesized Gaussian-RGB multiplex and HSI-synthesized human-eye RGB multiplexing. 
(a) Histogram of percent difference in AUC scores of tissue specimens between HSI and 
HSI-synthesized Gaussian-RGB multiplex imaging. The arrows show the bins that contain 
the patient specimens shown in the right panels, which are the two worst performing 
tissues. (b) RGB image of tissue specimen with large difference in AUC score performance 
between heat-maps produced from HSI, HSI-synthesized Gaussian multiplex, and HSI-
synthesized human-eye multiplex image. (c) Histogram of percent difference in AUC 
scores of tissue specimens between HSI and HSI-synthesized human-eye RGB multiplex 
imaging. The arrows show the bins that contain the patient specimens shown in the right 
panels, which are the two worst performing tissues. (d) RGB image of the tissue specimen 
with the largest difference in AUC score performance between heat-maps produced from 
HSI, HSI-synthesized Gaussian multiplex, and HSI-synthesized human-eye multiplex 
image. The tumor margin is delineated in white. 
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 The three-band HSI-synthesized RGB multiplex images from HSI are meant to 
represent RGB imaging. However, these multiplex images are still constructed from HSI 
data. Standard RGB camera sensors have different responses to the component of the red 
channel between 400 and 500 nm. Therefore, for fold 1 of the HSI-synthesized human-eye 
RGB multiplex thyroid tumor detection, the red channel component from 400 to 500 nm 
was multiplied by half and by zero, and two more CNNs were trained. The results are 
plotted in Figure 5-9. The original human-eye multiplex result for fold 1 using the original 
400-500 nm red component was an AUC score of 0.90 for thyroid tumor detection. 
Completely eliminating the 400-500 nm red component (by multiplying by zero) in human-
eye multiplex still resulted in an equivalent AUC score of 0.90 for thyroid tumor detection 
(p>0.05). Lastly, an equivalent AUC score of 0.89 for thyroid tumor detection was obtained 
when the 400-500nm red component was set to half the original value for human eye 
multiplexing (p>0.05). 
 
Figure 5-9. AUC score results with 95% confidence interval from 1 fold of the testing data 
comparing different methods of constructing HSI-synthesized RGB multiplex images. Left 
to right: Standard HSI; Gaussian-RGB from HSI; original HSI-synthesized human-eye 
RGB from HSI; human-eye RGB from HSI synthesized with half of the 400-500 nm red 




 To further investigate how CNN methods can utilize HSI and the relevant 
wavelengths for correctly predicting normal and thyroid tissues, we incorporated the 
gradient class-activated maps (grad-CAM) algorithm [218]. Briefly, the method is used for 
tracing the most relevant gradients from the input data to the class of interest, either normal 
or tumor, which is used to infer spectral feature saliency. The mean spectral signatures and 
class-activated gradients were averaged for 89 tissues that were correctly classified with 
high AUC scores and separated into normal thyroid and tumor (Figure 5-10). As can be 
observed in Figure 5-10A, the salient spectral features for correctly classifying normal 
thyroid tissues were from 570-700 nm. In Figure 5-10B, the most salient spectral features 
for correctly classifying thyroid tumors were also in the range of 550-700 nm, with 
additional bands near 500 and 750 contributing some lesser importance for classification.  
 
 
Figure 5-10. Mean spectral signatures of correctly-classified normal thyroid tissues (a) and 
thyroid tumors (b). The saliency of spectral features is identified below each plot using the 
grad-CAM technique. Red hues represent the most important features for correctly 
predicting each tissue class, and blue color hues represent less important wavelengths for 
correctly predicting each class. 
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5.3.2 Salivary Gland Tumor Detection 
 The intra-patient tumor detection results of the salivary gland tumors cohort are 
separated into parotid gland tumors and other salivary gland tumors. For parotid gland 
tumors, HSI was the best performing imaging modality with an AUC score of 0.92, 
accuracy of 88%, sensitivity of 90%, and specificity of 79% (all differences were not 
significant, p>0.05). For tumors of other salivary glands, autofluorescence was the best 
performing imaging modality with an AUC score of 0.80, accuracy of 84%, sensitivity of 
77%, and specificity of 85% (all differences were not significant, p>0.05). The full results 
are shown in Table 5-4.  
Table 5-4. Performance results from all optical imaging modalities for the salivary tumor 
cohort, separated by salivary gland group (average ± SEM). The best performing modality 
for each groups’ evaluation metrics is bolded. 
Group Imaging AUC Accuracy Sensitivity Specificity 
Parotid 
(N=3) 
HSI 0.92 ± 0.04 88 ± 4% 90 ± 4% 79 ± 7% 
Autofluorescence 0.60 ± 0.30 87 ± 2% 99 ± 1% 26 ± 26% 
2-NBDG Dye 0.77 ± 0.12 87 ± 2% 97 ± 3% 31 ± 31% 
 Proflavin Dye 0.64 ± 0.32 89 ± 2% 96 ± 2% 54 ± 27% 
 Gaussian-RGB 0.66 ± 0.15 81 ± 5% 97 ± 2% 38 ± 24% 




HSI 0.59 ± 0.14 76 ± 12% 55 ± 29% 85 ± 15% 
Autofluorescence 0.80 ± 0.14 84 ± 10% 77 ± 13% 85 ± 6% 
2-NBDG Dye 0.52 ± 0.08 76 ± 11% 49 ± 28% 84 ± 16% 
Proflavin Dye 0.62 ± 0.10 77 ±11% 60 ± 30% 78 ± 22% 
 Gaussian-RGB 0.45 ± 0.03 70 ± 10% 62 ± 31% 57 ± 43% 
 Human-Eye 0.78 ± 0.15 84 ± 9% 76 ± 12% 87 ± 6% 
 
5.4 Discussion 
 The results of this extensive study suggest that label-free HS-based imaging and 
autofluorescence does indeed outperform the two fluorescent dye-based imaging methods 
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tested here for thyroid tumor detection, but not to a significant degree. Interestingly, we 
discovered that HSI-synthesized RGB multiplex imaging significantly outperforms all 
imaging methods tested for thyroid tumor detection, including HSI and autofluorescence 
(p<0.05). For salivary tumor detection, HSI performs best in the parotid gland and 
autofluorescence in performs best in other salivary glands, but no difference was 
significant. As can be observed in Figure 5-6B, one main conclusion from this work is that 
with sufficiently large datasets, many different optical imaging modalities can be used to 
create deep learning algorithms for tumor detection with median AUC scores of 0.90 and 
upwards. This phenomenon can be seen specifically for the thyroid tumors combined 
cohort. 
 The experiments for the thyroid cohort and salivary gland cohort were processed 
separately in different ways because of vastly different numbers of tissue samples 
collected. The thyroid tumor cohort experiment was investigated in fully-independent 
testing patients because 200 tissue specimens from 76 patients were available. The salivary 
tumor cohort was comprised of only 16 tissues from 6 patients, so intra-patient experiments 
were performed using tumor-only and normal specimens for training and testing on tumor-
normal margin tissues.  
 The hypothesis that HSI-based methods would outperform fluorescent dye-based 
methods was upheld in the thyroid tumor combined category, largely because it was 
supported in the PTC group (N=54), which comprises 71% of cases. However, it was not 
supported for MTC, FTC, and poorly differentiated thyroid carcinoma groups (all p values 
were not significant). Additionally, the thyroid tumor detection results show that HSI-
synthesized human-eye RGB multiplex imaging made from HSI statistically outperforms 
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reflectance-based HSI. Despite differences in average AUC scores, the median values are 
equivalent around 0.95 (see Figure 5-6). Exploring this phenomenon further in Figure 5-8, 
it was demonstrated that only a few tissues differ between the HSI and HSI-synthesized 
RGB multiplex modalities. Moreover, the probability heat-maps from HSI seem to provide 
more consistent classification around regions of significant specular glare compared to the 
HSI-synthesized multiplex methods (Figure 5-7). These results are consistent with a 
previous study from our group that was limited to only 11 thyroid patients, in which RGB 
composite images (AUC score of 0.95) also outperformed HSI (AUC score of 0.92) [33]. 
 The purpose of the three-band HSI-synthesized multiplex images synthesized from 
HSI was to represent standard RGB imaging from a standard camera. However, these 
multiplex images are still constructed from HSI data. Additionally, there are differences in 
the spectral responses to the red channel component from 400-500 nm in standard RGB 
camera sensors. The impact of this red component value was studied, and no effect was 
observed in AUC score by altering these values for HSI-synthesized human-eye RGB 
multiplexing. To provide physical intuition for this conclusion, the grad-CAM method 
reveals that the most salient spectral features for correctly classifying normal thyroid 
tissues were from 570-700 nm, well above this range. Future studies are required to 
investigate if a standard RGB camera would indeed outperform HSI directly. Additionally, 
future work is needed to capture more thyroid tumor HSI data with higher spatial and 
spectral resolution HS cameras. It is possible that the spectral resolution of 5 nm in this 




 In conclusion, this chapter presents the extensive study using 216 glandular tissue 
samples from all 82 patients with thyroid and salivary gland tumors in our acquired dataset 
for this thesis work to evaluate the performance of HSI for tumor detection of the thyroid 
and salivary glands. For comparison to HSI, the tissues were imaged with label-free 
autofluorescence and two fluorescent dyes, 2-NBDG and proflavin dye. Additionally, HSI-
synthesized three-band multiplex images, representing the human-eye response and 
Gaussian RGBs, were synthesized from HSI. Several CNNs were developed for tumor 
detection that perform with median AUC scores of 0.90 and higher for all imaging 
modalities in combined thyroid tumors. Investigating each group specifically, our results 
suggest that HSI-synthesized human-eye RGB multiplexing can classify thyroid tumors 
significantly better than HSI. In salivary glands, label-free HSI and autofluorescence may 
offer the best performance for tumor detection. The conclusions from this chapter 






CHAPTER 6. TISSUE SUB-COMPONENT CLASSIFICATION 
USING HSI 
  This chapter details the investigation of the ability for HSI to perform sub-
component analysis, beyond normal versus cancer, in a subset of the head and neck tissues. 
We developed a method to use HSI, a non-contact optical imaging modality, and 
convolutional neural networks (CNNs) to perform an optical biopsy of ex-vivo, surgical 
gross-tissue specimens, collected from 21 patients undergoing surgical cancer resection. 
Using a cross-validation paradigm with data from different patients, normal tissue from the 
upper aerodigestive tract can be sub-classified into squamous epithelium, muscle, and 
gland with an average AUC score of 0.94. After separately training on thyroid tissues, the 
CNN can discriminate between thyroid carcinoma and normal thyroid with an AUC score 
of 0.95 and 92% accuracy/sensitivity/specificity. Moreover, further analysis was 
performed, detecting medullary thyroid carcinoma from benign multi-nodular goiter 
(MNG) with an AUC of 0.93, and papillary thyroid carcinoma from MNG with an AUC 
of 0.91. These preliminary results demonstrate that an HSI-based optical biopsy method 
using CNNs can provide multi-category diagnostic information for normal and cancerous 
head and neck tissue. 
6.1  Introduction 
 Cancers of the head and neck are the sixth most common cancer world-wide, 
including cancers that are predominately of squamous cell origin, for instance the oral 
cavity, nasopharynx, pharynx, and larynx, and others like carcinomas of the thyroid gland 
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[139]. Major risk factors include consumption of tobacco and alcohol, exposure to 
radiation, and infection with human papilloma virus (HPV) [140, 245]. Approximately 
90% of cancer at sites including the lips, gums, mouth, hard and soft palate, and anterior 
two-thirds of the tongue are squamous cell carcinoma (SCC) [2]. The diagnostic procedure 
of SCC typically involves physical examination and surgical evaluation by a physician, 
tissue biopsy, and diagnostic imaging, such as PET, MRI, or CT. Patients with SCC tend 
to present with advanced disease, with about 66% presenting as stage III or IV disease, 
which requires more procedures for successful treatment of the patient [141]. The standard 
treatment for these cancers usually involves surgical cancer resection with potential 
adjuvant therapy, such as chemotherapy or radiation, depending on the extent, stage, and 
location of the lesion. Successful surgical cancer resection is a mainstay treatment of these 
cancers in order to prevent local disease recurrence and promote disease free survival [4].  
 Previous studies have investigated the optical properties of normal and malignant 
tissues from areas of the upper aerodigestive tract [246-249]. Muller et al. acquired in-vivo 
reflectance-based spectroscopy from normal, dysplasia, inflammation, and cancer sites in 
the upper aerodigestive tract from patients with SCC to extract tissue parameters that yield 
biochemical or structural information for identifying disease. Varying degrees of disease 
and normal tissue could be distinguished because of their different optical properties that 
were believed to be related to collagen and nicotinamide adenine dinucleotide (NADH) 
[246]. Similarly, Beumer et al. acquired reflectance spectroscopy measurements from 450 
to 600 nm from patients with SCC and implemented an inverse Monte Carlo method to 
derive oxygenation-based tissue properties from the optical signatures, which were found 
to be significantly different in malignant and non-malignant tissues [249]. 
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 Hyperspectral imaging (HSI) is a non-contact, optical imaging modality capable of 
acquiring a series of images at multiple discrete wavelengths, typically on the order of 
hundreds of spectral bands. Preliminary research demonstrates that HSI has potential for 
providing diagnostic information for a myriad of diseases, including anemia, hypoxia, 
cancer detection, skin lesion and ulcer identification, urinary stone analysis, enhanced 
endoscopy, and many potential others in development [14-25]. Supervised machine 
learning and artificial intelligence algorithms have demonstrated the ability to classify 
images after being allowed to learn features from training or example images. One such 
method, convolutional neural networks (CNNs), have demonstrated astounding 
performance at image classification tasks due to their capacity for robust handling of 
training sample variance and ability to extract features from large training data sizes [26, 
27]. 
 The need for an imaging modality that can perform diagnostic prediction could 
potentially aid surgeons with real-time guidance during intra-operative cancer resection. 
This study aims to investigate the ability of HSI to classify tissues from the thyroid and 
upper aerodigestive tract using convolutional neural networks. This work was initially 
presented as a conference proceedings and oral presentation [171]. First, a simple binary 
classification is performed, i.e. cancer versus normal, and second, multi-class sub-
classification of normal upper aerodigestive tract samples is investigated. If proven to be 
reliable and generalizable, this method could help provide intra-operative diagnostic 
information beyond palpation and visual inspection to the surgeon’s resources, perhaps 
enabling surgeons to achieve more accurate cuts and biopsies, or as a computer-aided 
diagnostic tool for physicians diagnosing and treating these types of cancer. 
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6.2 Methods 
 To investigate the ability of HSI to perform optical biopsy, we recruited patients 
with thyroid or upper aerodigestive tract cancers into our study, acquired and processed 
gross-level HSI of freshly excised tissue specimens, trained our convolutional neural 
network, and evaluated system performance. 
6.2.1 Experimental Design 
 In collaboration with the Otolaryngology Department and the Department of 
Pathology and Laboratory Medicine at Emory University Hospital Midtown, 21 head and 
neck cancer patients who were electing to undergo surgical cancer resection were recruited 
for our study to evaluate the efficacy of using HSI for optical biopsy [147, 170]. From these 
21 patients, a total of 63 excised tissue samples were collected. From each patient, 3 tissue 
samples were obtained from the primary cancer gross specimen in the surgical pathology 
department after the primary cancer had been resected. The specimens were selected to 
include tumor, normal, and a tissue at the tumor-normal interface. Each specimen was 
typically around 10 by 10 mm in area and 3 mm in depth. The collected tissues were kept 
in cold PBS during transport to the imaging laboratory where the specimens were scanned 
with a hyperspectral imaging system [33, 113].  
 Two regions of interest were used for this study: firstly, the upper aerodigestive 
tract sites, including tongue, larynx, pharynx, and mandible; and secondly, the thyroid and 
associated carcinomas. Head and neck squamous cell carcinoma (HNSCC) of the 
aerodigestive tract represented the first group, comprised of 7 patients. Normal tissue was 
obtained from all patients in the HNSCC group, and SCC was obtained from 6 of these 
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patients. In head and neck cancers, the non-cancerous tissues adjacent to SCC may be 
dysplastic, inflammatory, or keratinized, which could affect the hyperspectral imaging 
results. Therefore, the normal tissues included in this study were regions of normal tissue 
that were not dysplastic or heavily inflamed tissues. The thyroid group consisted of 14 
patients total and included one benign neoplasm and three malignant neoplasms: benign 
multi-nodular goiter (MNG, 3 patients), classical-type papillary thyroid carcinoma (cPTC, 
4 patients), follicular-type papillary thyroid carcinoma (fPTC, 4 patients), and medullary 
thyroid carcinoma (MTC, 3 patients), respectively.  
 After imaging with HSI, tissues were fixed in formalin, underwent haemotoxylin 
and eosin (H&E) staining, paraffin embedded, sectioned, and digitized. A certified 
pathologist with head and neck expertise confirmed the diagnoses of the ex-vivo tissues 
using the digitized histology slides in Aperio ImageScope (Leica Biosystems Inc, Buffalo 
Grove, IL, USA). The histological images serve as the ground truth for the experiment. 
6.2.2 Hyperspectral Imaging and Processing 
 The hyperspectral images were acquired using a CRI Maestro imaging system 
(Perkin Elmer Inc., Waltham, Massachusetts), which is comprised of a Xenon white-light 
illumination source, a liquid crystal tunable filter, and a 16-bit charge-coupled device 
(CCD) camera capturing images at a resolution of 1040 by 1,392 pixels and a spatial 
resolution of 25 µm per pixel [113, 145, 170, 183]. The hypercube contains 91 spectral 
bands, ranging from 450 to 900 nm with a 5 nm spectral sampling interval. The average 
imaging time for acquiring a single HSI was about 1 minute.  
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 The hyperspectral data were normalized at each wavelength (λ) sampled for all 
pixels (i, j) by subtracting the inherent dark current (captured by imaging with a closed 
camera shutter) and dividing by a white reference disk according to the following equation 
[145, 170]. The normalized HSI spectral signatures are plotted by class in Figure 6-1. 
𝐼𝑛𝑜𝑟𝑚(𝜆, 𝑖, 𝑗) =
𝐼𝑟𝑎𝑤(𝜆, 𝑖, 𝑗) − 𝐼𝑑𝑎𝑟𝑘 𝑐𝑢𝑟𝑟𝑒𝑛𝑡(𝜆, 𝑖, 𝑗)
𝐼𝑤ℎ𝑖𝑡𝑒 𝑟𝑒𝑓(𝜆, 𝑖, 𝑗) − 𝐼𝑑𝑎𝑟𝑘 𝑐𝑢𝑟𝑟𝑒𝑛𝑡(𝜆, 𝑖, 𝑗)
 
 
Figure 6-1. Normalized spectral signatures, which were averaged across tissues. Presented 
by anatomical location: (a) normal tissue and SCC of the upper aerodigestive tract, (b) 
normal, benign, and carcinoma of the thyroid. 
 Specular glare is created on the tissue surfaces due to wet surfaces completely 
reflecting incident light. Glare pixels do not contain useful spectral information for tissue 
classification and are hence removed from each HSI by converting the RGB composite 
image of the hypercube to grayscale and experimentally setting an intensity threshold that 
sufficiently removes the glare pixels, assessed by visual inspection. 
 A schematic of the classification scheme is shown in Figure 6-2. For binary cancer 
classification, the classes used are normal aerodigestive tissue versus SCC, and medullary 
and papillary thyroid carcinoma versus normal thyroid tissue. For multi-class classification 
of oral and aerodigestive tract tissue, squamous epithelium, skeletal muscle, and salivary 
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glands in the oral mucosa are used. For binary classifications of thyroid cancer, classical-
type papillary thyroid carcinoma, medullary thyroid carcinoma, and multi-nodular thyroid 
goiter tissue are used.  
 
Figure 6-2. Tissue classification scheme. (a) For classification of the HNSCC group, first 
a binary classification is considered to test the ability of the classifier to distinguish normal 
samples from SCC samples. Next, histologically confirmed normal samples are sub-
classified squamous epithelium, skeletal muscle, and mucosal salivary glands. (b) For 
classification of the thyroid group, first a binary classification is considered to test the 
ability of the classifier to distinguish normal thyroid samples from thyroid carcinoma of 
multiple types. In addition, thyroid HSI classification is tested to discriminate MNG from 
MTC and to discriminate MNG from classical-type PTC. 
 To avoid introducing error from registration of tissue samples that contain a tumor-
normal boundary, only samples that contain exactly one class were used for binary 
classification. For example, the tumor sample and normal sample are held out for testing, 
so that validation performance can be evaluated on both class types. Out of the initial 63 
samples acquired from 21 patients recruited for this study, this elimination process 
excluded 22 tissue samples because it was found that two tumor-normal margin samples 
were obtained from one patient. The normal samples from the patients with MNG thyroid 
neoplasm were not included in the binary cancer detection experiment. Additionally, after 
clinical histological evaluation, it was determined that one ex-vivo specimen from one 
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papillary thyroid carcinoma patient was an adenomatoid nodule. This type of lesion is 
reported in the literature to commonly cause misdiagnoses in initial needle biopsies [250, 
251], and importantly, this lesion type was not adequately represented in the current study. 
Therefore, the two remaining tissue samples from this patient were removed from this 
study because we aimed to have balanced tissue specimens from the thyroid carcinoma 
patients, normal and tumor. After all exclusionary criteria were determined, there were 36 
tissue specimens from 20 patients, 7 HNSCC and 13 thyroid, incorporated in this study, 
and the epithelium, muscle, and gland tissue components were selected as ROIs from 7 
tissue samples from the HNSCC group. The number and type of tissue specimens is 
detailed in Table 6-1. 
Table 6-1. Number of ex-vivo tissue specimens included in this study from the 13 patients 
with thyroid neoplasms and 7 patients with SCC. The number of image patches for CNN 
classification obtained from each specimen type is also reported. 
Group Class No. Tissue Specimens Total Patches 
Thyroid Normal Thyroid 10 14,491 
MNG 3 9,778 
MTC 3 10,334 
Classical PTC 3 6,836 
Follicular PTC 4 13,200 
HNSCC Squamous Epithelium 4 6,366 
Skeletal Muscle 3 5,238 
Mucosal Gland 4 5,316 
SCC 6 4,008 
 
 For training and testing the CNN, each patient HSI needs to be divided into patches. 
Patches are produced from each HSI after normalization and glare removal to create 
25×25×91 non-overlapping patches that do not include any “black-holes” where pixels 
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have been removed due to specular glare; see Table 6-1 for the total number of patches per 
class. Glare pixels are intentionally removed from the training dataset to avoid learning 
from impure samples. In addition, patches were augmented by 90, 180, and 270 degree 
rotations and vertical and horizontal reflections, to produce six times the number of 
samples. For cancer classification, the patches were extracted from the whole tissue. While 
for multi-class sub-classification of normal tissues, the regions of interest comprised of the 
classes of target tissue were extracted using the outlined gold-standard histopathology 
images. 
6.2.3 Convolutional Neural Network 
 The convolutional neural networks used in this study were built from scratch using 
the TensorFlow application program interface (API) for Python. A high-performance 
computer was used for running the experiments, operating on Linux Ubuntu 16.04 with 2 
Intel Xeon 2.6 GHz processors, 512 GB of RAM, and 8 NVIDIA GeForce Titan XP GPUs. 
Two distinct CNN architectures were implemented for HNSCC classification, which 
incorporated inception modules, and thyroid classification, which used a 3D architecture. 
Both architectures are detailed below and shown schematically in Figure 6-3. During the 
following experiments, only the learning-related hyper-parameters that were adjusted 
between experiments, which include learning rate, decay of the Adadelta gradient 
optimizer, and batch-size. Within each experiment type, the same learning rate, rho, and 
epsilon were used, but some cross-validation iterations used different numbers of training 
steps because of earlier or later training convergence.  
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Figure 6-3. CNN architectures implemented for classification of HSI of thyroid tissue (left) 
and tissue from the upper aerodigestive tract (right). 
 To classify thyroid tissues, a 3D-CNN based on AlexNet, an architecture originally 
designed for ImageNet classification, was implemented using TensorFlow [26, 192]. The 
model consisted of six convolutional layers with 50, 45, 40, 35, 30, and 25 convolutional 
filters, respectively. Convolutions were performed with a convolutional kernel of 5×5×9, 
which correspond to the x-y-λ dimensions. Following the convolutional layers were two 
fully connected layers of 400 and 100 neurons each. A drop-out rate of 80% was applied 
after each layer. Convolutional units were activated using rectified linear units (ReLu) with 
Xavier convolutional initializer and a 0.1 constant initial neuron bias [252]. Step-wise 
training was done in batches of 10 patches for each step. Every one thousand steps the 
validation performance was evaluated, and the training data were randomly shuffled for 
improved training. Training was done using the AdaDelta, adaptive learning, optimizer for 
reducing the cross-entropy loss with an epsilon of 1×10-8 and rho of 0.9 [253]. For thyroid 
normal versus carcinoma, the training was performed at a learning rate of 0.1 for two to six 
thousand steps depending on the iteration. For MNG versus MTC and for MNG versus 
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cPTC, the training was done at a learning rate of 0.005 for exactly two thousand steps for 
all iteration.  
 Classification of upper aerodigestive tract tissues was hypothesized to be a more 
complex task, so a 2D-CNN architecture was constructed to include a modified version of 
the inception module appropriate for HSI that does not include max-pools and uses larger 
convolutional kernels, implemented using TensorFlow [26, 27, 192]. The modified 
inception module simultaneously performs a series of convolutions with different kernel 
sizes: a 1×1 convolution; and convolutions with 3×3, 5×5, and 7×7 kernels following a 1×1 
convolution. The model consisted of two consecutive inception modules, followed by a 
traditional convolutional layer with a 9×9 kernel, followed by a final inception module. 
After the convolutional layers were two consecutive fully connected layers, followed by a 
final soft-max layer equal to the number of classes. A drop-out rate of 60% was applied 
after each layer. For binary classification, the number of convolutional filters were 355, 
350, 75, and 350, and the fully connected layers had 256 and 218 neurons. For multi-class 
classification, the number of convolutional filters were 496, 464, 36, and 464, and the fully 
connected layers had 1024 and 512 neurons. Convolutional units were activated using 
rectified linear units (ReLu) with Xavier convolutional initializer and a 0.1 constant initial 
neuron bias [252]. Step-wise training was done in batches of 10 (for binary) or 15 (for 
multi-class) patches for each step. Every one thousand steps the validation performance 
was evaluated and the training data were randomly shuffled for improved training. Training 
was done using the AdaDelta, adaptive learning, optimizer for reducing the cross-entropy 
loss with an epsilon of 1×10-8 (for binary) or 1×10-9 (for multi-class) and rho of 0.8 (for 
binary) or 0.95 (for multi-class) [253]. For normal oral tissue versus SCC binary 
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classification, the training was done at a learning rate of 0.05 for five to fifteen thousand 
steps depending on the patient-held-out iteration. For multi-class sub-classification of 
normal aerodigestive tract tissues, the training was done at a learning rate of 0.01 for three 
to five thousand steps depending on the patient-held-out iteration.  
6.2.4 Validation 
 The final layer of the CNN labels each test case as the class with the highest 
probability overall, so each test patch has exactly one label. In addition, the probabilities 
of each test patch belonging to all classes are output from the network. All testing is done 
on a patch-based level to ensure class accuracy. The typical classification time for one 
patient’s entire HSI was on the order of several minutes. The class probabilities for all 
patches of a test patient case are used to construct receiver operator characteristic (ROC) 
curves using MATLAB (MathWorks Inc, Natick, MA, USA). For binary classification, 
only one ROC curve is created per patient test case, but for multi-class classification, each 
class is used to generate a respective ROC curve; true positive rate and false positive rate 
are calculated as that class against all others. The CNN classification performance was 
evaluated using leave-one-patient-out external-validation to calculate the sensitivity, 
specificity, and accuracy, defined below, using the optimal operating point of each patient’s 
ROC curve [33, 170]. The area under the curve (AUC) for the ROC curves is calculated as 
well and averaged across patients.  
Sensitivity =
True Positives








True Positives + True Negatives
Total Number of Samples
 
6.3 Results 
6.3.1 Aerodigestive Tract Normal Tissue Sub-classification 
 Using a leave-one-patient-out cross-validation paradigm with HSI obtained from 
different patients, the CNN can distinguish SCC from normal oral tissues with an AUC of 
0.82, 81% accuracy, 81% sensitivity, and 80% specificity. Table 6-2 shows the full results. 
The ROC curves for all HNSCC patients are shown in Figure 6-4. Additionally, normal 
oral tissues can be sub-classified into squamous epithelium, muscle, and glandular mucosa 
using a separately trained CNN, with an average AUC of 0.94, 90% accuracy, 93% 
sensitivity, and 89% specificity. Representative normal sub-classification results are shown 
in Figure 6-5, and full results are detailed in Table 6-3.  
Table 6-2. Results of inter-patient CNN classification (leave-one-patient-out cross-




AUC Acc. (%) Sens. (%) Spec. (%) 
Thyroid Normal vs Carcinoma 20 0.95±0.07 92±9 92±8 92±10 
cPTC vs MNG 7 0.91±0.10 86±13 86±14 86±13 
MTC vs MNG 6 0.93±0.04 87±5 88±4 85±7 
HNSCC Normal vs SCC 13 0.82±0.13 81±11 81±15 80±16 
Multi-class 7 0.94±0.08 90±9 93±6 89±13 
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Figure 6-4. HSI classification results ROC curves for HNSCC experiments generated 
using leave-one-out cross-validation. (a) binary classification of SCC and normal head and 
neck tissue; (b) multi-class sub-classification of normal aerodigestive tract tissues. 
 
Figure 6-5. Representative results of sub-classification of normal oral tissues. Left: HSI-
RGB composites are shown with ROI of the tissue type outlined. Center: Respective 
histological gold standard with corresponding ROI outlined. Right: Artificially colored 
CNN classification results of the ROI only. True positive results representing correct 
tissue-subtype are visualized in blue, and false negatives are shown in red. Tissue within 
the ROI that is shown in grayscale represents tissue that is not classified due to glare pixels 
or insufficient area to produce the necessary patch-size. 
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Table 6-3. Results of inter-patient CNN classification of sub-classified normal upper 
aerodigestive tract tissues. Values reported are averages shown with standard deviation. 
 
6.3.2 Thyroid Tissue Sub-classification  
 After separately training on thyroid tissue, the CNN differentiates between thyroid 
carcinoma and normal thyroid with an AUC of 0.95, 92% accuracy, 92% sensitivity, and 
92% specificity. The ROC curves for all thyroid patients are shown in Figure 6-6. 
Moreover, the CNN can discriminate MTC from benign MNG with an AUC of 0.93, 87% 
accuracy, 88% sensitivity, and 85% specificity. Classical-type papillary thyroid carcinoma 
is differentiated from MNG with an AUC of 0.91, 86% accuracy, 86% sensitivity, and 86% 
specificity. 
 
Figure 6-6. HSI classification results ROC curves for HNSCC experiments generated 
using leave-one-out cross-validation. (c) binary classification of normal thyroid and 
thyroid carcinomas; (d) binary classification of MNG and MTC; (e) binary classification 





AUC Accuracy Sensitivity Specificity 
Squamous Epithelium 4 0.94±0.06 90±5% 91±3% 91±7% 
Skeletal Muscle 3 0.99±0.01 98±3% 98±3% 97±4% 
Mucosal Gland 4 0.89±0.10 83±13% 90±8% 79±18% 
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6.4 Discussion 
 We developed a deep learning based classification method for hyperspectral images 
of fresh surgical specimens. The study demonstrated the ability of HSI and convolutional 
neural networks for discriminating between normal tissue and carcinoma. The novel results 
of normal tissue sub-classification into categories of squamous epithelium, skeletal muscle, 
and glandular mucosa demonstrate that there is further classification potential for HSI. 
 A review of surgical cases found that head and neck surgery has the most intra-
operative pathologist consultations (IPC) per surgery, typically around two consultations 
per surgery, compared to other organ systems [254]. The average time at our institution 
was about 45 minutes per IPC. Despite being currently un-optimized and performed off-
line, our method takes around 5 minutes including imaging time, classification, and post-
processing. The main benefit is that the proposed method does not require excising tissue 
or any tissue processing to provide diagnostic information of the surgical area. 
Additionally, our method is demonstrated to be significantly faster than an average IPC. 
However, we do not suggest that the proposed method could replace an IPC, but rather 
provide guidance during surgery to reduce the number or increase the quality of IPCs.  
 In this study, the limited patient dataset reduces the generalizability of the results. 
In addition, the ROI technique for outlining tissues of interest for normal multi-class sub-
classification creates the potential to introduce error into the experiment. Both of these 
issues could be resolved by utilizing a large number of patient data. Moreover, the gross 
tissue specimens utilized in this study are entirely cancer or normal, so the cancer samples 
are comprised of sheets of malignant cells. In order for the proposed method to be extended 
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to the operating room to aid in the resection of cancer, the method needs to be investigated 
on detecting cancer cells extending beyond the cancer edge. Therefore, future studies will 
investigate the ability of the proposed method to accurately predict the ideal resection 
margin of cancerous tissues.  
 When the diagnosis of thyroid cancer is suspected, a needle biopsy is performed, 
which can provide information on the histological and intrinsic type of cancer that is 
present. It is not uncommon for thyroid cancer to be present with benign hyperplasia of the 
non-malignant portions of the effected lobe. However, the co-occurrence of both MTC and 
PTC is rare, although cases have been documented [255-257]. We hypothesized that HSI 
has further potential than binary cancer detection, as we explored in this work, and that 
different types of cancer can be identified from benign hyperplasia. Therefore, we 
performed a set of two binary classifications (MTC versus MNG, and PTC versus MNG) 
to show both can be successfully identified from MNG. In order to determine if HSI can 
detect normal thyroid and the range of thyroid neoplasms: MTC, PTC, hyperplasia, 
follicular carcinoma, adenomas, and nodules; all in one multi-class approach, more patient 
data collection and more investigation into the robustness HSI and the classifiers needs to 
be performed. 
 We acknowledge that with a limited patient set for the experiments detailed, we do 
not have a fully-independent test set and employ a leave-one-patient-out cross validation 
approach, as was reported in the results section. This approach has several limitations with 
regards to potential over-fitting from hyper-parameter tuning. However, in order to avoid 
bias, the CNN architectures and number of filters in each network were not adjusted during 
the experiments conducted. As stated, a more complex CNN design was used for SCC 
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because it was deemed a more complex problem. During the experiments, the only 
parameters that were adjusted were the learning-related parameters, which are detailed in 
the method section. These included the learning rate and the epsilon and rho of Adadelta, 
which control the decay of learning rate and gradient optimization. Importantly, the same 
learning rate, rho, and epsilon were used within each experiment type so that all cross-
validation iterations had the same hyper-parameters. We found that different experiments, 
for example HNSCC binary compared to multi-class, required different learning-based 
parameters because they trained at different rates. 
 Another potential source of errors from the cross-validation experiments was the 
effect of over-fitting during training of each cross-validation iteration, within an 
experiment type. With the relatively small sample sizes employed in this study, swapping 
one patient from the validation to training set could drastically change the training time of 
the network.  Therefore, performance of each cross-validation iteration was evaluated 
every 1,000 training steps, and different training steps for cross-validations were 
sometimes used. In the methods section, we report the range of training steps for each 
experiment type; in order to reduce bias, the same training step number was used when it 
was possible for all or most cross-validation iterations. 
 Another limitation of this work is the issue of specular glare. Glare was 
systematically removed during pre-processing, so that training patches did not contain any 
glare pixels. This was done to avoid any training biases or error that could have been 
introduced from glare. Moreover, since glare was removed from training, it was also 
removed from the testing dataset to ensure that the quantified results were unblemished by 
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glare artifacts to fully evaluate the classification potential of HSI. Regions that were not 
classified due to large amount of surface glare can be seen as grayscale in Figure 6-5.  
6.5 Conclusion 
 In summary, this chapter presented preliminary results for this proof-of-principle 
experiment, which demonstrates that an HSI-based optical biopsy method using CNNs can 
provide multi-category diagnostic information for normal head and neck tissue and thyroid 
carcinomas. Future work involves acquiring and processing more patient HSI data for these 
types of tissue and to conduct studies of more tissue types and potentially produce results 
with a more universal application. Additionally, this line of research will be important in 
determining if the proposed technique has the potential to aid surgeons, providing a wealth 





CHAPTER 7. HEAD & NECK CANCER DETECTION IN 
DIGITIZED HISTOLOGY 
 This chapter presents the development and evaluation of a computer-aided 
diagnostic algorithm with the goal of aiding surgical pathologists in the detection of cancer 
in digitized whole-slide histological images. Pathologists guide surgeons during head and 
neck cancer resection operations by performing microscopic analysis of histology slides 
made from the excised tissue. In this study, 381 digitized, histological whole-slide images 
(WSI) from 156 patients with head and neck cancer were used to train, validate, and test 
an inception-v4 convolutional neural network. The proposed method can detect and 
localize primary head and neck SCC on WSI with an AUC of 0.916 for patients in the SCC 
testing group and 0.954 for patients in the thyroid carcinoma testing group. Moreover, the 
proposed method can diagnose WSI with cancer versus normal slides with an AUC of 
0.944 and 0.995 for the SCC and thyroid carcinoma testing groups, respectively. For 
comparison, we tested the proposed, diagnostic method on a publicly-available dataset of 
WSI from sentinel lymph nodes with breast cancer metastases, CAMELYON 2016, to 
obtain patch-based cancer localization and slide-level cancer diagnoses. The experimental 
design yields a robust method with potential to help create a tool to increase efficiency and 
accuracy of pathologists detecting head and neck cancers in histological images. 
7.1 Introduction 
 Head and neck cancer is the sixth most common cancer world-wide, and majority 
of cancers of the upper aerodigestive tract are squamous cell carcinoma (SCC) [2]. 
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Approximately two-thirds of SCC patients present with either stage III or IV advanced 
disease [141]. Surgical cancer resection remains the primary management SCC of the head 
and neck, with concurrent chemotherapy or radiation therapy depending on the extent of 
the disease [4].  
 Commonly, the safe margin for surgical resection of oral squamous cell carcinoma 
(SCC) at sites including the surfaces of the lips, gums, mouth, plate, and anterior two-thirds 
of the tongue is considered 5 mm from the permanent edge of the tumor [196]. Alternative 
distances for resection margins have been proposed, as low as tumor clearance of 2.2 mm 
to be declared a “negative” margin [197]. However, closer margins, for example within 1 
mm, are associated with significantly increased recurrence rates [258]. In head and neck 
surgical histology, there are two techniques to investigate surgical margin clearance: 
perpendicular sectioning and en-face technique. Perpendicular sectioning, also known as 
“bread loafing”, allows the margin clearance from the edge of the resected tissue to be 
easily quantified, but it is resource exhaustive and limited by the number of slices, which 
can create false negatives. The en-face technique evaluates the surface area in a 
longitudinal fashion to determine if there is any cancer on surface of the submitted 
specimen [196]. Both require examining a large quantity of histological slides and 
considerable diagnostic time. 
 Previous studies have implemented computer-assisted detection methods using 
histological images for machine learning [259]. Colorectal epithelial and stromal tissues 
have been classified on histological images using support vector machines with hand-
crafted features, such as color and texture [260, 261]. Additionally, convolutional neural 
networks (CNNs), which are a family of machine learning algorithms that learn to extract 
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features from training images, have also been applied to classifying epithelium and stromal 
tissues from colorectal and breast cancers [262]. Non-small cell lung cancers, including 
metastatic SCC to the lungs, have been classified in histological images using CNNs that 
are trained to work regions of the image, called image-patches [263]. Another method for 
detecting lung cancers in histological images of needle core biopsies used morphological 
and color features for classification with an ensemble of artificial neural networks [264]. 
Head and neck SCC was investigated once before, but only in cell lines xenografted into 
mice, and a CNN was implemented with histological images to predict hypoxia of tumor-
invaded microvessels [259, 265]. Additionally, computerized methods have been 
developed for thyroid carcinomas to detect and classify malignant versus benign nuclei 
from thyroid nodules and carcinomas, including follicular and papillary thyroid 
carcinomas, in histological images on a cellular level with promising results [266-268]. 
However, most of the work involving thyroid carcinoma has been implemented on a 
cellular or nuclear level using hand-crafted features, such as texture or shape, and support-
vector-machines are employed for nuclei classification, with many algorithms using an 
ensemble of classifiers [267-271]. 
 In the field of digital pathology, whole slide imaging (WSI) refers to the acquisition 
of high-resolution images of stained tissue slides, which retains the ability to magnify and 
navigate these digital slides just as standard microscopy [272]. After reviewing nearly 
2,000 patient cases, it has been concluded that WSI is non-inferior to microscopy for 
primary diagnosis in surgical pathology across multiple staining types, specimen types, and 
organ systems [273]. Computer-assisted detection algorithms have recently been 
implemented using CNNs for diagnosis in WSI with considerable success for identifying 
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metastasis in lymph nodes [274, 275]. Several state-of-the-art methods using CNNs have 
been applied during a grand challenge hosted at the IEEE International Symposium for 
Biomedical Imaging in 2016 and 2017 to detect breast cancer metastasis in WSI of sentinel 
lymph nodes (CAMELYON) with AUCs up to 0.99, comparable to expert pathologists 
performing with an AUC of 0.81 to 0.97, with and without a time constraint [274, 276, 
277].  
 This study aims to investigate the ability of CNNs for detecting head and neck SCC 
and thyroid carcinomas in a novel dataset of digitized whole-slide histological images from 
surgical pathology. A recent literature review shows that this is the first work to investigate 
SCC and thyroid carcinoma detection on a WSI level in primary head and neck cancers 
[259], and we implement state-of-the-art classification methods in an extensive dataset 
collected from our institution. The major contribution of this paper focuses on the first 
application of deep learning for the histological detection of H&N SCC and thyroid cancers 
in a sufficiently large head and neck cancer dataset that is best suited for a patch-based 
CNN approach. The anatomical variation of the head and neck is astonishingly complex. 
The inclusion of multiple, most common locations of SCC yields a successful and 
substantial generalization for this application. Additionally, three of the major forms of 
thyroid carcinoma are studied, and despite extensive morphological differences, the 
method allows successful performance. Altogether, the dataset and applied methodology 
of this work demonstrate the current potential to create a tool to increase the efficiency and 
accuracy of surgical pathologists performing real-time SCC cancer detection on WSI for 
intraoperative guidance during primary head and neck cancer resection operations. 
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7.2  Materials and Methods 
 In this section, the materials for this study, including the cancer histological 
datasets, are described. Additionally, the methods of image processing, convolutional 
neural networks, and performance evaluation are detailed.  
7.2.1 Head and Neck Cancer Dataset 
 Informed, written consent was obtained from all patients consented for our study. 
All experimental methods were approved by the Institutional Review Board (IRB) of 
Emory University under the Head and Neck Satellite Tissue Bank (HNSB, IRB00003208) 
protocol. In collaboration with the Otolaryngology Department and the Department of 
Pathology and Laboratory Medicine at Emory University Hospital Midtown, freshly 
excised, ex-vivo head and neck cancer tissue samples were obtained from previously 
consented patients undergoing surgical cancer resection [113, 147].  Tissue specimens 
collected from patients were de-identified and coded by a clinical research coordinator 
before being released to our laboratory for research purposes only. Three tissue samples 
were collected from each patient: a sample of the tumor, a normal tissue sample, and a 
sample at the tumor-normal interface.  
 For this study, we present the first application of the histological component of this 
dataset of 381 WSI from 156 patients, which is detailed by dataset in Table 7-1. In the 
upper aerodigestive tract SCC group, there were 228 tissue samples collected from 97 
patients. The number of patients and tissue specimens is enumerated per anatomical origin 
of the SCC in Table 7-2. The only tissues that were excluded in this study were from three 
patients that had SCC of Waldeyer’s ring. These tissues were excluded because they were 
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comprised of entirely lymphoid tissue, and the samples from only 3 patients of this diverse 
tissue type was not sufficient for inclusion in this study. The normal specimens collected 
were non-dysplastic and non-cancerous, which may have inflammation, atypia, or reactive 
epithelium.  
Table 7-1. Summary of the number of patients and whole-slide images (WSI) included in 
this study for training, validation, and testing of the proposed method. 
Dataset 
Training Validation Testing Total 
Patients WSI Patients WSI Patients WSI Patients WSI 
Head & Neck SCC 45 91 13 32 39 105 97 228 
Thyroid Carcinoma 24 48 8 23 27 82 59 153 
Breast Cancer Mets. 250 250 20 20 129 129 399 399 
 The thyroid carcinoma group was comprised of primary papillary, medullary, and 
follicular thyroid carcinomas. There were 153 tissue specimens collected from 59 patients, 
which included 47 patients with papillary thyroid carcinoma, 5 patients medullary thyroid 
carcinoma, and 7 patients with follicular carcinoma. Each dataset was subdivided into 
separate groups for training, validation, and testing of the proposed computer-assisted 
cancer detection algorithm.  
 Fresh ex-vivo tissues were collected from the surgical pathology department and 
fixed, paraffin embedded, sectioned, stained with haemotoxylin and eosin (H&E), and 
digitized using whole-slide scanning at an equivalent magnification to 40x objective using 
a NanoZoomer (Hamamatsu Photonics), which produces a final digital slide with pixel-
level resolution of 0.23 μm × 0.23 μm. A board-certified pathologist with expertise in H&N 
pathology outlined the cancer margins on the digital slides using Aperio ImageScope 
(Leica Biosystems Inc, Buffalo Grove, IL, USA). 
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Table 7-2. Summary of the number of patients in the SCC dataset and WSI obtained from 
tissue specimens per anatomical location of the head and neck. Tissue specimens refer to 
the ex-vivo samples used to construct the histological WSI (T: tumor, N: normal, TN: 
tumor-normal interface). 
Location # Patients # T # N # TN 
Tongue 18 9 17 17 
FOM 12 7 10 13 
Larynx 10 10 9 3 
Mucosal 
Gingiva 
9 7 9 4 
Mandible 8 6 6 5 
Maxillary 
Sinus 
6 4 6 5 
Oral Cavity 6 4 7 6 
Hypopharynx 5 4 5 1 
RMT 5 6 3 5 
Tonsil 5 4 3 6 
Supraglottis 4 2 4 3 
BOT 4 0 4 4 
Nasal Cavity 2 2 1 0 
Other 3 2 2 3 
Total 97 Patients 228 WSI 
 
7.2.2 Breast Cancer Lymph Node Metastases Dataset 
 For external validation, we implemented the proposed cancer detection algorithm 
on the open-source CAMELYON 2016 dataset [275, 278], in order to compare the results 
of our proprietary head and neck cancer dataset since currently no similar independent 
dataset exists. The CAMELYON 2016 dataset consists of 399 whole-slide digital images 
from sentinel lymph nodes (SLN) obtained from 399 patients, one SLN from each patient 
that underwent breast cancer surgical resection. The dataset is collected at two institutions: 
Radboud University Medical Center (RUMC) Netherlands and University Medical Center 
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Utrecht (UMCU) Netherlands [275, 278]. One slide was constructed from one SLN from 
each patient. Table 7-1 shows the numbers of patients and slides in each group. 
 The whole-slide images were digitized at each institution separately, so the 
different hospitals each use a different scanner. The slides that were digitally scanned at 
RUMC were produced at 20× objective magnification using a Pannoramic 250 Flash II 
digital slide scanner (3DHISTECH), which corresponds to the pixel-level resolution of 
0.24 μm × 0.24 μm. The slides that were digitized at UMCU were acquired with a 
NanoZoomer-XR digital slide scanner at 40x objective magnification (Hamamatsu 
Photonics) with a pixel-level resolution of specimens of 0.23 μm × 0.23 μm [275, 278]. 
7.2.3 Histological Image Processing 
 The histological dataset presented consists of primary tumor specimens acquired 
from surgical resections. Our SCC and thyroid cancer datasets do not have fine cellular-
level annotations. Instead, regions were broadly marked as cancer if there were any cancer 
cells present, even if surrounded by normal structures, to establish which areas would 
require surgical removal. For this task, cell-by-cell annotations are not necessary. 
Clinicians require accurate regional diagnosis of cancer invaded tissues with an estimate 
of border clearance distance to the edge of the resected tissue. Therefore, the nature of the 
ground-truth for this work necessitates a patch-based deep learning approach. Moreover, a 
fully-convolutional network (FCN), as is widely used in the literature, would be 
problematic for this approach. Firstly, the tissue specimens of primary cancers collected 
tend to have large regions of each class. Therefore, the large majority of patches tend to be 
one class (all normal or all tumor), with few border patches that contain both classes. This 
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would create problems with loss calculation and gradient optimization for training an FCN. 
Lastly, as stated the ground truth is coarse, so if a FCN could be adequately trained to 
produce fine-level segmentations, not only are they not needed for this task, but the ground 
truth would call potentially correct areas as misclassifications. 
 A ground-truth binary mask of the cancer area is produced from each outlined 
histology slide. The WSIs and corresponding ground-truths were down-sampled by a factor 
of four using nearest neighbor interpolation. The proposed method classifies the WSI in a 
patch-based method using a window that slides over the entire image. Due to the unique 
challenges of working with digital pathology images, which can create datasets of hundreds 
of images that are each tens of gigabytes, it is the current state-of-the-art to perform both 
down-sampling and patch-based image reconstruction approaches to computationally 
handle this type of data [112, 274, 279-284]. Image patches (I) are produced from each 
down-sampled H&E slide using 101×101 pixels and are labeled corresponding to the center 
pixel, where 𝑰 ∈ ℝ101×101×3. Representative patches from H&N SCC are shown in Figure 
7-1 showing the histological variation of normal anatomical structures and various 
appearances of SCC of various identifiable difficulty. The SCC and thyroid carcinoma 
training groups were comprised of patches only from the tumor and normal tissue WSI, 
and the validation and testing groups were comprised of patches from all slides. Since the 
lymph node dataset contained more WSI but with smaller cancer areas, the training dataset 
was constructed by taking up to 5000 image patches from the cancerous area of each of the 
101 cancer WSI in the training dataset, and using up to 1000 image patches from each slide 
of the 149 normal WSI. The training group was approximately balanced between cancer 
and normal patches for better performance.  
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Figure 7-1. Histological images (101×101 pixel image-patches) showing anatomical 
diversity. Top: Patches of various normal structures, including chronic inflammation, 
stratified squamous epithelium, stroma, skeletal muscle, and salivary glands (from left to 
right). Bottom: Patches of SCC with varying histologic features: keratinizing SCC, 
keratinizing SCC with keratin pearls, basaloid SCC, SCC with chronic inflammation, SCC 
with hemorrhage (from left to right). 
 
 Histology slides have no canonical orientation, meaning the tissue will have the 
same diagnosis from all vantage points. Therefore, the number of image patches were 
augmented by 8× by applying 90-degree rotations and reflections to develop a more robust 
diagnostic method. Additionally, to establish a level of color-feature invariance and 
tolerance to differences in H&E staining between slides, the hue, saturation, brightness, 
and contrast of each patch were randomly manipulated to make a more rigorous training 
paradigm. 
7.2.4 Convolutional Neural Network Implementation 
 The three distinct cancer datasets in this study were employed to separately train, 
validate, and test a 2D-CNN classifier based on the Inception V4 architecture, implemented 
in TensorFlow on 8 Titan-XP NVIDIA GPUs [27, 192, 217, 285]. The Inception V4 CNN 
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architecture was modified slightly in the early layers, which is detailed in Table 7-3, in 
order to accommodate the patch-size selected for this study. The CNN architecture 
consisted of 3 convolutional layers and 1 max-pooling layer to accommodate the patch-
size used, and in total the CNN contained 141 convolutional layers and 18 pooling layers 
[27, 217]. Gradient optimization was performed using the Adadelta optimizer with an 
initial learning rate of 1.0 that was exponentially decayed by 0.95 every 3 epochs of training 
data [253]. The softmax cross entropy was used as the loss function. If the kth training patch 
is denoted as 𝑰𝑘 ∈ ℝ
101×101×3, 𝑘 = 1, 2, … , 𝐾, where K is the number of training patches 
in a batch, the CNN training process is to find a function 𝐹: ℝ101×101×3 → ℝ that minimize 

















𝑃 are the ground truth labels for cancer-negative and cancer-positive tissue 




Table 7-3. Schematic of the proposed modified Inception V4 CNN. The input size is given 
in each row, and the output size is the input size of the next row. All convolutions were 
performed with sigmoid activation and 40% dropout. 
Layer Kernel size / Remarks Input Size 
Conv 3×3 / ‘valid’ 101×101×3 
Conv 3×3 / ‘valid’ 98×98×32 
Max Pool 2×2 / stride=2 ‘valid’ 96×96×64 
Conv 3×3 / stride=2 ‘valid’ 48×48×64 
4 x Inception-A Block 1×1 and 3×3 / ‘same’ 23×23×80 
Reduction-A Block 1×1 and 3×3 / ‘same’ 25×25×384 
7 x Inception Block 1×1, 1×7, 7×1, and 3×3 / ‘same’ 11×11×1024 
Reduction-B Block 1×1, 1×7, 7×1, and 3×3 / ‘same’ 11×11×1024 
3 x Inception-C Block 1×1, 1×3, 3×1, and 3×3 / ‘same’ 5×5×1024 
Avg. Pool 5×5 / ‘valid’ 5×5×1536 
Linear Logits 1×1536 
Softmax Classifier 1×2 
 
 The validation groups were used to determine the optimal number of training 
epochs used for each of the three datasets. Each CNN was trained with a batch size of 128 
image patches, and batches were converted from RGB to HSV before being passed into 
the CNN. Both RGB and HSV were tested in early validation experiments, and HSV 
without any other modification out-performed RGB results. One reason could be the 
separation of the image intensity from the color information in HSV color model. 
Additionally, one major challenge of H&E stained images is inconsistency of the stain 
quality. To demonstrate that color feature augmentation can solve this problem, working 
in HSV directly, the hue, saturation, and brightness were perturbed randomly in each 
channel independently. The SCC CNN was trained for 30 epochs of training data, 
equivalent to 295,000 steps using a batch-size of 128 patches. The random color 
augmentation was using the native color feature variance in the training group: hue 4%, 
saturation 15%, brightness 8%, and contrast 2%. The thyroid carcinoma CNN was trained 
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for 70 epochs of training data (equivalent to 433,000 steps). HSV and contrast perturbation 
was 5%, 5%, 8%, and 5% respectively. The breast cancer SLN metastasis CNN was trained 
for 20 epochs (equivalent to 203,400 steps). HSV and contrast were each randomly 
perturbed in range of -10% to 10%.  
7.2.5 Image Reconstruction and Post Processing 
 Each of the 𝑁 testing slides (𝑺𝑇𝑡 , 𝑡 = 1,2, … , 𝑁) were tiled into image patches of 
size 101×101 pixels (𝑰𝑚,𝑛
𝑇𝑡 ), produced with a stride of 50 pixels, which makes an overlap of 
51 pixels. 
𝑰𝑚,𝑛
𝑇𝑡 = {𝑺𝑇𝑡(𝑥, 𝑦)|𝑚 ≤ 𝑥 ≤ 𝑚 + 100, 𝑛 ≤ 𝑦 ≤ 𝑛 + 100} 
where 𝑚 = 1,51,101, … , 𝑀𝑡, 𝑛 = 1,51,101, … , 𝑁𝑡, and 𝑀𝑡 × 𝑁𝑡 is the size of the t
th testing 
slide. Therefore, the final classified whole-slide image is a cancer probability heat-map 
with a level of detail equal to 50×50 pixel blocks. Each image patch, 𝑰𝑚,𝑛
𝑇𝑡 ∈ ℝ101×101×3, 
was classified in all 8 orientations with randomized HSV and contrast features and 











𝑇𝑡 ) is the cancer prediction for the sth orientation of 𝑰𝑚,𝑛
𝑇𝑡  and ?̅?(𝑰𝑚,𝑛
𝑇𝑡 ) ∈ [0,1] 
is the average cancer prediction of the patch. Additionally, the results of overlapping image 







𝑇𝑡 ) + ?̅?(𝑰𝑖+49,𝑗
𝑇𝑡 ) + ?̅?(𝑰𝑖,𝑗+49
𝑇𝑡 ) + ?̅?(𝑰𝑖+49,𝑗+49
𝑇𝑡 )) 
where ?̅? is the final probability of the final resolution block size (𝑯𝑖,𝑗 ∈ ℝ
50×50) of the 
heat-map. The benefit of this post-processing method was to increase the resolution of the 
heat-map from 101-pixel image patches to 50-pixel image patches. Moreover, the image 
patches that constituted the free edge of the tissue were averaged less than four times 
because they did not have the complete number of neighboring patches. This image 
reconstruction and post-processing method was determined to increase accuracy by about 
2% in early validation experiments.  
 To investigate the ability of the CNN to detect cancer on histological images, we 
implemented the gradient class-activated map (grad-CAM) method to visualize gradients 
activated by each class for the example input image patches [218]. We traced the gradients 
from the last convolutional layer before the inception modules to the logits layer to 
separately visualize cancer and normal components. This technique produces a weighted 
combination of the convolutional filters and gradients as the CNN is activated by a specific 
input image for each class. 
7.2.6 Performance Evaluation 
 The reference standard cancer margin was annotated by hand for all digital slides 
employed in this study. For the head and neck cancer database, a board-certified pathologist 
with expertise in H&N pathology outlined the cancer margins on the digital slides.  For the 
breast cancer metastasis database, an experienced lab technician and a clinical Ph.D. 
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student outlined the cancer margins, which were then confirmed by one of two board-
certified pathologists with expertise in breast cancer [278].  
 During training, the performance of the validation group was calculated and 
monitored. The optimal operating threshold was calculated from the validation group for 
generalizable results, and it was used for generating performance evaluation metrics for the 
testing group. To reduce bias in the experiment, the fully-independent testing group was 
only classified a single time at the end of the experiment, after all the network optimizing 
had been determined using the validation set. To test the ability to diagnose and localize 
cancer on WSI, we used AUC, F1 score, accuracy, sensitivity, and specificity to evaluate 
cancer detection on a patch-based level. Confidence intervals were calculated using a boot-
strapping algorithm. Additionally, the ability of the proposed algorithm to diagnose slides 
with cancer from normal slides was investigated. This slide-level AUC was calculated by 
assigning the value of the image patch with the maximum cancer probability to the entire 
WSI.  
7.3 Results 
7.3.1 Digital Whole-slide Image Cancer Detection 
 Head and neck primary SCC was detected on digitized WSI with an AUC of 0.916 
and 85% accuracy for patients in the testing group. The ideal threshold for distinguishing 
SCC from normal tissue was SCC probability of greater than 62%. Thyroid carcinoma was 
detected on digitized WSI with an AUC of 0.954 and 89% accuracy for patients in the 
testing group. The ideal threshold for distinguishing thyroid carcinoma from normal 
thyroid tissue was cancer probability of greater than 50%. Breast cancer lymph node 
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metastasis was detected on digitized WSI with an AUC of 0.967 and 93% accuracy for 
patients in the testing group. The ideal threshold for identifying metastasis in SLNs was 
cancer probability of greater than 28%. Reported in Table 7-4 are the AUC for the 
validation groups and the AUC, accuracy, sensitivity, and specificity of the testing groups.  
Table 7-4. Cancer detection results, obtained from ROC curves using all histological 
images’ patch-level statistics. Reported are the AUC for the validation group and the AUC, 
F1 score, accuracy, sensitivity, and specificity of the testing group with 95% confidence 
intervals for all values. Also shown in the right-most column is the ability of the proposed 
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 Receiver operator characteristic (ROC) curves for slide-level and patch-level 
cancer detection in the testing groups from all three datasets are shown in Figure 7-2. Patch-
level ROC curves are generated using all histological images’ patch-level data for cancer 
localization, and slide-level ROC curves demonstrate WSI diagnosis. Additionally, two 
representative WSI from each of the three testing groups and their corresponding predicted 
heat-maps are shown in Figure 7-3. Several regions of interest (ROI) are detailed in Figure 
7-4 to identify the strengths and weaknesses of the proposed method in the detection of 
SCC. The ideal threshold for whole-slide level detection of SCC was above 95% 
probability, so the regions detailed as true negatives in Figure 7-4 fall below this threshold. 
Additionally, the grad-CAM technique was used to visualize the contributing normal and 
cancerous components of a few example input images that were corrected classified with 
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high probability (Figure 7-5). This approach reveals that a contribution of the cancer 
prediction is made by nuclear features. 
 
Figure 7-2. The ROC curves are shown for patch-level cancer detection (left) and slide-
level cancer diagnosis (right) in the testing groups from all three datasets. The dotted gray 
line corresponds to random guess. 
 
Figure 7-3. Representative whole-slide classification results. (a, b) Papillary thyroid 
carcinoma WSI from two patients. (c, d) SCC WSI from patients with tongue and 
retromolar trigone SCC. (e, f) Breast cancer metastasis to lymph node WSI from two 
patients. The cancer area is outlined in green on the H&E images, and the heat maps are 




Figure 7-4. Heat maps representing cancer probability of several regions of interest. From 
left to right, the CNN correctly identifies salivary gland and muscular components as 
having a low probability of SCC; stratified squamous epithelium correctly shown as a true 
negative; a false positive area representing inflammatory infiltration near the SCC border 
(not shown); correctly classified true positive SCC classified with a high probability of 
SCC. 
 
 The ability of the proposed method to diagnose the entire WSI that contain any 
cancer was also investigated. WSIs with SCC were diagnosed with an AUC of 0.944. 
Thyroid carcinoma WSIs were diagnosed with an AUC of 0.995. WSI of SLN with breast 
cancer metastases were diagnosed with an AUC of 0.901.  
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Figure 7-5. Representative, correctly-classified cancer image-patches from each dataset, 
visualized with cancer and normal components using the grad-CAM technique. The 
gradients were traced from the last convolutional layer before the inception modules to the 
cancer and normal logits separately to visualize contributions from cancer and normal 
features leading to a correct cancer prediction. (a) Breast cancer SLN metastasis image 
patch correctly classified as cancer with 58% probability. (b) Papillary thyroid carcinoma 
image patch correctly classified as cancer with 89% probability. (c) SCC image patch 
correctly classified as cancer with 99% probability. 
7.4 Discussion 
 In this work, we present a new and extensive histological dataset of primary head 
and neck cancer and implement a state of the art Inception V4 CNN architecture for cancer 
detection and WSI diagnosis. The results are generalizable because of the division of 
patients across training, validation, and testing. To the best of our knowledge, this is the 
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first work to investigate SCC detection in digitized whole-slide histological images from 
primary head and neck cancers. 
 The digitized, whole-slide histological images were saved as TIF files with 
resolution equivalent to 40x microscopic objective. After 4x down-sampling, the image 
patches correspond to 10x objective equivalence. Different down-sampling factors and 
patch-sizes were explored, but this method yielded the best validation group results, so it 
was used for testing. Similarly, pathologists detecting SCC in histology slides use a variety 
of objectives, not exclusively 40x, which may be too zoomed-in to determine if the region 
is cancerous or benign. We see this issue in our dataset as well. It is not only possible, but 
likely that in some slides labeled as ‘tumor only’, there may be some areas inside the tissue, 
or in between tumor nests, that is entirely normal. Therefore, it is understandable that 
classification using 4x down-sampled images obtains the highest accuracy. Other CNN 
architectures were explored in early experiments using the validation set only, and various 
patch-sizes were experimented with, but ultimately the Inception V4 CNN architecture 
with a patch-size of 101×101×3 in HSV color space, yielded the most promising validation 
results. 
 Additionally, the regions of interest that are presented show true negative, false 
positive, and true positive regions that vary from 1 to 3 mm in size. These results 
demonstrate the proposed method is able to distinguish normal anatomical structures like 
epithelium and salivary gland from SCC with high probability. Also, the most common 
false positive observed in the classified result is tissue areas that contain dense 
inflammation. This result is most likely a by-product of the training paradigm. As SCC 
develops, there is an accompanying immune response that leads to massive inflammatory 
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infiltration into the tissue [286]. Therefore, the proposed algorithm learned the association 
between SCC and inflammation. 
 To our knowledge, there are no other studies that attempt to detect or diagnose 
H&N SCC or thyroid carcinoma on WSI, and we used a proprietary dataset collected from 
patients at our institution. Therefore, we wanted to test the proposed, diagnostic algorithm 
on a similar, open-source dataset for comparison. Our slide-level results would have placed 
3rd in the original CAMELYON 2016 [275, 278].  
 The grad-CAM technique was used to visualize what components of the input 
image are determined as useful features with a significant contribution to the cancer 
prediction from the CNN, as shown in Figure 7-5. This reveals that the decision is made 
by looking at the nuclei, just like a pathologist detects cancer. The proposed method does 
not segment all cancerous nuclei in the image patch, but it identifies a few cancerous nuclei 
with a high probability of being cancer and uses this information for making the decision. 
We did not train the proposed algorithm specifically with this in mind. Rather, this 
phenomenon was learned naturally by the training paradigm. The trained CNN model also 
has a level of stain invariance.  
7.5 Limitations 
 One limitation of the presented approach results from the application of the down-
sampled resolution and the patch-based Inception V4 CNN implementation. After down-
sampling, each pixel represents approximately 0.91 microns, which produces a patch size 
that spans about 92 microns in each x-y dimension for the patch size of 101×101 that was 
implemented in this approach. The typical diameter of an SCC single-cell nucleus in our 
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dataset was about 12 microns, which agrees with values reported in the literature of about 
13 +/- 2 microns [287]. Therefore, the theoretical limit of the smallest carcinoma that could 
be detected would be a nest of SCC cells with an approximate diameter of 92 microns. This 
value corresponds with an SCC nest on the order of tens of cells of SCC, depending on the 
cytoplasmic overlap in the arrangement of the SCC nest.  
 Another limitation of this approach was that the algorithm suffered from whole-
slide scanning artifacts, such as out-of-focus regions and including errors from slide 
processing, such as tissue folding and tearing. This was discovered after the completion of 
the experiment, and the effect was substantial, accounting for the reason in 
misclassification of the lowest performing WSI in the SCC testing dataset, which is shown 
in Figure 7-6. As can been in Figure 7-6, the left side of the WSI is classified correctly as 
a true positive SCC region, but the out-of-focus regions result in misclassification a similar 
ROI (shown in the cut-out boxes on the right) to be classified as false negative incorrect 
result. These misclassifications were retained in the testing dataset to not manipulate or 
bias the results, but in future work, slide scanning artifact detection should be additionally 
performed to determine which slides cannot be classified because of limited quality. 
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Figure 7-6. Representative false negative resulting from slide scanning artifacts. This 
accounts for the misclassification result of the lowest performing WSI in the SCC test 
group. The left side of the WSI was a correct true positive classification (green box), but 
the out of focus artifact results in false negative misclassification (red box). 
 Digital pathology with WSI allows pathologists to view high-resolution 
histological images, just as standard microscopy, and it was concluded that digital 
pathology is non-inferior to microscopy for primary diagnosis in surgical pathology cases 
across multiple institutions, staining types, and organ systems [272, 273]. Therefore, we 
believe the robust experimental procedure of the proposed method, designed to eliminate 
bias, has demonstrated potential benefit in a modern, digitized clinical setting. However, 
primary diagnosis of surgical specimens for intraoperative guidance is performed on 
frozen-sections rather than formalin-fixed, paraffin embedded tissues, as were investigated 
in this study. Additionally, frozen-sections are typically lower quality than those created 
from fixed, embedded specimens because they suffer from many different artifacts and 
depend heavily on the skill of the operator. Therefore, we believe the presented work 
demonstrates potential for clinical benefit, but more investigation needs to be performed. 
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Moreover, the generalization of the results beyond head and neck cancers to breast cancer 
metastasis in sentinel lymph nodes suggests this method is not limited to any organ system 
and could be adapted to serve multiple purposes if implemented in a more clinical setting.  
7.6 Conclusion 
 In summary, this chapter details the first application of deep learning for the 
histological detection of H&N SCC and thyroid cancers. The proposed method can detect 
and localize primary head and neck SCC on whole-slide, digitized histological images with 
an AUC of 0.916 for patients in the SCC testing group and 0.954 for patients in the thyroid 
carcinoma testing group. Moreover, the proposed method can discriminate WSI with 
cancer versus normal slides with an AUC of 0.944 and 0.995 for the SCC and thyroid 
carcinoma testing groups, respectively. The SCC detection method is performed across all 
anatomical locations, which indicates the algorithm is not limited to one location of the 
head and neck anatomy. For thyroid cancers, three major thyroid carcinomas are studied 
together, which additionally demonstrates the generalizability of the method. For external 
validation, we tested the proposed method on a publicly-available dataset, CAMELYON 
2016, and obtained good results. The agreement between validation and testing 
demonstrate that the technique is generalizable due to the robustness of the training 
paradigm and the careful experimental design to reduce bias. Together, the novel 
application to our dataset and promising results of this work demonstrate potential that 
such methods as the one proposed could help create a tool to increase efficiency and 
accuracy of pathologists performing head and neck cancer detection on histological slides 
for intraoperative guidance during head and neck cancer resection operations. 
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CHAPTER 8. CONCLUSION 
8.1 Summary and Key Findings 
8.1.1 Ex-vivo HSI Patient Database 
 A dataset of 204 patients with head and neck cancer was acquired (Table 8-1). 
Optical imaging was performed with HSI, autofluorescence, 2-NBDG dye, and proflavin 
dye on all the 204 patients collected for this thesis work. Digitized histological slides were 
made from all tissue specimens and annotated by a pathologist. The data were sorted into 
groups according to the patients’ medical and histological information. All imaging data 
were calibrated, processed, and registered to the ground truth with the method described in 
Chapter 3. Thus, this processed dataset was prepared for analysis within this thesis work 
and can be used for future studies in HSI using this same dataset by other researchers. 
Table 8-1. Summary of patient dataset acquired for this thesis. 
HNSCC (Chapter 4)  Thyroid (Chapter 5)  
SCC, Conventional 85 Thyroid, Papillary Carc. 54 
SCC, HPV+ (p16+) 13 Thyroid, Follicular 13 
SCC, Basaloid 1 Thyroid, Medullary Carc. 5 
SCC, Neuroendocrine 1 Thyroid, Insular Carc. 1 
SCC, Spindle Cell 1 Thyroid, Poorly Diff. Carc. 3 
Adenosquamous Carcinoma 1 Thyroid, Benign Goiter 6 
Total 102 Total 82 
    
Other (Not used)  Salivary Glands (Chapter 5)  
Spindle Cell Carcinoma 1 Pleomorphic Adenoma 2 
Osteosarcoma 1 Mucoepidermoid Carcinoma 1 
Reactive Tonsil 1 Salivary Duct Carcinoma 1 
Lymph Nodes 1 Polymorphous LG Adenoma 1 
Lung Adenocarcinoma 1 Adenoid Cystic Carcinoma 1 
Jugular Vein SCC Metastasis 1 Total 6 
Incomplete Information 8   
Total 14   
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8.1.2 Cancer Detection with HSI 
This thesis work focused on the use of deep learning, particularly deep CNNs for 
cancer detection using HSI input. As discussed in Chapter 3, the rationale of the selection 
was that CNNs can tolerate variance in the training data, learn generalizable features, can 
be deployed in seconds after the model is fully-trained, and have demonstrated superior 
performance to traditional, regression-based machine learning methods since CNNs utilize 
non-linear activations. In the ML methods compared in this thesis, both spectral only and 
spectral-spatial methods that utilized traditional regression-based ML were tested, and it 
was observed that the CNN could outperform them, particularly when using a large training 
group. However, the experiments comparing different ML algorithms were intentionally 
limited in number and performed on a subset of the patients to reduce the substantial bias 
that could arise from “over-testing” with our only large dataset.  
 In Chapter 4, we reported on the investigation of deep CNNs for SCC detection and 
the performance of label-free, reflectance-based HSI and autofluorescence imaging in 293 
tissue specimens from 102 patients, comparing with fluorescent dyes. The inter-patient 
experiments showed that reflectance-based HSI and autofluorescence imaging 
outperformed proflavin dye and standard RGB images (p<0.05) for conventional SCC 
detection. Up to 2 mm near the cancer margin, in specimens from the larynx, oropharynx, 
and nasal cavity, HSI detected conventional SCC with 0.85–0.95 AUC score. In the oral 
cavity, hypopharynx, and maxillary sinus, HSI detected conventional SCC with around 
0.80 AUC score. The tongue specimens were the worst performing location for SCC 
detection using HSI, around 0.65 AUC score, which may be a result of myoglobin 
absorption signals interfering with the hemoglobin absorption signal that the CNN uses for 
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prediction. These results confirmed the hypothesis that HSI would outperform other 
imaging modalities for conventional type SCC. In HPV+ SCC, autofluorescence imaging 
detected in tonsillar tissue with 0.91 AUC score, outperforming other modalities. This 
study demonstrates that label-free, reflectance-based HSI and autofluorescence imaging 
methods can accurately detect the cancer margin in ex-vivo specimens within minutes, 
which could aid surgeons and reduce inadequate surgical margins during SCC resections. 
 In Chapter 5, we reported on the use of CNNs for thyroid and salivary gland tumor 
detection with HSI and autofluorescence imaging in 216 tissue specimens from 82 patients, 
comparing with fluorescent dyes. For thyroid tumor detection, with average and median 
AUC scores of 0.86 and 0.95, HSI outperformed autofluorescence, 2-NBDG, and proflavin 
dyes, thus confirming the initial hypothesis. However, we observed an unexpected result. 
Additionally, HSI was used to synthesize three-band RGB multiplex images to represent 
the human-eye response and Gaussian RGBs. The average and median AUC scores of 0.90 
and 0.96 results for human-eye HSI-synthesized RGB images significantly outperformed 
HSI (p<0.05). In salivary gland tumors, HSI had the best performance for parotid gland 
tumors with 0.92 AUC score, and autofluorescence had the best performance for other 
salivary glands (0.80 AUC score). This study demonstrates that HSI could aid surgeons 
and pathologists in detecting tumors of the thyroid and salivary glands. 
A major contribution of this work was to provide a solution to the specular glare 
problem, shown in Chapters 4 and 5. Previously, one major limitation of HS acquisitions 
of wet tissue surfaces was creating specular glare from perfect reflections, which contain 
no useful information for diagnosis and confound ML classifiers. When using a very large 
number of tissues for training, the CNN methods demonstrated in both SCC and thyroid 
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cancers to be invariant or agnostic to specular glare with HSI, compared to RGB imaging 
methods, which was very susceptible to glare-induced misclassifications. Originally, 
specular glare was believed to be a large confounding factor with tissue classification, even 
in deep learning, but it was discovered that training a very deep CNN (hundreds of layers) 
with a large number of HSI tissue specimens (here several hundred) could solve the glare 
issue. 
8.1.3 Tissue Sub-component Classification using HSI 
 In Chapter 6, we reported sub-component classification of normal aerodigestive 
tract tissues into skeletal muscle, salivary glands, and stratified squamous epithelium. 
Additionally, the ability of HSI to discriminant benign hyperplasia / goiter from two kinds 
of thyroid carcinoma was investigated. This chapter presented proof-of-principle results 
with limited patient sample size experiments to study the ability HSI to provide multi-
category diagnostic information for normal head and neck tissue and thyroid carcinomas.  
8.1.4 Cancer Detection on Histology Slides 
 In Chapter 7, we reported on the use of deep learning algorithms for cancer 
detection in RGB digitized whole-slide histology imaging using the histological specimens 
acquired in our database. The rationale for this investigation is that during operations, 
pathologists guide surgeons by detecting cancer in histology slides made from the excised 
tissue. We reported on the results of automated cancer detection in 381 digitized, 
histological whole-slide images (WSI) from 156 patients with head and neck cancer, using 
CNNs. The proposed method demonstrated ability to detect and localize head and neck 
SCC in WSI with an AUC score of 0.92 and with 0.95 AUC score for thyroid carcinoma. 
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Moreover, we reported that simplifying the task to determine if the slide has any cancer 
resulted in AUC scores of 0.94 and 0.99 for the SCC and thyroid carcinoma cohorts, 
respectively. The experimental design yields a robust method with potential to help create 
a tool to increase efficiency and accuracy of pathologists detecting head and neck cancers 
in histological images. 
 
8.2 Limitations 
One of the major limitations that should be discussed first is that the tissue specimens 
collected for this study were excised, ex-vivo specimens. This imposes restrictions for two 
main reasons: (1) the imaging acquisition settings are ideal, and (2) the ability of ex-vivo 
cancer detection is not necessarily equivalent to in-vivo detection. The HSI system used in 
this work was intended for small animal studies and ex-vivo tissues samples. Tissues were 
imaged in a black box with ideal illumination conditions, focusing, and no motion artifacts. 
Acquiring in-vivo HSI creates all of these issues commonly [168].  Additionally, in Chapter 
4, we demonstrated that the oxy-hemoglobin signal is the most salient spectral component 
for the CNN to extract strong gradients that enable correct cancer prediction. In ex-vivo 
tissues, all hemoglobin will be oxygenated, which creates a distinct absorption profile from 
deoxygenated hemoglobin [288], which may be found more abundantly in in-vivo 
acquisitions.  
The metabolism of cancer has a well-studied change, called the Warburg effect, 
which states that cancer tends to prefer metabolism with glycolysis instead of the normal, 
efficient oxidative phosphorylation pathway [289]. The relative tissue compositions of key 
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molecules, such as pyruvate (the final product of glycolysis), oxidized and reduced FAD 
and NAD, with spectral signatures in the range of the VNIR acquired for this study, may 
yield differences in-vivo compared to ex-vivo. This change could lead to in-vivo 
observations that could confound or enhance the ability of HSI for cancer detection. As 
discussed, our ex-vivo results found oxy-hemoglobin to be the most significant feature for 
deep learning-based predictions. In the literature on diffuse spectroscopy of breast cancer 
using in-vivo acquisitions, it was demonstrated that both oxy- and deoxy-hemoglobin 
increase significantly in cancer compared to normal tissue, but the deoxy-hemoglobin 
signal was more predictive [290]. Therefore, by extension, not only will the spectral 
signature likely change moving from ex-vivo to in-vivo, but the most significant spectral 
features may also change. 
The ex-vivo HSI acquisition system used for this study employed a LCTF for 
separating spectral bands, which may have limited the performance of this study. The 
resolution between spectral bands was only 5 nm, which produced a coarse spectral 
signature, but allowed for very high spatial resolution. Currently, systems, such as the snap-
scan system, are able to capture very high-quality spectral signatures, with spectral 
resolution around 1-2 nm, and spatial resolutions that are beyond or equivalent the 1040 
by 1392 pixels used for this thesis work. These evolving technologies allow for fast 
acquisitions that will hopefully limit motion artifacts. Additionally, these systems are easy 
to focus and more compact, which are two key components necessary for clinical 
translation.  
The deep learning-based computer-aided diagnostic algorithm for histological 
images presented in Chapter 7 demonstrated successful performance in head and neck 
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SCC, thyroid carcinomas, and breast cancer metastasis to lymph nodes. Cancer was 
detected in whole-slide images with pixel-level resolution, which suggests that there is 
clinical value is exploring these methods further. However, there were several notable 
limitations. Firstly, inspecting the theoretical limit of the proposed method, cancer was 
detectable down to micro-carcinomas with diameter of 92 microns, which may not be 
sufficient for all use cases. Second, the algorithm performance suffered significantly at 
instances of slide scanning artifacts, such as out-of-focus regions, and errors from slide 
processing, such as tissue folding and tearing. 
The deep learning methods used for cancer detection with HSI for this thesis were 
tested on our dataset, which contained many samples from many sites, but was obtained 
from a single institution with a single HS acquisition system. The methods presented here 
for both HSI and digital histology must be rigorously investigated on large patient 
populations from multiple institutions and using different HS cameras and slide scanners. 
Deep learning systems are ideal for HSI-based detection because they can be rapidly 
deployed once fully-trained. Therefore, additionally, a streamlined user interface should be 
designed for straight-forward HS acquisitions, deployment, and prediction maps that can 
be easily interpreted by clinicians. 
 
8.3 Future Work 
The future research in the field of medical HSI should be directed in the following 
areas: more in-vivo patient acquisitions, fine tuning machine learning diagnostic programs, 
developing better HS acquisition systems, and user-friendly deployment systems. 
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8.3.1 In-vivo HSI Acquisition 
This thesis has both reviewed current works in the literature and presented the use 
of HSI and optical imaging for a comprehensive and large 204 patient ex-vivo tissue 
specimen dataset. Future work of this thesis work on head and neck cancer involves the 
extension from ex-vivo imaging with tissue specimens to in-vivo intraoperative 
acquisitions of human patients. There are challenges, both known and unknown, in moving 
from the former to the latter. Once the new in-vivo data is acquired, it should be 
investigated if an algorithm trained on ex-vivo data, such as presented in Chapter 4 and 5, 
can be generalizable enough to apply to in-vivo data for testing. Additionally, it should be 
investigated if the ex-vivo data can serve as pre-training or transfer learning for deep 
learning methods to initiate weights, which would allow fine-tuning of the models with a 
lower learning rate, which can be achieved using a limited number of patient HS images. 
Therefore, even with a smaller number of in-vivo acquisitions, the work presented in this 
thesis using ex-vivo HSI from 204 patients will be utilized for clinical and translational 
purposes.  
Alternatively, if there is a delay with in-vivo acquisitions during routine clinical 
surgical service, it would be possible to obtain human cadaveric in-situ acquisitions to 
establish geometry and lighting challenges and test transfer learning from ex-vivo deep 
learning models. More acquisitions are required to determine the clinical viability of HSI 
for surgical guidance, as ex-vivo alone does not provide enough information since the 
acquisition protocols are in ideal circumstances. Another avenue of exploration is to 
determine if a single predictive model for an entire organ system, such as all sub-locations 
head and neck in Chapter 4 or all thyroid tumor types in Chapter 5, can be sustainable and 
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reliable. If not, it would require investigation into subcategorizing and re-training the 
cancer predictive models to obtain, for example, one model for oral cancers, one model for 
laryngeal cancers and so on. However, since deep learning allows meaningful feature 
extraction and learning from large and varied datasets, we hypothesize that a broad organ 
system approach as was implemented will be proven to be acceptable. 
8.3.2 Emerging HSI Technology 
 While the use of HSI for clinical application is still in its adolescence, the 
development of new and emerging HSI will undoubtedly help accelerate the translation. 
Firstly, as described above, the HS cameras are becoming higher quality, both in spatial 
and spectral resolution, with faster acquisitions. However, currently a specific HS camera 
is needed for a specific window of the electromagnetic spectrum, such as visible, VNIR, 
NIR, or SWIR. The development of HS cameras that acquire shorter wavelengths than 
visible light (below 400 nm) needs to be established to allow for spectroscopy of signals 
like NAD and keratin, which are less than 350 nm. Additionally, extending the signal of 
HS cameras beyond 1000 nm for these same cameras would greatly help clinical utility. 
The depth penetration of NIR light is up to tens of millimeters, which is significantly deeper 
than shorter UV and visible light, which ranges from one-tenth to only a few millimeters.  
In a clinical scenario, it is challenging and unrealistic to expect multiple 
acquisitions on multiple HS cameras in the operating room, so this process needs to be 
streamlined into one HS camera. Additionally, the computer aided diagnostic programs 
need to be packaged in operator friendly interfaces. The current acquisition programs and 
computer diagnostic programs for surgical guidance are cumbersome and finicky without 
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expert knowledge, which would stall adoption. The hurdles to both HS acquisition and 
deployment need to be addressed. If this happens, the wealth of HS data that can be 
captured could lead to better performance and accuracy across more types of cancer in 
other organ systems as well. 
8.3.3 Computer-Aided Histology Detection 
Current practice for pathological consultation during head and neck surgeries 
involves processing specimens using frozen-sections and standard microscopy. A recent 
study found that digital pathology, navigating digital images of slides in a fashion 
equivalent to standard microscopy, was non-inferior for primary diagnosis [273]. 
Therefore, if pathologists and surgeons adopt digital histology for making diagnoses, the 
deep learning models developed in this thesis in Chapter 7 could aid in the clinical 
workflow with quantitative cancer detection. On the other hand, even if pathologists do not 
adopt digitized slides for reading, for example because it adds time, microscopes are being 
developed that scan simultaneously and seamlessly without interrupting standard 
pathology workflows to instantly detect cancer in the microscope field of view and apply 
an augmented reality overlay for cancer visualization [291].  
The wealth of histological data available to clinics can be utilized for training 
models with reduced expert annotations. Specifically, training deep learning approaches 
can be automated even for training, without requiring human pathologist annotations, 
simply needing one label per slide [292]. Reducing the work needed by expert pathologists 
could make it possible to create a training dataset with tens of thousands of slides from 
multiple institutions. Therefore, to make the translational leap from proof-of-concept to 
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improving surgical pathologists’ clinical workflow, thousands of slides should be made 
available for training and more research should be conducted to these new digital 
microscopy methods. 
8.3.4 Summary of Future Research Directions 
 In conclusion, several future research steps are outlined, which are necessary for 
the clinical translation of hyperspectral imaging: testing of new and emerging HS cameras 
for better acquisition systems, collecting cadaveric or in-vivo HS acquisitions, exploring 
how this affects CNN-based deep learning algorithms, rigorously investigating on large 
patient populations from multiple institutions, and streamlining the deployment of these 
systems clinically. Additionally, future steps needed for translation of deep learning for 
assisting surgical pathologists are outlined.  However, the methods developed and 
presented in this thesis are not exclusive to HSI or histological imaging, and this work can 
be of value to any aspiring optical imaging modality for translation surgical guidance. 
Indeed, it is possible that future and emerging optical imaging modalities currently under 
investigation by the scientific community could be combined with the methods developed 
in this thesis to offer equivalent or superior cancer detections abilities for guiding surgeons 
in the operating room.  
 189 
APPENDIX A. HISTOLOGICAL GRADING OF SCC USING 
HYPERSPECTRAL IMAGING 
 In this appendix section, we explore the predictive ability of HSI beyond cancer 
detection to investigate the use HSI for predicting histological SCC grade. Histological 
grading of SCC of the head and neck has been correlated with disease prognosis and patient 
survival. SCC is graded from well, moderately, to poorly differentiated (grades 1, 2, and 3, 
respectively). The objective of this project is to determine the ability of label-free, non-
contact HSI for predicting histological grade of SCC in gross-level ex-vivo tissue 
specimens. Using tissue specimens from patients with known histological grade from the 
head and neck SCC dataset (N=56 patients, N=73 tissue specimens), we trained a CNN to 
predict the SCC grade. Validation and testing was performed on 22 tissues specimens from 
15 fully-independent patients to determine performance. Overall accuracy for predicted 
grade of tissue specimens was 67% and 60%, which is significantly higher than randomly 
guessing SCC grade (33%). Agreement, measured with Cohen’s kappa statistic, was 0.50 
and 0.44, indicating a fair to moderate agreement. The inter-reader reproducibility of SCC 
grading is about 0.60 in the literature. The preliminary results of this work show that HSI 
may hold potential for automatic grading of head and neck SCC of gross-level tissue 
specimens. This work warrants future investigation into the comparison of the automated 
methods as performed with digitized histology of the same specimens to determine the 
agreement of grade predictive algorithms with different imaging modalities. 
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A.1     Introduction 
 Label-free HSI is a non-contact, non-ionizing, optical imaging modality that 
acquires a sequence of two-dimensional images over discrete wavelengths (2-5 mm) in a 
broadband electromagnetic spectrum, typically from 400 to 900 nm [14, 211]. Originally 
implemented in biomedical imaging for calculating vascularization and hemoglobin 
saturation, HSI has been recently applied to cancer detection, in multiple areas, including 
brain cancer and head and neck cancer [113, 166, 169, 179].  
 Head and neck cancer is the sixth most common cancer worldwide, and surgery 
remains the well-established standard treatment. Recurrence rates for cancer after surgical 
resection are largely dependent on negative, cancer-free surgical margins, along with 
several factors that cannot be controlled, such as histological cancer grade and staging of 
the cancers [293, 294]. Nearly two-thirds of patients with head and neck SCC present with 
advanced, late stage disease. 
 The histological grade of head and neck SCC has been studied as an independent 
prognostic factor in Cox's multivariate survival analysis (p <0.01) [293]. Several studies 
have calculated the inter-pathologist agreement for determining histological SCC grading, 
with Cohen kappa values of agreement ranging from 0.60 to 0.64 [293, 295, 296]. 
Therefore, current practice, which involves performing histological preparation of ex-vivo 
tissue specimens/biopsies, only yields moderate inter-rater agreement. We hypothesize that 
deep learning can provide an automated tool to improve SCC grading, with potential to 
provide clinically relevant information in-vivo and in-situ using non-contact optical 
imaging. Previously in the literature, similar studies have been performed to predict 
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histological grade of other cancer types with other imaging modalities, such as MRI and 
digitized histology, with acceptable values of correlation agreements [111, 297, 298]. 
 The objective of this project is to determine the ability of label-free, non-contact 
HSI for automatically predicting the histological grade of SCC in gross-level, ex-vivo tissue 
specimens using deep convolutional neural networks. The preliminary results of this work 
suggest that the combination of HSI and deep learning has the potential to produce near 
real-time SCC grading labelling, and future investigation is warranted. 
A.2     Materials and Methods 
 Patients with head and neck squamous cell carcinoma (SCC) were recruited for this 
study after written and informed consent, conducted at Emory University School of 
Medicine, in collaboration with the Emory University Hospital Midtown (EUHM) 
departments of surgical pathology and otolaryngology [33, 113, 179]. Patient information 
was de-identified by a research coordinator at EUHM. For this investigation, we included 
only specimens of conventional, keratinizing SCC without HPV, all histological grades 
from well to poorly differentiated, and acquired tissue specimens of both the primary 
cancer and the tumor-involved cancer margin. The size of tissue specimens was 
approximately 10 mm in width and from 10 to 20 mm in height, by 2 to 3 mm in depth. 
Tissue specimens were acquired for research purposes from the surgical pathology 
department after being grossly examined, and the remaining tissue was used for the clinical 
pathology service.  
 The ex-vivo tissue specimens were imaged with HSI at an off-site imaging 
laboratory, after being transported in cold, buffered saline solution. After optical imaging, 
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specimens were fixed in formalin, paraffin embedded, microtome sectioned, and 
underwent H&E staining to produce histological glass slides. The H&E slides were used 
to obtain the ground truth for the gross, ex-vivo tissue specimens [33, 113, 179]. For 
specimens of the tumor-involved cancer margin, the cancerous SCC area was segmented 
and registered according to a previously reported protocol [184]. The histological ground 
truth was annotated by a board-certified pathologist with expertise in head and neck SCC. 
 This SCC grading study included 73 conventional SCC tissue specimens from all 
56 patients undergoing surgical SCC resection with histological grade. The origin sites for 
the primary cancer were from the upper aerodigestive tract. A summary of the SCC grades 
and groups is shown in Table A-1. Because of insufficient tissue size to perform image 
patch making, described below, 10 tissue specimens were excluded from this study: not 
reported in Table A-1. The histological grade of SCC differentiation was obtained from the 
de-identified pathology report used for EUHM clinical service. There was a relative excess 
of grade 2 compared to 1 and 3, so only one primary cancer specimen was used from each 
patient with grade 2, moderately differentiated SCC.  
Table A-1. Head and neck SCC data and samples, organized by histological grade of 
differentiation. Groups are shown as number of tissue specimens (number of patients). 
SCC Histological Grade Train Validation Test Total 
Well-differentiated (G1) 7 (4) 2 (1) 2 (1) 11 (6) 
Moderately differentiated (G2) 30 (28) 5 (4) 4 (4) 39 (36) 
Poorly differentiated (G3) 14 (9) 5 (3) 4 (2) 23 (14) 
Total 51 (41) 12 (8) 10 (7) 73 (56) 
 
 193 
 Hyperspectral images were acquired using a Maestro imaging system (Perkin 
Elmer Inc., Waltham, Massachusetts). The imaging system consists of a Xenon white-light 
illumination source, a liquid crystal tunable filter to separate spectral bands, and a 16-bit 
charge-coupled device that acquires high-resolution images, 1,040 by 1,392 pixels, with a 
specimen-level resolution of approximately 25 microns per pixel [33, 113, 179]. The HSI 
were captured throughout the broad-band spectral range from 450 to 900 nm in 5 nm 
spectral increments, producing a hypercube with 91 spectral bands. The HSI data was 
calibrated and normalized using a standardized white reference disk and subtracting the 
inherent dark current of the sensor to obtain arbitrary units of reflectance [33, 113, 179]. 
There was substantial specular glare on some tissue specimens; this was left intact in the 
HSI, but reflectance values were capped at an intensity of 1. 
 To perform automatic SCC grading into three categories using HSI, a convolutional 
neural network (CNN) was used to train and classify the 3 SCC grades, validated on 12 
tissues from 8 patients, and tested on 10 tissues from 7 patients to determine final 
performance. The CNN was implemented in TensorFlow [192] in Python on an Ubuntu 
machine with an i5 processor and NVIDIA Titan-XP GPU. The CNN architecture was 
originally inspired by the Inception-V4 CNN [217], but substantial modifications were 
made and squeeze-and-excitation modules were added. The input for the CNN was 3D HSI 
patches of size 101×101×91 (height, width, spectral bands). Patches were augmented by 
flips and rotations to be balanced across the three classes.  
 The CNN architecture was customized due to the uniqueness of the HSI input data 
and differing patch size from the original Inception-V4 architecture [217]. The customized 
CNN consisted of two convolutional layers, one max-pooling layer, and a final strided 
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convolutional layer with dropout to reduce the size to 25×25 before the inception modules. 
Only one inception-v4 A module was used, followed by 3 squeeze-and-excitation layers, 
before the reduction A module. One inception-v4 B module was used, followed by 6 
squeeze-and-excitation layers, before the reduction B module. Lastly, one inception-v4 C 
module was used, followed by 2 squeeze-and-excitation layers, which was output to the 
logits by global average pooling. The adaptive delta gradient descent optimizer, AdaDelta, 
used to for training and weight optimization. The CNN was trained for 35 epochs of 
training data, using a batch size of 24 and learning rate of 0.01. The validation performance 
of all validation patches was calculated every 5 epochs, and training was stopped when 
patch-level performance peaked. The training time for one epoch was about 2 hours, and 
performing the testing on a series of patches was on the order of tens of seconds. After 
stopping training, tissue-level validation performance was calculated by taking the 
maximum probability of belonging to a SCC grade across all patches produced from a 
tissue and assigning that grade label to the entire tissue. Assigning tissue-level SCC grade 
using the maximum probability of all patches was also used for testing results. The 
rationale for this technique is that SCC grade is determined by the most aggressive grade 
present in a cancer specimen; therefore, it does not have to be uniform across and entire 
cancer tissue. 
 The CNN classification performance was evaluated using an external validation 
group and a fully-independent testing group of tissue specimens and patients. To evaluate 
the performance, the metrics of tissue level percent accuracy, Cohen’s kappa statistic, and 
predictive probability were implemented. Cohen’s kappa statistic (κ) for is a commonly 
used metric for determining agreement or concordance in ranking tasks, and the kappa 
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values ranges from [-1, +1], where 0 corresponds to randomly guessing. The predictive 
probability (Pk) was selected because it converges to area under the curve (AUC) for 
binary, continuous problems, so it offers relatability [299]. Values for predictive 
probability range from 0 to 1, where 0.5 corresponds to randomly guessing, just like AUC 
values. 
 The labels for the training data and the labels for the validation and testing groups 
was the SCC grade obtained from the EUHM clinical service. It is possible that there is 
some uncertainty in the grade labels because the labels were obtained from the entire 
clinical service gross tissue, not only the small specimens used for this research study. 
Additionally, there may be some inter-reader variability in the SCC grades labelled. 
A.3     Results and Discussion 
 The overall multiclass performance on a tissue level for the validation group was 
67% accuracy, 0.81 predictive probability, and a Cohen’s kappa of 0.50 agreement. Within 
the validation group, one out of two grade 1 SCC were predicted correctly, with one 
incorrectly predicted as grade 2. Four out of five, grade 2 were predicted correctly, with 
one incorrectly predicted as grade 1. Three out of five, grade 3 were predicted correctly, 
with two incorrectly predicted as grade 1.  
 The tissue level multiclass performance for the testing group (10 tissues from 7 
patients) was 60% accuracy, 0.70 predictive probability, and a Cohen’s kappa of 0.44 
agreement. One out of two grade 1 SCC were predicted correctly, with one incorrectly 
predicted as grade 2. All four grade 2 were predicted correctly. One out of four, grade 3 
 196 
were predicted correctly, with three incorrectly predicted as grade 1. Table A-2 shows the 
summarized results for validation and testing groups. 
Table A-2. Performance of HSI using CNN for automatic SCC grading, reported with 
predictive probability (Pk), percent accuracy, and Cohen’s kappa (κ) calculated on a tissue 
specimen level. 
HSI vs. Clinical Service Tissues (Patients) Pk Acc. κ 
Validation 12 (8) 0.81 67% 0.50 
Testing 10 (7) 0.70 60% 0.44 
 
 According to interpretation values for kappa, the validation and testing results 
represent fair to moderate agreement (0.44-0.50), while the inter-rater agreement represents 
borderline moderate to substantial agreement (0.60-0.64) [300]. This indicates that the 
results are promising, but the CNN training could benefit from more patient data, 
particularly grades 1 and 3, where we did not have enough samples. In the literature, 
automated histological grade has been performed directly using digitized histology with 
high kappas for different cancers: prostate cancer (0.71-0.75) [301], lung cancer (0.53) 
[284], and breast cancer (0.64) [302]. It is evident that maximum agreement, even using 
histology directly, differs by cancer type. Our results comparatively range from 0.44 to 
0.50 and use gross-level tissue information only.  
 There a several limitations of this study. Firstly, due to a limited sample size, the 
statistical power of the results cannot be confidently stated. Moreover, with the limited 
number of specimens for grade 1 and 3, it can be seen that our proposed CNN method may 
be prone to over-predicting grade 2 carcinoma. Because of the over-abundance of grade 2 
tissue specimens, it was possible to only use specimens of the primary tumor for grade 2. 
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However, grade 1 and 3 required including both primary tumor tissues and cancer-involved 
margin tissues that need to be registered and have the normal components segmented out.  
 It is possible that there could be disagreement between independent pathologist 
graders for SCC, as the literature suggests. With only one set of SCC grades for this study, 
we cannot identify the bounds of grade ranking disagreement for this sample size. A 
potential reason for the disagreement in SCC grading of the HSI predicted labels and the 
results of the EUHM clinical service could be that the tissue specimens acquired were not 
the exact grade of the entire gross-level tissue removed. This would confound the results 
and yield artificially lower evaluation metrics. The solution to this problem would be 
having several independent pathologist graders assign scores to the testing and validation 
groups for comparison. Nonetheless, the promising preliminary results demonstrate fair 
agreement of HSI predicted grade and pathologist assigned SCC grade. 
 We consider this study to be innovative because it designs and validates a 
quantitative, non-contact, and label-free approach for determining histological grade using 
optical imaging and deep learning. This method could have potential in helping surgeons 
and pathologist identify the aggressiveness of SCC either in the operating room or in the 
surgical pathology department without the need for histological sample preparation. The 
promising preliminary results warrant future investigation into the comparison of the 
automated methods as performed with digitized histology of the same specimens. 
A.4     Conclusion 
 In conclusion, this addendum section reports the preliminary results from HSI for 
automatically predicting SCC grade of head and neck gross-level tissue specimens. This 
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work is the first of its kind to explore HSI for the automatic grading of SCC gross tissues, 
and predictions from the proposed HSI and CNN method agree with the SCC grade from 
clinical service to a fair to moderate degree. The clinical problem of SCC grading is a 
challenging task with only moderate inter-rater agreement. This warrants future 
investigation into the comparison of the automated methods performed with digitized 
histology of the same specimens to determine the agreement of grade predictive algorithms 
with different imaging modalities. This addendum to the thesis work further demonstrates 
the potential of HSI for clinical application. 
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